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Abstract 
The hippocampus is a brain region involved in the creation of certain 
types of memory. The work that contributes to this thesis concerns 
molecular biological investigations into the functioning of this region 
and can be divided into two parts. 
Firstly, the analysis of genes which are restricted in expression to the 
hippocampus would not only go some way to explain the functional 
characteristics of this region, but would also provide genetic elements 
capable of directing spatially restricted expression of transgenes for the 
purpose of informatively perturbing the formation of memory. A variety 
of techniques such as degenerate PCR and subtractive hybridisation 
were therefore applied in an attempt to identify such transcripts. While 
two novel genes were cloned together with several exhibiting 
hippocampus-enrichment, none were exclusively expressed in this 
tissue. 
Secondly, temporary amnesia occurs in patients who have undergone 
electroconvulsive therapy as a treatment for severe depression. One 
potential explanation for this is a saturation of the synaptic plasticity that 
may underlie memory (known as long-term potentiation, or LTP). A 
subtractive hybridisation technique has been applied to a rat model of 
this treatment to investigate the possibility that the occlusion of LTP is 
maintained by long-term changes in hippocampus gene expression; 
induced gene expression may also be responsible for the anti-depressive 
effects of this treatment. 
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Glossary of Terms and Abbreviations 
Chemicals 
EDTA Ethylenediaminetetraacetic acid 
EGTA Ethylene glycol bis (-aminoethyl ether)-N,N,N',N'- 
tetraacetic acid 
PEG Polyethylene glycol 
NAD Nicotinamide-adenine dinucleotide 
SDS Sodium dodecyl sulphate 
TRIS Tris(hydroxymethyl)methylamine 
DEPC Diethyl pyrocarbonate 
Measurements 
cm Centimetre 
mm Millimetre 
g Gram 
jig Microgram 
1 Litre 
ml Millilitre 
gl Microlitre 
S Second 
min Minute 
hr Hour 
A Ampere (current) 
V Volt (potential) 
Ohm (resistance) 
°C Degree Celsius 
M Molar 
mm Millimolar 
jiM Micromolar 
cpm Counts per minute 
Ci Curie (lCi=37 GBq, 1 Bq=60 dpm) 
Bq Becquerel 
dpm Disintegrations per minute 
Hz Hertz (cycles per second) 
g Acceleration due to gravity 
OD Optical density 
A Absorbance 
Tm Nucleic acid hybrid melting temperature 
DNA 
A Adenosine 
C Cytidine 
Vi 
G Guanosine 
T Thymidine 
U Uridine 
I Inosine 
DNA Deoxyribonucleic acid 
RNA Ribonucleic acid 
mRNA Messenger RNA 
cDNA Complementary DNA 
rRNA Ribosomal RNA 
RNase Ribonuclease 
DNase Deoxyribonuclease 
Poly A Polyadenylate 
dNTP Deoxy nucleotide triphosphate 
NTP Nucleotide triphosphate 
(d)(A/T/C/G)(T/D)P (Deoxy)(base)(trildi)phosphate 
cAMP Cyclic adenosine monophosphate 
nt Nucleotide(s) 
bp Base pair(s) 
kb Kilobase(s) 
aa Amino acid(s) 
ORF Open reading frame 
Neurobiology 
PCR Polymerase chain reaction 
RT Reverse transcript(ion/ase) 
Taq Taq polymerase (heat-stable DNA polymerase) 
CCLS Chemical cross-linking subtraction 
CNS Central nervous sytem 
LTP Long-term potentiation 
LTD Long-term depression 
STP Short-term potentiation 
PPF Paired-pulse facilitation 
PTP Post-tetanic potentiation 
ECS Electroconvulsive stimulation 
ECT Electroconvulsive therapy 
LTM Long-term memory 
STM Short-term memory 
MTL Medial temporal lobe 
NO Nitric oxide 
CO Carbon monoxide 
AA Arachidinic acid 
PAF Platelet-activating factor 
NMDA N-methyl-D-aspartate 
AMPA a-Amino-3-hydroxy-5-methylisoxasole-4-propionate 
KA Kainic acid 
5-HT 5-hydroxy tryptamine/Serotonin 
1P3 
GPCR 
Inositol triphosphate 
G protein-coupled receptor 
mGluR Metabotropic glutamate receptor 
Get G protein a subunit 
PTP Protein tyrosine phosphatase 
FN III Fibronec tin type III domain 
Ig Immunoglobulin-like domain 
Vii 
CREB cAMP response element-binding protein 
PKC Protein kinase C 
PLA2 Phospholipase A2 
PLC Phospholipase C 
CAMK II Calcium-calmodulin-dependent protein kinase II 
TM Transmembrane domain 
CCLS Chemical cross-linking subtraction 
DZQ Diaziridinylbenzoquinine 
RoB Rest of brain (brain with hippocampus removed) 
ECU ECS upregulated clone 
ECD ECS downregulated clone 
lEG Immediate early gene 
This thesis is dedicated to my grandfather, Dr G.B.R. Feilden. 
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Chapter I 
Introduction 
'The lack of definitive answers on brain/mind matters is not a cause for despair—and 
is not to be seen as a sign offailure of the scientific fields no engaged in the effort. 
On the contrary, the spirit of the troops is high since the rate at which new findings 
are accruing is greater than ever ... If there is any cause for worry, it comes not from a 
lack of progress but rather from the torrent of new facts that neuroscience is 
delivering and the threat that they may engulf the ability to think clearly.' 
Antonio R Damasio, in Descartes' Error: Emotion, Reason and the Human Brain 
(Putnam) 
1.1: The central nervous system is comprised of distinct regions. 
The nervous system has evolved as a means for an organism to sense and interpret 
environmental stimuli and convert them into behavioural/physiological responses 
which aid the survival of that organism. Due to its highly specialised biological role 
and mechanistic complexity, it requires the expression of a large number of genes; a 
substantial number of which are to be found exclusively in this organ. 
There exists a large degree of division of labour within the central nervous system 
such that anatomically and functionally distinct regions have been well defined (ref. 
1). In a caudal to rostral progression through the CNS, the spinal cord is followed by 
the hindbrain (cerebellum, medulla, and pons), the midbrain, and finally, the 
forebrain (thalamus and hypothalamus (the diencephalon) together with the basal 
ganglia, hippocampus, amygdala, and cerebral cortex (the telencephalon)). This 
progression also charts the increasing functional complexity of these subregions and 
the increasing relative volumetric change throughout evolution. For example, the 
medulla and pons, among other functions, regulate blood pressure and respiration, 
whereas the cerebral cortex is involved in higher order processing of sensory and 
motor information together with the organisation of complex cognitive behaviour. 
This latter region, above all others, has undergone the most profound increase in 
relative and absolute size in the evolution of the human brain. 
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1.2: Memory 
A focus for all disciplines of neuroscience has been the study of memory (refs. 2 and 
3). The concept of memory can be summarised as a persistent change within the brain 
brought about by a stimulus. This definition applies to the psychological study of 
human individuals displaying cognitive disruption after brain injury, the behavioural 
study of rats learning the location of the platform in a swim-maze, and the 
macromolecular changes in a synapse brought about by neuronal stimulation. The 
study of memory could be seen as the first step towards understanding the more 
complex cognitive processes that occur in the brain. Indeed, experiments showing the 
link between emotional state and memory storage efficiency (ref. 4), together with the 
large body of information concerning the varied effects of psychoactive drugs, have 
already shown that memory is linked with other psychological phenomena. 
The following sections outline the succession of neurobiological research trends that 
have led to a better understanding of specific kinds of memory and which form the 
background for the work described in this thesis. 
1.3: The hippocamnpus is a vital brain region for the formation of certain types of 
memory 
The study of memory began in earnest in the 1950's with the detailed psychological 
evaluation of several patients suffering from amnesic symptoms: the result of brain 
lesions or injuries. The temporal categorisation of memory into 'short-term memory' 
(S.T.M.) and 'long-term memory' (L.T.M.) was the first outcome of these studies 
(refs. 5 and 6). It was observed that amnesic patients exhibited a loss of the latter with 
the retention of the former. Anterograde amnesia is the term applied to the deficits 
seen in many of these patients who were unable to form new memories post-lesioning 
but who had a good recall for events in their lives that occurred prior (although 
maybe not immediately prior) to the lesion. Generally, memories were unimpaired if 
they had been formed between 1 and 10 years beforehand. 
Post-mortem and PET scan studies of the brains of a number of the patients (ref. 7) 
showed that the principal regions affected by the lesions were a brain structure known 
as the hippocampus and the surrounding cortical tissues; collectively this region is 
described as the medial temporal lobe (M.T.L.). The second major conceptual 
advance in the study of M.T.L. (and diencephalic) damage was that a particular type 
of memory was affected, called 'declarative' memory. Declarative memory (also 
known as conscious, explicit or relational memory) can be distinguished from a 
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second type of memory, variously called non-declarative, non-conscious, skill, habit, 
simple classical conditioning, or implicit memory. The former, as the name suggests, 
relates to the ability to 'know something', as opposed to the latter, which is involved 
in 'knowing how to'. The two memory types differ in other respects apart from their 
storage location and informational content. Declarative memory is usually rapidly 
created but not one hundred percent accurate. Another characteristic of this type of 
memory is its inherent 'flexibility'; it seems to be able to cope with multi-sensory 
inputs (modalities) such as phonological and visual information and is able to 
translate these into different outputs. Under the umbrella of declarative memory come 
two further categories: episodic and semantic memory. Episodic memory denotes 
those personal or autobiographical memories that contain within them spatial and 
temporal pointers that create the contextual background to an event. This memory 
type seems particularly susceptible to M.T.L. and frontal lobe damage. Semantic 
memories are second-hand experiences which can be described as general knowledge. 
M.T.L. damage does not have such a profound effect on this form of declarative 
memory because multiple repetitions of the information can recover the loss. As 
mentioned before, short-term memories are not affected by M.T.L. lesions. Tests of 
declarative memory such as 'delayed non-matching to sample' (ref. 8), when carried 
out in such a way that the factual presentation and the test of recall are separated by a 
very short time (0.5 secs. in monkeys; up to 10 secs. in humans) are not affected by 
such lesions. The explanation for this is that there is a momentary or 'working 
memory' store outside of the hippocampus which operates for a few seconds (ref. 9). 
This working memory seems to consist of temporary speech and visual memory 
systems as well as another system responsible for attention. Recent work on this type 
of memory has shown that its principal location is the pre-frontal cortex. 
Research has been carried out to determine precisely which regions of the M.T.L. are 
responsible for the creation of memories. This has been approached by performing 
progressively more selective lesions in animals (usually Macacque monkeys, but rats 
show similar results) and assessing their performance in a number of tests designed to 
expose particular facets of declarative memory. Lesions described as H+A+  removed 
the hippocampus, subiculum, amygdala and the associated cortical regions. H+ 
lesions removed the hippocampus, subiculum, and some cortical regions, whereas H 
lesions selectively affect the hippocampus and subiculum. In brief, it was seen that 
the more extensive the dissection, the more profound the cognitive deficits. However, 
removal of the amygdala alone did not seem to have an effect on these memory tests 
and so it was deduced that the hippocampus and directly associated regions were the 
key sites of this type of memory acquisition. 
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1.4: The hippocampus is not the final repository for memories 
The temporally discriminating nature and localisation of amnesia led to the idea that 
the hippocampus was not the final resting place of memories but was responsible for 
their temporary storage until they could be relocated in the neocortex. Thus, the 
ability of anterograde amnesiacs to recall events in the distant past could be explained 
because their retrieval and storage are hippocampus-independent processes. 
Nevertheless, one unexplained aspect of the symptoms of amnesia is the occasional 
loss of one year or more of declarative memory prior to the hippocampus lesion 
(retrograde amnesia). It is hard to reconcile the function of the hippocampus as a 
temporary memory store when it is so clearly required to retrieve memories created 
up to 12 months previously, even in the least-affected cases. Perhaps this is caused by 
the collateral damage of the lesions in these patients, but one other explanation is that 
as the cortex becomes more complex as one progresses up the evolutionary ladder, 
there is an increase in the time-lag for the transfer of memories from the hippocampus 
to the cortex (monkey models of retrograde amnesia exhibit a lag of 12-16 weeks and 
rats even less). This is also a key feature of a recent, and convincing, attempt to 
explain the role of the hippocampus and, more precisely, the process whereby 
memories are 'consolidated' in the cortex (ref. 10). In simple terms, the model 
proposes that the long-term memories are stored in the various cortical regions that 
were initially responsible for the interpretation of the incoming sensory information. 
These regions individually innervate the hippocampus which flexibly and rapidly 
stores the associations of the cortical inputs. Even if it receives excitatory input from 
just one of the cortical domains in the ensuing period, the hippocampus can re-
establish the original cortical pattern of excitation. However, the hippocampal 
associations are not permanent and fade as a function of time. Thus, it is the emerging 
intracortical connections between the relevant domains that form the basis of the 
long-term memory. In contrast to the flexible nature of the associations within the 
hippocampus these connections are very slow to form (but slow to degrade) and so 
require the hippocampus to repeatedly recreate the original combinatorial excitations 
until they are competent to achieve them independently. 
1.5: The anatomy of the hippocampus 
The anatomical structure of the hippocampus has been studied by many in search for 
an explanation of its function. Fig. 1.1a shows that the hippocampus is a bilateral 
limbic brain region intimately associated with the neocortex. The cross-section 
diagram of the hippocampus clearly shows the arrangement of neurons which forms a 
'tn-synaptic' circuit. It is the arrangement of the neuronal pathways withih this circuit 
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Figure 1.1 a Illustration of the position of the hippocampus within the rat brain: 
anterior parts of the brain are towards the bottom left of the picture. A section of the left 
neocortex has been removed to reveal the underlying hippocampus (shown in red). The 
coronal cross-section through the hippocampus illustrates the components of the tn-
synaptic circuit. Synapse 1 represents connections between the entirhinal cortex (EC) 
and the granule cells of the dentate Gyrus (DG). Synapse 2 is the non-Hebbian mossy-
fibre synaptic connection in the CA3 region of the hippocampus. Finally, the Schaffer 
Collateral pathway forms Synapse 3 with the pyramidal neurons of CAl b Summary 
of the major biochemical events initiated in the post-synaptic neuron in response to 
glutamate release. Glutamate stimulates the NMDA and metabotropic (mGluR) 
receptors. Secondary messengers such as phospholipid metabolites (produced by 
phospholipases A2 and C), cAMP (produced by adenylyl cyclase II), and Calcium ions 
act on downstream proteins (such as protein kinase C, aipha-calcium/calmodulin-
dependent protein kinase II, and cAMP response element-binding protein) to induce the 
short and long-term events of synaptic potentiation. 
Fig. I. la 
Fig. 1.lb 
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and their modifiable synaptic transmission efficacies that have not only made this 
brain region easier than others to investigate by electrophysiological means but have 
also contributed to hypotheses concerning the creation of memory. 
The first projection of the trisynaptic circuit enters the dentate gyrus of the 
hippocampus from the entorhinal cortex and synapses onto the granule cells localised 
there. These cells, in turn, form synapses with the pyramidal cells in region CA3 of 
the hippocampus. Axonal projections from CA3 neurons (collectively termed 
Schaffer collaterals) enter region CAI where they form synapses with the dendrites of 
pyramidal neurons. From here, although not part of the tn-synaptic circuit, 
projections re-enter the cortex via the subiculum. In recent years this serial circuit 
diagram has become a less satisfactory model in the light of more detailed anatomical 
and electrophysiological observations (ref. 11). It is now clear that some regions of 
the entorhinal cortex send axonal projections into the hippocampus that bypass the 
dentate gyrus and even the CA3 regions. CAI and CA3 projections are not targeted 
as simply as was once thought; an individual axon from these regions has many 
terminations which form synapses in different, yet well-defined domains along the 
length of the CAI region. In vitro labeling of individual inhibitory interneurons has 
highlighted their extensive projections and synapsing within the hippocampus. Also, 
it was observed that some of these located in the CA! region can project 'backwards' 
to the CA3 region (ref. 12). The emerging picture is that there may be functional 
significance not only to the precise origin of hippocampal innervation from the 
cortex, but also the precise routing of information throughout the sub-regions of the 
hippocampus. Particular cognitive tasks may only require the participation of defined 
regions of the hippocampal 'tn-synaptic' circuit. Furthermore, recent work on 
hippocampus lesioning has convincingly demonstrated that only the dorsal (septal) 
region of the hippocampus is required for the accomplishment of spatial memory 
tasks (ref. 13). Thus, functional divisions exist along the length of the hippocampus 
as well as within the tn-synaptic circuitry itself. 
1.6: Synaptic transmission modifications underlie certain behavioural responses 
Donald Hebb, in his book 'The Organization of Behavior' (1949, New York, Wiley) 
made one of the first proposals as to how the brain's constituent neurons could act to 
create memories. Subsequent refinements resulted in the hypothetical model known 
as the 'Hebbian synapse' (refs. 14 and 15). In outline, this model states that the 
connections between neurons, the synapses, are the site of memory creation. If two 
connected neurons are activated simultaneously by their respective excitatory inputs 
then any synaptic connections between the two will be strengthened. This 
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strengthening allows the neurons to become more permissive in mutual 
communication such that when one is active then there is an increased likelihood that 
it will cause activation of the other. The corollary is also deemed to take place: when 
only one of the pair is active, the shared synapses will be weakened; this is the anti-
Hebbian synapse. The Hebbian synapse's critical component is its associative nature; 
two events have to coincide before there is a change in synapse strength. This 
hypothetical cellular property has been shown to have an exact behavioural 
counterpart in vivo as will be described. 
The neural basis of behaviour has been studied in simple invertebrates such as 
Aplysia californica which have a defined repertoire of reactive behaviours and a 
simple nervous system consisting of just 20,000 neurons. Three historically well-
understood behavioural paradigms are represented in this animal: habituation, 
sensitization, and classical conditioning (ref. 1). 
Habituation is the decreasing responsiveness to a repeated stimulus and is a non-
associative form of learning. For example, when the siphon of this animal is touched, 
there is a reflexive withdrawal of the siphon and the gill apparatus. If this stimulus is 
repeated a number of times then the response becomes less acute. This decreased 
reactiveness lasts a few minutes in this case but has a duration of up to 3 weeks when 
there are 4 rounds of 10 stimulations over a short space of time. 
Sensitization is also a non-associative behaviour. If a noxious stimulus, such as an 
electrical shock to the tail, is administered to the animal then the reflex to siphon 
stimulation will be much stronger. The animal's behavioural reaction has undergone a 
'priming' procedure which makes it respond more vigorously. 
Classical conditioning is an associative behaviour as it requires the apposition of two 
events to elicit a strengthening of a response; a situation very similar to the Hebbian 
model. In this case, a 'conditioned stimulus' such as the stimulus of the mantle shelf 
elicits the gill-withdrawal response. If there is also an 'unconditioned stimulus' in the 
form of a shock to the tail directly after the stimulus (causing a large defensive 
reaction in the animal) then after a few repetitions of this procedure the large 
response can be induced by the conditioned stimulus alone. Thus, the animal has 
learned that the mantle stimulus immediately precedes a noxious event and acts pre-
emptively. It can be shown that this is a discriminating response because stimulation 
of the siphon will not produce the same degree of reaction. 
In depth analyses of the neural pathways that contribute to these three behavioural 
systems together with the biochemical events occurring inside the relevant neurons 
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have given us insight into their underlying mechanisms, although there has been 
argument over the extent to which it is possible to infer the processes that take place 
in higher organisms from those in a mollusc. 
Habituation seems to occur through a reduction in neurotransmitter released by the 
sensory neurons at the synapses with the motor neurons. Thus, a point is reached at 
which, the level of transmitter released from a stimulated sensory neuron is not 
sufficient to overcome the threshold of activation of the motor neuron, thus 
preventing the reflex. One possible mechanism for this reduction is the decrease in 
calcium influx through calcium channels into the pre-synapse; a critical requirement 
for vesicle exocytosis and neurotransmitter release. Sensitization requires the same 
pathway to come under the modulatory influence of synaptic transmission from the 
sensory neurons of the (shocked) tail. This acts on the pathway by increasing synaptic 
vesicle/neurotransmitter release onto the motor neuron dendrites. The interaction is 
therefore known as 'heterosynaptic facilitation'. Serotonin is the principal modulatory 
neurotransmitter involved and it seems to act in the sensory neuron by causing a 
chain of short- and long-term events mediated by the increased intracellular 
production of cyclic adenosine monophosphate (cAMP) by the enzyme adenylyl 
cyclase. Classical conditioning is brought about by similar process but, in this case, 
there is an additive effect brought about by the near-simultaneous activation of the 
two pathways such that the shocked tail facilitator connection elicits a large increase 
of calcium influx into the mantle sensory neurons. The calcium is chelated by 
calmodulin protein which then acts as a cofactor for adenylyl cyclase resulting in 
large cAMP increase. The biochemical cascade which ensues results in the 
strengthening of synaptic connections onto motor neurons. In comparison with 
sensitization, the resulting increase in reflex response is much greater and longer-
lasting. 
1.7: LTP is a model for synaptic transmission changes in the hippocampus 
The first concrete evidence of a neuronal mechanism for memory came in 1973. The 
hippocampus, because of its simple, laminar structure, allows the relatively easy 
implantation of stimulus and recording electrodes into defined neuronal fields. Bliss 
and LØmo recorded the change in post-synaptic potentials of neurons from various 
regions in the rabbit hippocampus and showed that they increased when the 
presynaptic neurons had undergone trains of high frequency (100Hz) stimulation (ref. 
16). This change in the activity of the postsynaptic cell in response to presynaptic 
stimulation lasted from days to weeks and was dubbed 'long-term potentiation' (LiP: 
refs. 17-22). The change in potentiation occurring at a synapse is generally measured 
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as a change in the slope of the excitatory post-synaptic potential (EPSP). Typically, a 
10011z tetanus induces a 2-3-fold increase in this value which remains stable at this 
new level for a period of time depending on the precise experimental procedures 
used. 
As described earlier, the hippocampus contains three major synaptic domains. All 
exhibit LTP, but the precise nature of this potentiation is not always the same. The 
synapses between the perforant pathway and the dentate gyrus and the synapses 
between CA3 Schaffer collaterals and neurons in the CAl region were shown to be 
additive/cooperative, which means that a minimum number of simultaneous neuronal 
inputs are required to potentiate a postsynaptic cell. They were also shown to be 
associative and specific, that is, only the connections between those active 
presynaptic neurons and simultaneously active postsynaptic neurons become 
stronger. In contrast, the mossy fibre synapses which connect dentate gyrus granule 
cells with CA3 pyramidal neurons are neither associative nor cooperative; if a 
sufficiently strong excitatory signal is passed onto a CA3 neuron then the responsible 
synapse will become potentiated even if the CA3 neuron was not in an active state 
(ref. 23). 
1.8: The molecular mechanisms of memory: glutamate receptors 
The discovery of LTP as a possible cellular mechanism for memory has led to the 
investigation of molecular processes which may cause this synaptic potentiation. 
Glutamate is the major excitatory neurotransmitter in the CNS and several classes of 
glutamate receptor were originally defined by virtue of their pharmacological and 
electrophysiological characteristics (these will be dealt with in detail below). In 
particular, the 'NMDA' receptor (named after its high affinity agonist, N-methyl-D-
aspartate), exhibited unusual physiological parameters which made it an ideal 
candidate for the molecular mechanism responsible for the cooperative and 
associative characteristics of LTP (ref. 24). Firstly, unlike the other glutamate 
receptors, it did not gate ions when stimulated with glutamate under normal neuronal 
potentials. However, gating did occur with glutamate addition when the postsynaptic 
cell had been depolarized to a threshold level by the combined action of conventional 
glutamate ion conductance at numerous cooperatively activated synapses. Therefore, 
it exhibits an activation profile that matches that required to shift a neuron into a 
potentiated state. It has since been discovered that the voltage-gating property is 
mediated by a magnesium ion blocking the channel at normal cellular potentials. 
Upon sufficient post-synaptic depolarization, this block is removed and ions can pass 
freely through the channel provided that glutamate is bound to the ligand-binding 
N. 
portion of the receptor. Interestingly, electrophysiological conditions which may 
contribute to the alleviation of the magnesium block have been observed in the 
hippocampus when a rat is actively involved in a hippocampus-dependent task such 
as the exploration of a novel environment. During such activity, cholinergic fibres 
from the medial septal nuclei (MSN) induce a regular (4-10 Hz) innervation of the 
hippocampal inhibitory interneuron network. These neurons in turn provoke theta 
rhythmicity in pyramidal cells. The presence of this 'theta' rhythm may act to 
synchronise the activity of the hippocampal neurons and push them into a more 
suitably depolarized state for the induction of LTP (refs. 25-27). The other key 
feature of this receptor, in comparison with the other glutamate receptor channels, is 
that not only does it permit the passage of sodium and potassium ions, but it also 
allows the gating of calcium ions; a process which is crucial for the stimulation of 
long-lasting potentiation changes. 
The application of molecular cloning techniques to the analysis of glutamate receptor 
biology has revealed the complexities behind their pharmacological profiles (refs. 28-
32). Original classification defined glutamate receptors as being of the 'non-NMDA' 
class (comprising AMPA and kainate (KA) ligand-gated ion channels), the 'NMDA' 
class of ligand-/voltage-gated ion channels, and the 'metabotropic' class of G protein-
coupled glutamate receptors. Cloning of the genes encoding these functions (initially 
by expression of cDNA libraries in an assay system such as Xenopus oocytes) has 
revealed that there are at least 7 non-NMDA receptor genes (GluRl-5, KA-1, and 
KA-2), at least 5 NMDA receptor genes (NMDA Ri and R2A-D), and at least 8 
metabotropic glutamate receptor genes (mGluR 1-8). Adding to this complexity are 
the variety of post-transcriptional changes that modify the structure and functioning 
of these receptors; for example, the 'flip/flop' splice-forms of the AMPA receptor 
transcripts and the RNA editing of the AMPA and kainate receptor transcripts. With 
respect to the correct function of the NMDA receptor, it has been demonstrated by 
co-transfection experiments that a heteromultimeric (probably pentameric from 
evidence of molecular weight) structure is required to reproduce the in vivo 
electrophysiological and pharmacological characteristics. Within the channel 
complex, the requirement for the NMDA Ri subunit seems to be absolute; this is 
confirmed by expression data which suggests that, of the NMDA R mRNAs, Ri is 
the only one ubiquitously distributed in the brain (refs. 33 and 34). 
The functional parameters of these glutamate channels can be subject to modification 
by post-synaptic proteins (refs. 35-40). This may be responsible for some of the 
electrophysiological effects observable after LTP-inducing stimuli. Phosphorylation 
(mediated by kinases such as src and cAMP-dependent protein kinase A) may 
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increase the activity of these receptors, whereas dephosphorylation (by a variety of 
phosphatases, including PP1, PP2A, and PP2B/calcineurin) may act in the opposite 
manner. 
The metabotropic glutamate receptors transduce the glutamate-binding signal into 
cellular responses via the action of G proteins. Therefore, their effects are subject to a 
slight time-delay in comparison to the channel-forming receptors. In addition, unlike 
NMDA receptors, there is no associative component to their activation. The section 
of the hippocampal synaptic circuit between the dentate gyrus and CA3 region is 
known to exhibit a non-associative LTP called mossy fibre LTP. No NMDA 
receptors are to be found in this region and so it may be that mGluRs are responsible 
for this form of potentiation. Alternatively, because the LTP in this region is assumed 
to be pre-synaptic, the atypical pre-synaptic glutamate receptor, GR33 (see Chapter 
V) might be involved. A mGluR agonist, ACPD, augments tetanus-induced 
potentiation in the hippocampus, whereas the antagonist, MCPG, inhibits LTP. This 
latter effect is notable because it occurs in regions of the hippocampus where LTP 
can be either NMDA-dependent or NMDA-independent. Metabotropic glutamate 
receptors seem to represent a necessary component of LTP induction even in regions 
where LTP was previously considered wholly dependent on the NMDA receptor. 
This has been rationalised in one report by the suggestion that the mGluR component 
of NMDA receptor-mediated LTP may act as a competence switch to aid the full 
induction of LTP (ref. 42). 
1.9: The molecular mechanisms of memory: calcium influx 
In the post-synaptic neuron, the induction of LTP seems to rely on a transitory 
increase in intracellular calcium ion concentration. The introduction of the Ca2+ 
chelating agent, EGTA, into the cytoplasm of the post-synaptic neuron prevents the 
induction of LTP (ref. 43). The NMDA receptor channel itself can act as one source 
of this Ca2+ ion influx but several other systems are also capable of causing this 
increase (refs. 44-46). Voltage-sensitive calcium channels allow the entry of calcium 
into the post-synapse after depolarization. It is also evident that the Ca2+ ions do not 
have to originate from the extracellular medium. Ca2+ influx can trigger the 
subsequent release of calcium ions from the intracellular stores: inhibitors of the 
receptors on the storage vesicles that mediate this Ca2+ release also inhibit the 
induction of LTP. In addition, metabotropic glutamate receptor activation can cause 
the release of this internal Ca2+ by the action of one of its downstream messengers, 
inositol-1,4,5-trisphosphate (ref. 47). The post-synapse is usually a bulbous spine 
attached to a dendritic fibre. It has been postulated that the spine operates to limit the 
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diffusion of Ca2+ ions into the dendrite and hence neighbouring post-synapses (ref. 
48). Thus, an individual synapse can simultaneously create a high post-synaptic Ca2+  
ion concentration by being of limited volume as well as maintaining the synapse-
specificity required. When sufficient numbers of spines are simultaneously activated, 
possibly coupled with the opening of the spine neck, the dendritic shaft Ca2+  
concentration increase might achieve a degree of summation that could cause a 
somatic change (more specifically, a transcriptional change) in the neuron that would 
consolidate the potentiation. These kinds of localised and widespread changes in 
Ca2+ concentration have been examined in detail recently with the advent of real-time 
Ca2+ imaging techniques which make use of Ca2+  concentration-sensitive fluorescent 
compounds (ref. 49). 
1.10: The molecular mechanisms of memory: synaptic biochemistry 
With calcium being accepted as a general trigger for the induction of LTP, much 
work has centred on its cellular targets (ref. 17). These can be broken down into 
several groups of enzymes (e.g. protein kinases, phosphatases, phospholipases, 
adenylyl cyclases, and proteases). 
Studies of an invertebrate, the fruit fly (Drosophila melanogaster), have contributed 
greatly towards our understanding of the biochemistry of the synapse. Initial work 
involved the creation of specific behavioural tests which could be used to assess the 
presence or absence of memory capabilities in the fly (ref. 50). Then a large-scale 
mutagenesis screen was performed from which flies were subjected to the testing 
procedure. Using this technique two major memory-affecting alleles were discovered; 
'dunce' (ref. 51), and 'rutabaga' (ref. 52). Subsequently, alleles which include 
'amnesiac', 'radish', 'lathed, 'linotte', 'DCO', 'turnip', 'cabbage', 'zucchini', 'shaker', 
and 'mushroom body damaged' have been discovered using similar approaches. 
Interestingly, some of the genes which are affected in these mutants have been cloned 
and identified. Dunce mutants were originally described as having unusually high 
intracellular concentrations of cyclic AMP. This was due to the fact that dunce 
encodes a cAMP phophodiesterase which, when mutated, was not able to catabolise 
excess cAMP. Because this secondary messenger has many downstream effectors, the 
mutant phenotype observed probably arises from the cumulative overactivity of all 
cAMP-responsive proteins. The gene affected by the rutabaga mutation encodes a 
calcium/calmodulin-sensitive adenylyl cyclase. Hence, the memory phenotype seen 
in this mutant results from a lack of cAMP production. Other mutant genes isolated 
include amnesiac (a putative neuropeptide involved in a middle-term potentiation 
step), DCO (the catalytic subunit of the cAMP-dependent protein kinase), shaker 
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(voltage-dependent potassium channels), and linotte (its protein product has no 
database homologies but seems to be involved in the acquisition of memory) (refs. 53 
and 54). Latheo (another acquisition-affecting mutation) and radish (which affects 
anaesthesia-resistant memory) have not yet been cloned. 
With the important role of cAMP in memory processes so evident from many of the 
isolated alleles, further work has analysed the role of cAMP-responsive transcription 
factors in the creation of memory in Drosophila. A dominant negative mutation of the 
CREB (cAMP-responsive element-binding protein) transcription factor results in the 
severe impairment of long-term memory whilst short-term retention is unaffected 
(ref. 55). The complementary experiment of overexpressing a constitutively active 
form of the transcription factor leads to an enhancement in that particular stage of 
memory (ref. 56). 
The following section (together with fig. l.lb) briefly outlines the biochemistry of the 
vertebrate synapse which plays a part in the early stages of long-term potentiation 
(refs. 17 and 18). 
Two protein kinases which have been implicated in the processes underlying LTP are 
protein kinase C (PKC) and ct-Ca2 /calmodulin-dependent kinase type II (CAMK H). 
PKC has been reported to phosphorylate a large number of neuronal membrane-
associated proteins in the presence of Ca2 and phospholipids. These include 
glutamate receptors, adenylyl cyclase type II, and GAP-43 amongst others. The use of 
an inhibitory peptide against this kinase blocks the formation of LTP. CAMK II is a 
highly abundant protein in the hippocampus and its activation seems to be another 
critical step in the induction of LTP; possibly by the phosphorylation of non-NIMDA 
receptors amongst other proteins. Because both of these kinases are able to become 
constitutively active (by autophosphorylation, in the case of CAMK II, and calpain 
protease activity, in the case of PKC) several models have been proposed in which 
these may act as 'molecular switches' for the induction of memory (ref. 57). While the 
induction of both kinases is important in the creation of LTP, it would be wrong to 
attribute all activity-dependent synaptic excitability changes to their actions. 
As in other species investigated (such as Drosophila and Aplysia), the production of 
cyclic AMP is a necessary step in the production of early and late forms of 
potentiation. At least five forms of adenylyl cyclase are known to be expressed in the 
mouse brain, each encoded by a separate gene (ref. 58). Type II seems to be 
important in the production of cAMP in the context of LTP. cAMP as a secondary 
messenger has many varied sites of action in the neuron including the stimulation of 
protein kinase A activity (another important protein kinase) and the triggering of 
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some transcription pathways via the activation of CREB (cAMP response element-
binding protein). 
G protein activity (for example, from metabotropic glutamate receptor stimulation) is 
known to trigger the operation of a number of downstream proteins. Two of these, 
phospholipases A2 and C (PLA2 and PLC) break down membrane lipids into 
diacylglycerol and arachidonic acid (which activate PKC) and inositol-1,4,5-
trisphosphate (1P3), which results in the release of calcium from intracellular stores. 
Hence, the activation of key proteins in activated neurons causes the short-term 
potentiation events that are detectable in the first few minutes after stimulation and 
also permits the induction of other events (including some at the nucleus) which will 
lead to long-lasting potentiation changes. 
1.11: Have links between synaptic molecules, LTP, and memory been conclusively 
demonstrated? 
Because memory at the behavioural level might be due to LTP at the synaptic level 
and LTP seems to rely on the functioning of the NMDA receptor, there have been 
attempts to unify the interrelationships of these processes by experimentation. In a 
seminal study of this nature (ref. 59), the effect of the administration of an NMDA R 
antagonist (AP5) was observed on the ability of rats to learn a swim maze test; a test 
intended to involve hipp oc ampu s- dependent spatial learning (ref. 60). Chronic 
infusion of the antagonist during training prevented performance improvement in 
these rats in comparison with untreated control rats. Therefore, by inhibiting the 
function of a molecule in the hippocampus, effects were seen not only on LTP 
induction, but also on memory acquisition. Recently, this belief has had to undergo 
some revision in the light of new evidence that suggests that NMDA R-dependent 
LTP and hippocampus-dependent spatial learning may not be the only contributors to 
performance in this behavioural assay. Hence, either additional cognitive systems 
responsible for the task acquisition must be discovered, or a more specific test 
devised such that only the cognitive systems under study are required for its 
completion. Only in this way will causal links be confirmed between gene products, 
electrophysiological phenomena, and behaviour in vivo. (refs. 61-63). 
To these experiments must be added the growing list of transgenic perturbations of 
synaptic molecular function (described in more detail in section 1.13) which have 
shown, in a number of cases, simultaneous disruption of LTP and spatial learning. 
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1.12: Changes in transmission efficacy could arise through different effects on 
synaptic function 
Section 1.10 listed the biochemical pathways that are active during LTP induction. 
However, the precise way in which the synaptic transmission efficacy change is 
brought about is still somewhat controversial (refs. 64 and 65). 
A synapse could become potentiated by a number of mechanisms. In the presynaptic 
cell there could be an increase in the likelihood of an action potential triggering 
neurotransmitter release (refs. 66-69), an increase in the amount of neurotransmitter 
within each synaptic vesicle released, or an increase in the number of vesicles 
released per stimulus. In the postsynaptic cell, either the number of receptor sites 
could increase (ref. 70) or their responsiveness. 
In an attempt to reveal the locus of expression of LTP many experimental approaches 
have been taken. It is a feature of this field that appropriate evidence can be found to 
support the notions that potentiation events are wholly presynaptic, wholly 
postsynaptic, or a combination of the two. Techniques that have been used to detect 
changes after potentiation include the monitoring of labeled glutamate release from 
the presynaptic bouton, quantal analysis of spontaneous miniature synaptic potentials 
(refs. 71 and 72), sensitivity of receptors to agonists, activity-dependent inhibition 
rates of NMDA receptors, and the analysis of synaptic transmission failure. With the 
wide variety of stimulus paradigms, experimental conditions, and interpretations 
possible it remains to be seen if the locus can be assigned convincingly. 
1.13: Associative LTP with a presynaptic component requires a retrograde 
messenger 
In the case of associative LTP, where both pre- and post-synaptic cells are active at 
the same time, there is a coincidence detection mechanism in the form of the NIMDA 
receptor. If potentiation is to have a pre-synaptic component in this instance, then a 
post- to pre-synaptic signal must be transmitted to trigger those events. It is with this 
in mind, that a 'retrograde messenger' has been postulated and recent efforts have 
concentrated on a number of candidates for this messenger. 
Arachidonic ccid is produced by the action of the enzyme phospholipase A2 and, like 
the other messenger candidates discussed, has the ability to diffuse freely through cell 
membranes which is a prerequisite for a trans-synaptic activity. Once in the pre-
synaptic neuron, its mode of action maybe the stimulation of PKC or participation in 
prostaglandin synthesis (ref. 73). 
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Platelet-activating factor (PAF) is another product of the action of phospholipase A2. 
Administering this chemical (even post-synaptically) seems to enhance or even create 
(de novo) synaptic LTP. This effect is inhibited by PAF antagonists such as BN52021 
although subsequent high-frequency stimulation can overcome this block which 
probably means that additional mechanisms are participating (refs. 74 and 75). 
Nitric oxide (NO) is a gas which has already been shown to have biological activity 
in a number of systems (refs. 76-80). These include blood vessel endothelium 
relaxation in response to bradykinin or acetylcholine and the macrophage response to 
endotoxins. In the context of the brain, NO was implicated as a retrograde messenger 
when it was shown that the addition of haemoglobin to the fluid surrounding a 
synapse could prevent the retrograde message from reaching its goal; NO was 
therefore a candidate because the haem moiety in this protein chelates NO and similar 
gases. NO synthase (NOS, also known as NADP diaphorase) is the enzyme 
responsible for the production of this gas (ref. 81). NO synthase activity is present in 
the brain and inhibitors of this enzyme, such as L-NMMA, have an inhibitory effect 
on the induction of LTP. To date, three genes encoding members of the NO synthase 
family have been cloned; endothelial NOS (eNOS), inducible NOS (iNOS; found in 
macrophages), and neuronal NOS (nNOS) (ref. 82). The neuronal form has been 
shown to be activated by calmodulin after an increase in intracellular calcium levels. 
Unexpectedly, nNOS was shown not to be expressed in the CAI region of the 
hippocampus: a region known to exhibit NOinhibitor- sensitive LTP. This was later 
resolved by the discovery that eNOS is found in high levels in this region. Targeted 
disruption of all three NOS genes has been reported. Inducible NOS-null mice are 
immuno-compromised. Neuronal NOS-null mice were expected to display memory 
deficits (perhaps erroneously, due to the distribution anomaly) but have normal LTP. 
They do, however, exhibit behavioural disorders such as aggressiveness which may 
be due to the gene product's absence from other brain regions. In addition, they 
exhibit increased protection from NMDA-dependent neurotoxicity as well as having a 
gut disorder which closely resembles the human condition of pyloric stenosis. The 
deletion of the endothelial form of NOS has a large effect on hypertension regulation 
in the mouse resulting in a 35% increase in mean blood pressure. It remains to be 
reported if these mutant mice possess memory impairments. 
Observations concerning the functioning of NO in the hippocampus suggest that the 
Hebbian description of the synapse may be slightly limited in some circumstances. 
As expected of a retrograde messenger, NO only seems to potentiate a synapse when 
associative activity is occurring. If NO is administered to a synapse where the NMDA 
receptor component has not been triggered then inhibitory processes occur such that 
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the NMDA receptor activation threshold is increased (refs. 83 and 84). This effect is 
known as 'heterosynaptic depression' and still conforms to the Hebbian model. 
However, a series of experiments have shown a slight deviation from the traditional 
Hebbian system. In these experiments two parallel fibres in close proximity were 
stimulated. Both fibres' synapses were recorded for electrical activity changes, but 
one of these had been iontophoretically loaded with NOS inhibitor. The observation 
was that even though this synapse (in isolation) could not become potentiated, when 
stimulated in conjunction with the other synapse, potentiation was observed in both. 
To explain this phenomenon a diffusible NO signal (from the uninhibited synapse) 
must be involved in the potentiation of the inhibited synapse. Thus a synapse which 
has not met the requirements for LTP can be potentiated if certain 'local' 
environmental conditions are met (ref. 85). 
The routes by which NO can exert its influence are defined by its strong interaction 
with the iron moieties of several proteins. Chief amongst these is guanylyl cyclase, 
whose activity is increased in the presence of NO. The subsequent rise in 
concentration of its product, cyclic guanine monophosphate (cGMP), can be thought 
of as analogous to the rise in cAMP in the post-synaptic cell with respect to the 
possibilities for effector activation. Other direct targets probably include aconitase (a 
citric acid cycle enzyme and mRNA-binding protein; see Chapter V), NADH-
ubiquinone oxidoreductase, NAD succinate oxidoreductase, and ribonucleotide 
reductase; all of which are distinguished by possessing iron cofactors. 
Another gas which could behave in a similar way to NO, and which has comparable 
reactive characteristics, is carbon monoxide, CO (ref. 86). CO is synthesized by 
haem-oxygenase 2 (H02) which is present in the brain. ZnPP (zinc protoporphyrin 
IX) acts as an inhibitor of this enzyme and has been shown to block the synthesis of 
LTP in some laboratories (ref. 87). Very surprising is this inhibitor's described ability 
to eliminate previously induced LTP. With the publication of a knock-out of haem-
oxygenase 2, (ref. 88) the role of CO in the production of LTP has been thrown into 
further doubt. No H02 activity is seen in the homozygote mutant animals and yet 
they exhibit normal LTP. Furthermore, the mutant mice are as susceptible as wild-
type mice to LTP blockage by the administration of ZnPP. This suggests that the 
inhibitory action of ZnPP is not specific to H02. 
1.14: Later phases in the formation of LTP 
The above descriptions of synapse potentiation only go so far as to document the 
immediate changes that result in an increased level of synapse excitability. These 
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include the influx of calcium ions and the resultant phosphorylation events that alter 
the activities of synaptic proteins. However, experiments have shown that there are 
critical periods of transcription and translation in the minutes and hours subsequent to 
the induction of LTP. 
The role of transcription and translation in activity-dependent synaptic efficacy 
changes has been investigated in Aplysia, Drosophila and rat. Much of this work has 
been associated with the administration of transcriptional and translational inhibitors 
to explants of neuronal tissue in order to observe their effects on the longevity of 
stimulated potentiation. In Aplysia, the ability to dissect out the principal synaptic 
components of the gill-withdrawal reflex pathway has enabled investigation into the 
effects of these inhibitors, which is ruled out in the intact animal in view of their 
toxicity (ref. 89). The overall conclusion drawn from investigations in this system is 
that the inhibition of transcription (by drugs such as actinomycin D) or translation (by 
drugs such as anisomycin or cycloheximide) prevents the conversion of short-term 
facilitation/sensitization into the long-lasting forms (refs. 90 and 91). Activity-
dependent structural changes of synapses (thought to be a contributory mechanism to 
changes in synaptic efficacy) are also subject to the effects of these drugs. Moreover, 
the precise time of administration determines the extent of this inhibition (ref. 92). 
The critical 'time-window' for effective drug administration (and, therefore, the 
biological processes involved) seems to be within minutes of the training stimulus. It 
can be concluded that there is both a need for the translation of existing transcripts 
into proteins and a need for de novo transcription in the processes leading to 
consolidation of potentiation. 
Similar work has been performed on rat brain slices with comparable results (refs. 93-
95). Tetanus-induced potentiation of hippocampal synapses has been monitored in the 
presence of the same inhibitors of transcription and translation. Again, they act in a 
dose-dependent and time-dependent fashion to block the conversion of short-term 
potentiation into long-term potentiation. Interestingly, the early phase of potentiation 
is left relatively unaffected by the presence of these drugs; effects only appear 
approximately ten minutes after the stimulation. This has led to the acceptance of the 
hypothesis that the immediate electrophysiological sequelae of tetanic stimulation are 
mediated by 'covalent' processes, such as the phosphorylation of key regulatory 
molecules, whereas the longer-term effects are dependent upon 'macromolecular 
synthesis'. The latter must occur for the potentiation to be long-lasting and classified 
as genuine LTP. If it is disrupted then the potentiation is short-lived and designated 
'short-term potentiation' (STP). 
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Details of the gene expression changes that correlate with full LTP are summarised in 
the context of experiments designed to examine similar 'activity-dependent' gene 
expression changes (see Chapter V) and will not be dealt with further here. 
1.15: Activity-dependent neuronal morphology changes 
One line of investigation into how a synapse can become potentiated is based on the 
assumption that the nuclear products that are synthesized in response to synaptic 
activity will have a function in changing the operation of that synapse. It has been 
proposed, therefore, that these changes might be found in the ultrastructure of the 
synapse (refs. 96 and 97). Several groups have applied microscopical techniques to 
the examination of the size, shape and number of dendritic spines before and after the 
induction of LTP or the exploration of a complex environment. One report has shown 
an increase in the number of CAI dendritic spines in rats which have undergone 
spatial training in such an enriched environment (ref. 98). 
Others have focused on the action of proteins that may create or reorganise the cell-
cell interactions, intracellular cytoskeletal networks, and the extracellular matrix that, 
together, form the basis for the connection of one neuron to another. Antisera raised 
against the NCAM (neural cell adhesion molecule) protein and infused into the brain 
has an amnesic effect on chicks assayed in a one-trial passive avoidance test. Similar 
experiments carried out in rats using antibodies against NCAM and Li (another cell 
adhesion molecule) also resulted in memory impairments (refs. 99-101). Li 
expression also seems to be down-regulated in cell cultures of sensory neurons which 
have been subjected to low frequency (0.1Hz) electrical stimulation (ref. 102). A 
large number of serine protease genes are expressed in the hippocampus (at least ten; 
B. Davies (C.G.R.), personal communication) these may play a role in the 
restructuring of the extracellular matrix and the cleavage of cell-surface proteins. 
Two members of this family, neuropsin and tissue-plasminogen activator, are known 
to be up-regulated in response to LTP-causing stimuli in the hippocampus (see 
Chapter V). The actions of the intracellular protease, calpain, have been tightly linked 
with the induction of LTP in the hippocampus through the effect of specific inhibitors 
(ref. 103). By the cleavage of substrate proteins that make up the cytoskeleton, 
synaptic and neuronal morphology may be altered such that synaptic transmission 
efficiency is modified. 
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1.16: The application of transgenesis to the study of memory 
With the advent of techniques permitting the manipulation of the mouse genome, it 
has become possible to extend the mutagenesis work carried out in flies to 
vertebrates. In an attempt to probe their roles, several genes which were presumed to 
be involved in the biochemical pathways that underlie UP have been disrupted in the 
mouse genome using homologous recombination (refs. 104-110). Briefly, embryonic 
stem cells are electroporated with DNA which is, in part, complementary to the locus 
under study. This DNA is arranged so that if it becomes correctly incorporated into 
the chromosomal DNA it either deletes the gene's functional exons or results in the 
production of non-functional transcripts. Selection for these rare recombination 
events is made possible by the inclusion of antibiotic resistance markers in the 
exogenous DNA sequence. Mutant stem cells can then be injected into blastocysts 
which are then implanted in pseudopregnant mice. The chimaeric offspring can be 
bred to produce the mutant allele in the heterozygous or homozygous state. These 
'knock-out' experiments produce mice which are deficient in the gene under study. 
With respect to the analysis of learning and memory, mice null for a particular gene 
can be assayed with a battery of electrophysiological, molecular biological, 
anatomical, and behavioural tests. The phenotype obtained provides evidence for or 
against that gene's involvement in memory formation. 
The following list of knock-out and transgenic experiments is not exhaustive but has 
been chosen because of the pronounced effects on hippocampal function; other 
experiments which have a bearing on more specific brain functions are described 
elsewhere in this thesis. 
The role of glutamate receptors in the induction of LTP is central to the models of 
memory that have been proposed to date and this has been confirmed by studies of 
mice mutant for the relevant genes. Of the five NMDA receptor subunits identified, 
NMDA Ri () is ubiquitously expressed in the brain and is a necessary component of 
the correctly functioning channel complex. Two groups have described the disruption 
of this gene in mice and both report that the effect of the homozygous mutation is 
perinatal lethality due to breathing control difficulties (refs. 111 and 112). One group 
demonstrated that the whisker-related neuronal barrels fail to develop in the 
trigeminal brainstem nuclei, demonstrating a developmental role for the NMDA R 
family. The other group used hippocampal primary cell cultures from neonatal brains 
to assay glutamate and NMDA responses; as predicted, the latter were completely 
absent. There was an apparent knock-on effect of the deletion of this gene because 
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expression of the NMDA R213 subunit was greatly downregulated; this could be 
evidence for coordinate regulation of subunit expression in order to ensure functional 
receptors. Deletion of the NMDA R2A subunit (which is normally expressed in the 
cortex, hippocampus, cerebellum, and olfactory bulbs) resulted in a 50% reduction in 
elicited LTP and substantial underperformance in the water maze test of spatial 
learning (ref. 113). 
Two groups have also reported the successful disruption of the metabotropic 
glutamate receptor gene, mGluRl, which is normally expressed in cerebellum, 
olfactory bulb, and thalamus, together with the dentate gyrus and CA3 regions of the 
hippocampus (refs. 114 and 115). In both cases the mice were viable but possessed 
motor coordination deficits which resulted in tremorous movement. Combined, the 
results indicate that this isoform plays important roles in cerebellum and 
hippocampus function. Long-term depression (another form of synaptic excitability 
change) in the cerebellum is decreased in these mutants. In the hippocampus, 
mGluRl seems critical for the correct functioning of CA3 neurons; mossy fibre LTP 
(in which CA3 neurons are post-synaptic) and Schaffer collateral LTP (in which CA3 
neurons are pre-synaptic) are both decreased significantly. This is matched by similar 
deficits in spatial learning (carefully controlled for motor impairment factors). 
The brain-specific (y) isoform of the calcium- and phospholipid-responsive protein 
kinase C (PKC) has been deleted by homologous recombination (refs. 116 and 117). 
Whilst LTD and PPF remain unaffected in the hippocampus, a decrease in LTP was 
observed. However, this can be reinstated by prior treatment of the hippocampal 
circuit with low frequency stimulation; so-called 'priming'. The cause of this 
reversible LTP block is unknown but the low frequency stimulation might act to 
depotentiate 'saturated' neurons permitting subsequent LTP. The authors discount this 
as a possibility because they see no linear relationship between the extent of priming 
and the level to which LTP is subsequently inducible. However, the relationship 
between synaptic saturation and inducible LTP may not be linear (see chapter V, 
section 5 for a more complete explanation) so this remains a possibility. Spatial 
learning deficits are also observed in these mice. 
In the light of data showing that tyrosine kinase inhibitors prevent the induction of 
LTP, a systematic survey of four tyrosine kinase mutants (fyn, src, yes, and abi) was 
carried out. Only fyn homozygous mutant mice exhibited a memory impairment 
phenotype (ref. 118). This consisted of a 50% reduction in evoked LTP under strong 
tetanic stimulation whereas other electrophysiological parameters appeared normal. 
Spatial learning in a swim maze appeared almost completely absent in mutant mice 
although they do seem to exhibit some as yet unexplained deficit in the visible 
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platform test (a test of visual, motivational, or motor capacities), especially in the 
early stages of training. 
Perhaps the most extensively studied knock-out mouse line, in terms of memory 
phenotype, is one which lacks the gene encoding the a-calcium/calmodulin-
dependent kinase II (refs. 119 and 120). This highly abundant protein is localised in 
the post-synaptic densities of the hippocampus and cortex neurons and is thought to 
play an important role in the phosphorylation events that immediately follow LTP 
induction. In most cases, mutant mice show a severe deficiency in hippocampus LTP 
induction and are also poor performers in swim maze experiments. However, several 
problems complicate the interpretation of these results (refs. 121-124). Firstly, other 
experiments have shown that mutant mice are abnormal in behavioural tests designed 
to examine fear and aggression; and, moreover, the phenotypes observed in some 
behavioural tests do not follow an expected progression in severity relative to the 
mutant gene's dosage. Secondly, the mutant mice suffer from 'profound 
hyperexcitability' resulting in frequent epileptic seizures. Finally, the study of certain 
electrophysiological constants in these mice revealed unexpected results. PPF is 
decreased, indicating a presynaptic role for the protein, whereas PTP (post-tetanic 
potentiation) is actually increased. 
Homologous recombination resulting in the loss of the gene encoding the type I 
adenylyl cyclase (ref. 125) reduces the cAMP production activity by only 40-60% in 
the hippocampus (indicating that other isoforms of this enzyme exist). Nevertheless, 
compensation by these other proteins is incomplete because the mice exhibit both 
LTP induction and spatial learning deficits. 
The deletion of one of the four cAMP-dependent protein kinase A regulatory subunits 
(R1) results in deficits in LTD induction but leaves LTP unaffected, demonstrating 
the independent nature of these two forms of synaptic excitability modification (ref. 
126). 
The cAMP-responsive element-binding (CREB) protein is a transcription factor that 
may affect the transcription of genes responsible for the consolidation of LTP at the 
synapse. The absence of this protein in the brain (ref. 127) does not affect standard 
electrophysiological parameters but prevents the formation of long-term memories 
such that one-trial-a-day swim maze learning is severely disrupted, whereas intensive 
training over one day does not clearly distinguish between mutant and wild-type mice 
(this test does not require the long-term storage of information and is probably 
achieved in a hippocampus-independent fashion). Electrophysiological tests show 
that at 10 mins after tetanization, mutant hippocampus LTP is detectably attenuated. 
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NCAM is a cell adhesion molecule which is found, in adult mice, principally in the 
brain. The consequences of the loss of this gene are that the size of the brain overall, 
and the olfactory bulbs in particular, is decreased in comparison with wild-type mice. 
In addition these mutant mice do not perform well in spatial learning tests (ref. 128). 
Brain-derived neurotrophic factor (BDNF) is a secreted protein that has been shown 
to be responsible for the increased survival of explanted neurons in culture. Its 
expression pattern, which is primarily hippocampal, suggested that it may play a role 
in the functioning of this region of the brain: indeed, there is some evidence that 
neurotrophic factors can be secreted from neurons in an activity-dependent manner. 
Homozygote nulls for this gene do not survive for more than four weeks after birth 
(ref. 129). Comparative electrophysiology performed on hippocampal slices derived 
from wild-type, heterozygote, and homozygote mice revealed a novel form of LTP 
disruption. In mice with either one or both mutant alleles LTP was significantly 
harder to achieve (in terms of the number of successful experimental attempts) than in 
wild-type, but was apparently normal when obtained. It could be possible that one 
role of BDNF is to maintain neurons in a physiological state in which they can 
become potentiated. Because the homozygous lethal phenotype is affected by gene 
dosage, it appears that it is independent of the LTP deficit. 
Finally, examination of the learning phenotypes of two genes intimately associated 
with neurodegenerative diseases, the amyloid precursor protein and the prion protein, 
has shown that both possess some impairments (refs. 130 and 131). APP mutants 
exhibit deficits of learning in the swim maze assay and PrP mutants appear to have 
defective LTP. The undefined normal functions of these two proteins makes precise 
experimental design and assessment of results difficult. 
1.17: Some difficulties may exist in the interpretation of knock-out phenotypes in the 
context of hippocampal LTP and memory 
It is clear that the application of knock-out strategies to the analysis of LTP has 
provided much useful data. However, the interpretations of the mutant phenotypes 
described above are still open to some criticism (ref. 132). Some question whether the 
phenotype observed in the adult is a product of the absence of a particular gene in the 
neurobiological system under study at that time, or in the developmental processes 
that gave rise to the brain. An anatomical malformation exists in the fyn mutant 
hippocampus; the granule cells of the dentate gyrus and pyramidal cells of the CA3 
region have a concertinaed appearance which probably originates from the 
overabundance of neurons in this region. Therefore, processes which govern the 
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division or programmed cell-death of these cells must be affected during hippocampal 
development by the absence of thefyn gene product. Can the LTP deficit observed in 
these mice genuinely be attributed to the lack of the gene product in the functioning 
adult system or is the morphological disruption to the hippocampus the root cause? 
'Rescue' experiments (involving the reintroduction of the deleted gene during 
adulthood) should differentiate between the two possible origins of the phenotype. 
Using such an approach, provisional evidence for the ability to separate the 
morphological phenotype from the behavioural phenotype in the case of the fyn 
mutation has been reported ('Neuroscience' 1995, abstract). 
The second major criticism is the widespread nature of the mutation; the gene is 
disrupted in all cells throughout the body. This means that the phenotype might not 
be solely due to the absence of the gene product in the hippocampus (the site of the 
processes under study), but might be as a result of other brain or body defects. The 
disruption of the CAMK II gene might be such an example. Some behavioural tests 
designed to assay the function of the hippocampus with respect to its role in spatial 
learning could be subject to the effects of the mutation in other cognitive systems. For 
example, the swim maze test requires not only competence in the learning of the 
location of a platform, but also requires the correct functioning of the visual and 
motor control systems not to mention a host of other more subtle behavioural 
properties such as attention and reward comprehension. The CAMK II mice exhibit a 
wide range of neurological abnormalities which may interfere with or supersede the 
(hippocampal) cognitive functions required to complete a swim maze test 
successfully. This kind of criticism is only applicable in cases where the phenotypes 
are interpreted solely in the context of hippocampal function. 
Anther criticism levelled against the published data has been whether the cognitive 
phenotype of mice would be different if the mutation was in different genetic 
backgrounds. The contribution of the genetic background can result in the 
compensation or exacerbation of the mutant phenotype because of the presence of 
modifier alleles. 
The application of a wide selection of control experiments (such as the 'visible 
platform', 'visual discrimination' and 'transfer' tests) are also a critical part of the 
correct assessment of the neurological defect present. The direct electrophysiological 
study of hippocampal slices enables a more specific comprehension of the mutation 
phenotype because the fibre pathways recorded are separate from the rest of the CNS. 
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1.18: Hippocampus-specific genes as tools for the precise transgenic manipulation of 
memory processes 
In the light of these interpretational difficulties, it has been a long-term goal of those 
involved in this type of study to be able to achieve a more concrete analysis of the 
role of a gene in hippocampus function by the application of more refined techniques. 
To overcome the drawbacks of a simple knock-out strategy, a system of mutagenesis 
is required which not only restricts the genetic lesion to the tissue of interest, but 
which is also capable of being initiated at a set point in the mouse's life. Hence, the 
temporal and spatial control of a mutation is the key to the unambiguous 
interpretation of the resulting neurological phenotypes. 
In our group, one line of research has focused on the identification of genes which are 
restricted in their expression to the hippocampus. Such transcripts could prove 
invaluable in the analysis of this brain region's function. Firstly, the role of such a 
gene (with its specific localisation) might be linked to the specific function of the 
hippocampus. Assuming that this brain region performs a distinct cognitive role, it 
could be hypothesised that it would require a distinct set of molecular components. 
Secondly, (and more importantly with respect to the problems described above) the 
genetic elements which dictate the expression pattern of such a gene, such as the 
promoter and enhancer regions, could be utilised as a means to express transgenes in 
the same location. Transgenes under the control of such genetic elements could be 
designed to perturb the normal functioning of neurons in a spatially specific fashion. 
It can be appreciated that a host of potential experiments based upon such a genetic 
tool exist and some of these are outlined below. 
Modified forms of proteins which are known to play a role in LTP could be expressed 
in the hippocampus and their effects ascertained. Candidates for this type of study 
would include the glutamate receptors, kinases, phosphatases, signal cascade 
constituents, ion channels, transcription factors, neurotrophic factors and their 
receptors, amongst others. Some mutations might act in a dominant negative fashion, 
with effects similar to a knock-out, others would be gain-of-function mutations 
resulting in different phenotypes. 
One approach employed in other biological systems is the expression of a toxic gene 
product in a specified cell-type or organ. Examples of toxins used include ricin and 
the product of the thymidine kinase gene. Thymidine kinase converts the anti-herpetic 
drug, ganciclovir, into a cytotoxic product (ref. 133). Therefore, by expressing the 
thymidine kinase gene in a restricted region of the body and applying the drug at a 
specified time, it is possible to ablate that tissue in a controlled manner. Lesioning the 
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hippocampus in this way would be much more precise and complete than the surgical 
lesions described earlier in this chapter, and would not involve any extrahippocampal 
damage. In addition, specific subregions within the hippocampus could be targeted 
individually if appropriate promoters could be isolated. One problem with this 
approach is that the action of this kinase gene may require the cells expressing it to be 
actively dividing before the cytotoxic effects manifest themselves. Adult brain 
neurons, however, are in a terminally differentiated state. 
A hippocampus-specific promoter could be used as a means to 'rescue' hippocampus 
deficits present in knock-out mice by the reintroduction of the deleted gene to the 
hippocampus. A restoration of LTP or swim maze performance in such an experiment 
would indicate that the loss of function of this gene in the hippocampus was the cause 
of the deficit, and not deficits in other brain regions. 
1.19: Novel transgenic techniques could employ hippocampus promoters 
Several technological advances which have emerged since the inception of this 
project could be combined with a hippocampus expression-driving promoter. The cre 
recombinase derived from the P1 bacteriophage acts to excise any DNA sequence 
bracketed by specific palindromic sequences termed lox P sites. By placing these 
sites either side of a stretch of DNA and expressing the recombinase in a tissue-
specific manner then efficient deletion of the intervening DNA can be achieved solely 
in that tissue (ref. 134). Tissue-specific knockouts can therefore be performed if a 
suitable promoter is available: the gene to be disrupted is surrounded by lox P sites 
('foxed') by one round of transgenic intervention and the resulting mice crossed with 
others expressing the cre recombinase in the specific tissue of interest (obtained 
through a second round of transgenesis). It can be seen that it will be possible in the 
future simply to take previously created mouse lines which express the recombinase 
in the desired tissue (or, in a restricted developmental stage) and cross them with the 
experimental mouse line possessing the lox P sites in a suitable position. Refinements 
to this protocol have centred on making the cre recombinase inducible. One group 
have placed the recombinase under the control of an interferon-responsive promoter; 
at the required time-point this promoter could be exogenously activated permitting 
the cre-mediated recombination to occur (ref. 135). Another group have created a 
fusion protein linking the recombinase with the ligand-binding region of the 
oestrogen receptor. This protein was expressed in cells which possessed no 
endogenous receptor (ref. 136). Upon treatment with oestrogen, the protein was 
activated and transported to the nucleus where it could carry out its recombinase 
activity. If a similar system is to be useful in vivo it should be inducible by a non- 
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physiological signal; perhaps, a xenobiotic and its receptor could be adapted for this 
purpose. 
Another biological system presents itself as a possible tool for the analysis of brain 
function in a transgenic context. The product of the tTA gene is a modified 
transcription factor which upregulates expression (by virtue of its VP16 
transactivation domain) of genes which possess its binding-site motif (tetO) in their 
promoters (ref. 137). This upregulation is prevented by the antibiotic, tetracycline, 
which binds to the factor and prevents DNA-binding. Both tTA and 'X' transgenes, 
each under the control of promoters possessing the tet-responsive site, could be 
introduced into a line of mice which have been made null for the endogenous gene 
X. In this way, expression of the tTA and 'X' genes would be under the control of 
the tTA gene product. At a defined time-point, tetracycline could be administered to 
the mice which would result in the cessation of tTA and 'X' expression. In essence, 
this procedure is an inducible knockout, with respect to gene 'X', and could be used to 
distinguish between the developmental and functional factors which contribute to the 
null phenotype. 
In summary, the above procedures would allow either the spatial or temporal control 
of a transgenic manipulation; it still remains to be seen if both of these constraints can 
be combined in a single intervention. 
1.20: The existence of hippocampus-specific gene expression 
Possession of hippocampus-specific genes would only be useful for transgenic 
approaches if they were expressed above a certain level necessary for the transgene 
product's presence to register an effect on the tissue in question. Even though this will 
vary according to the function of the transgene, there are still minimum required 
levels. Genes restricted in expression to the brain are numerous and well-
characterised; for example the promoters of 'neural-specific enolase' and 'tyrosine 
hydroxylase' have been frequently used to direct the expression of transgenes to the 
CNS or a subregion thereof, respectively. 
As mentioned at the beginning of this chapter, the brain requires the utilisation of a 
disproportionate number of genes encoded in the genome. Current estimates of 
genome size in humans fall within the range of 50,000 to 100,000 genes (reviewed in 
ref. 138). It has been difficult to ascertain an exact figure for the number of genes 
expressed in the brain as the results from the principal technique, that of 
cDNA/mRNA or cDNA/genomic DNA reassociation kinetics, show wide variability 
between groups (refs. 139-142). One key point is that, of the genes expressed in the 
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brain, up to 50% may be employed solely in that tissue. The general trends observed 
point to the fact that the brain has between two to six times the transcriptional 
complexity of other tissues such as liver or kidney. This complexity is not due to the 
combination of sub-regional expression profiles. Dissection and analysis of brain 
regions such as cerebellum, hypothalamus, hippocampus, and cortex shows that, 
individually, they have the same order of transcriptional complexity as the brain as a 
whole (there is some evidence for the hippocampus being marginally less complex 
than the other regions). Between brain regions, the difference in the identity of genes 
expressed appears less than 20%. The authors of refs. 141 and 142, using 
reassociation rate curves, go some way in classifying gene expression in the brain. In 
essence, there are a small number of genes whose expression is at a very high level, a 
slightly larger set with lower expression levels, and a very large set of genes whose 
expression is seen at an extremely low level. Milner and Sutcliffe (ref. 143), through 
analysis of 191 clones picked randomly from a rat brain cDNA library, tried to assign 
rules about the type of gene and its expression level and distribution. About 18% 
showed expression in brain, liver and kidney. 26% showed expression in the brain 
and liver or brain and kidney. 30% showed expression limited to the brain and 26% 
were undetectable at Northern sensitivity. The abundance levels for each clone were 
also quantified and used to estimate that the brain expresses 2,000-3,000 genes at an 
abundance of 0.01% or more of total. This allowed a prediction of 30,000 genes 
expressed in the brain to be made. Another feature noted was that as the rarity of 
expression or the brain specificity increased, so did the average transcript length. 
These results and others seem to suggest that the higher the expression level of a 
gene, the more widespread its expression profile. Any attempt to isolate a brain 
region-specific gene would have to be sensitive enough to detect genes that are 
expressed at a low level. 
1.21: Aims of the experiments described in this thesis 
The aim of the work described in the following chapters was the isolation of 
hippocampus-specific genes. 
The techniques that were used for this purpose can be broken down into two groups; 
degenerate PCR of candidate gene families and subtractive hybridisation. In both 
cases a progression of modifications was adopted in response to technical problems 
or to increase sensitivity. Both of the approaches have benefits and disadvantages at 
the theoretical and experimental levels and these will be discussed where relevant and 
as a summary in Chapter VI. The approach described in Chapter V is based on the 
assumption that some hippocampus-specific gene expression may be activity- 
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dependent, and not present in the basal-activity hippocampus. The subtraction 
outlined in this chapter also attempted to examine the long-terrm gene expression 
changes associated with an LTP-like stimulation. 
Because of the varied nature of the approaches used in this thesis, it will be necessary 
to introduce them in more detail where they occur. Chapter II contains an 
introduction to the degenerate PCR amplification of gene families, Chapter III 
contains an introduction to differential screening/subtraction and Chapter V describes 
published attempts to identify activity-dependent neuronal gene expression. 
Chapter II 
Candidate Gene Family Approach 
2J: Rationale for PCR approach 
Many genes, if not the majority, can be placed into distinct groups on the basis of 
their sequences. The DNA complement of eukaryotes has been subjected, through 
time, to multiple rounds of chromosomal duplication and reverse transcriptional 
insertion events (known as retroposition; ref. 1) that have resulted in the scattering of 
multiple copies of ancestral genes (or domains thereof) throughout the genome. These 
copies have since undergone mutational changes and concomitant evolutionary 
selection. Related genes in different regions of the genome diverge at the nucleic acid 
level as a result of mutation and selection such that the proteins they encode differ in 
precise functional specificity, if not in overall function. Additionally, the elements 
controlling the expression of the genes undergo more radical shifts such that different 
members of a burgeoning gene family might be restricted in their expression to 
particular tissue types, developmental stages, or physiological conditions. Combined, 
these changes permit both independent operation and the specific control of a tissue 
or organ (for example endocrine control of the heart by adrenal gland secretion of 
adrenaline). The result, in general terms, is that this increase in genetic complexity 
has permitted an increase in the organisational complexity of higher eukaryotes. 
As discussed in the introduction, one aim of the work described in this thesis is to 
identify regulatory elements that direct hippocampus-specific gene expression. The 
remainder of this chapter concerns one route to the identification of such elements: 
the use of degenerate PCR in the search for members of gene families which are 
selectively expressed in rat hippocampus. It was reasoned that, among the members 
of the selected gene families, there might exist some specifically expressed in the 
hippocampus, meeting the particular operational requirements of this brain region. 
2.2: PCR technique 
The polymerase chain reaction (PCR: refs. 2-5) is the most direct technique for 
studying multi-gene families. By designing two oligonucleotide primers which are 
complementary to two regions of sequence bracketing the DNA stretch of interest, the 
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intervening region can be exponentionally amplified such that direct cloning and 
analysis is possible. 
The precise details of how the PCR technique was applied to the study of candidate 
gene families is described in the Materials and Methods chapter. Factors affecting the 
design of the PCR primers are also discussed. 
2.3: Application to multi-gene family amplification: Degenerate PCR 
PCR has been used in many ways; cloning, mapping, diagnostics, and genotyping 
among others. The first direction taken in this project was the cloning of members of 
defined multi-gene families. Between any two members of such a gene family there 
are regions of conserved amino acid sequence. These regions have been conserved 
because they define functional domains or structures in the complete protein (for 
example, a kinase domain in a receptor or a nucleotide-binding pocket in a G-
protein). Because this selection for conservation is at the amino acid level and the 
genetic code is redundant, the PCR primers must be designed to take into account the 
decreased conservation at the nucleic acid level. Therefore, the primers are 
synthesized such that the majority of the coding variants capable of producing the 
relevant amino acid motif are represented in the pool. This mixture of primer variants 
is known as a 'degenerate primer'. A balance has to be struck to ensure that the 
degeneracy is sufficient to amplify all possible gene family members but low enough 
to avoid indiscriminate priming. Often, where any one of the bases A, C, T, or G 
could be used in a codon, the nucleotide Inosine is specified to prevent excessive 
degeneracy (inosine can potentially hydrogen bond with all bases although it has a 
preference for G and A). This excessive degeneracy often occurs at the third position 
in a codon where most 'wobble' lies. This is especially true for the amino acids 
leucine, arginine, and serine which can each be encoded by any one of six codons. To 
reduce degeneracy further, reference can be made to data showing the the relative 
codon usage specifying a particular amino acid in the organism being studied (ref. 6). 
Rat hippocampus cDNA was used as a template in PCR reactions designed to find 
members of four gene families which were selected for their apparent large sizes and 
roles in neuronal function. They were:- 
G protein-coupled receptors 
Metabotropic glutamate receptors. 
G protein a subunits 
Protein tyrosine phosphatases. 
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2.4: Introduction to Gprotein-coupled receptors 
The first multi-gene family studied by the degenerate PCR technique was the G 
protein-coupled receptor (GPCR) family. The proteins encoded by these genes have 
seven hydrophobic regions which function as transmembrane domains (TM domains) 
to anchor them in the cytoplasmic membrane and to transduce signals across the lipid 
bilayer (refs. 7 and 8). Extracellular signals are converted into a structural 
conformation change which, in turn, stimulates members of the heterotrimeric G 
protein family to become active, setting in motion a chain of secondary messenger 
events evoking suitable cellular responses. 
To date, well over one hundred members of this family have been cloned from 
numerous species ranging from bacteria to humans (ref. 9). The GPCR signal 
transduction paradigm is found in many physiological systems, for example, 
photoreception, gustation, olfaction, and the more standard ligand-/hormone-
/neurotransmitter-receptor interactions. 
The prototypical seven transmembrane domain receptor is the photoresponsive 
bacteriorhodopsin (BR). The precise three-dimensional arrangement of the 
transmembrane domains of this protein in the cell membrane has been elucidated 
(refs. 10-12). The realisation that bovine rhodopsin (refs. 13 and 14), human 
rhodopsins, and the 0 adrenergic receptor had related structures prompted 
investigation into the GPCR multi-gene family. Nucleic acid homologies are not 
easily detected between bacteriorhodopsin and other members of the family. Pardo et 
al. (ref 15) have rectified this confusion by non-sequential sequence comparison 
between the transmembrane domains of BR and those of other GPCRs. They found 
that domains II to VII of BR showed homologies with domains 4, 5, 6, 1, 2, and 3 (in 
that order) of other GPCRs. Thus, the transition from prokaryotic to eukaryotic 
organisms seems to have coincided with exon-shuffling events resulting in the 
present-day arrangement of TM domains in higher organisms. Helical-wheel analysis 
of the alpha-helical TM domains has revealed amphipathic amino-acid residue 
distribution such that a model of the packing order of the domains in the membrane 
could be made (ref. 16). Hydrophobic (lipophilic) residues lie on the outside, whereas 
inside, the residues are primarily hydrophilic, forming a pocket which is involved in 
ligand binding. This model fits well with the X-ray structure analysis of BR. 
Fig. 2.1 shows a diagram of a typical GPCR upon which key residues involved in the 
functioning of the receptor have been labelled. With respect to the PCR approach to 
clone GPCRs, there a no large regions of sequence homology between all members of 
the family (ref 9); this is because different genes have been subjected to different 
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Figure 2.1 Diagram of a typical member of the G protein-coupled receptor family. 
Highlighted are the seven transmembrane domains with some of their conserved 
residues. Arrows represent regions of conserved amino acid sequence which acted as a 
basis for the design of degenerate PCR primers. Also featured are the N-terminal 
extracellular glycosylation, the extracellular disulphide bridge linking loops one and 
two, and the C-terminal palmitoylation. 
Figure 2.2 Diagram of a typical member of the metabotropic glutamate receptor 
family. In comparison to the GPCR proteins there is a longer N-terminal extracellular 
domain and the interaction with the G-protein complex is probably at a different 
position. 
Figure 2.1 
Figure 2.2 
lengths of evolutionary drift after successive gene duplication events. Hence, 
subfamilies of the GPCR family have emerged with higher sequence homology 
among themselves than with the family as a whole: this will be discussed later in the 
context of primer design. Despite this, certain key residues are to be found in most 
members of the family described to date and these are nearly always associated with 
the transmembrane domains. It is presumed that the role of these TM domains is 
critical for function, explaining their increased conservation. Proline residues, 
probably involved in kinking the alpha-helices to create a suitable ligand-binding 
pocket, are to be found in TM domains 4, 5, 6, and 7. TM 2 contains conserved 
glycine, asparagine, and valine amino acids. TMs 3 and 4 contain an isoleucine and a 
tryptophan amino acid, respectively. Phenylalanine and tryptophan residues are 
conserved in TM 6 and, finally, TM 7 possesses conserved asparagine and tyrosine 
residues. 
Cysteine residues contained within the first and second extracellular loops have been 
proposed to form a disulphide bridge which may contribute to the structure of the 
receptor. Another set of cysteines are often found in the intracellular carboxy-
terminus of the receptor and have been shown to be modified by palmitoylation. This 
has the effect of anchoring the tail to the membrane; seemingly a critical requirement 
in the case of the 132 adrenergic receptor, which becomes hyperphosphorylated and 
desensitised upon mutagenesis of the relevant cysteine residue (ref. 17). 
The large third intracellular loop and the carboxy-terminus appear to contain key 
regions of phosphorylation on the receptor (ref. 18). Persistent agonist stimulation of 
some receptors such as rhodopsin and the f32 adrenergic receptor leads to receptor 
desensitisation. This process requires protein kinase A (PKA) or specific GPCR 
kinases to phosphorylate serine/threonine residues on the two regions, permitting the 
binding of arrestin/arrestin-related proteins which prevent receptor-coupling to G 
proteins (ref. 19). At least seven GPCR kinases have been cloned from a variety of 
species (ref 20), the most studied of which is the 13  adrenergic receptor kinase 
(BARK). 
The amino-terminus of a typical GPCR possesses much N-linked glycosylation 
which, when removed by site-directed mutagenesis, as in the case of the 132 
adrenergic receptor (ref. 21), or by glycosylation inhibitors, as in the case of the ml 
muscarinic acetylcholine receptor (ref. 22), results in a decrease in the expression 
levels of the protein but not the agonist affinity: this is probably due to incorrect 
intracellular trafficking. 
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As mentioned earlier, the site of agonist binding in GPCRs seems to be the 
hydrophilic cleft created by the bundling together of the transmembrane domains. 
Analysis of the retinol moiety in the rhodopsin complex shows that it occupies this 
region. Point mutation and chimaeric protein experiments have shown that an 
aspartate residue in the third transmembrane domain is vital for agonist/antagonist 
binding in the case of the adrenergic (refs. 23 and 24) and ml muscarinic 
acetylcholine receptors (ref. 25). Serine residues in the fifth transmembrane domain 
are known to be involved in hydrogen bonding to the aromatic hydroxyl groups of 
catecholamine agonists. 
Coupling of the activated receptor to the appropriate G protein has been studied by 
various approaches. Luttrel et al. (ref. 26) showed, in cell culture, that by the addition 
of a synthetic peptide identical to the a lb adrenergic receptor's third intracellular 
loop, all coupling from that receptor and the related alc receptor was blocked 
whereas other GPCRs remained unaffected. A chimaeric 32 adrenergic receptor was 
created which possessed a third intracellular loop derived from the a2 adrenergic 
receptor (ref. 27). This behaved like an a2 receptor by coupling to the G protein Gai 
instead of the usual Gas.  Site-directed mutagenesis experiments have shown that 
many conserved residues present in the intracellular loops have a role in the receptor-
G protein coupling process. O'Dowd et al. (ref. 28) showed that the membrane 
proximal regions of the third intracellular loop and a proline in the second loop were 
critical for P adrenergic coupling. Others have reported that the aspartate in loop two 
and the lysine in loop three are also important for this coupling. 
Receptors of other types have been shown to be proto-oncogenes. This does not seem 
to be so evident in the case of GPCRs; perhaps because of the fact that they are not 
directly involved in phosphorylation events. However, the mas proto-oncogene is a 
member of the GPCR family (ref. 29) and site-directed mutagenesis of three residues 
on the third intracellular loop of the alb adrenergic receptor causes it to become 
deregulated such that injection of cells expressing this mutant form into nude mice 
results in the formation of tumours (ref. 30). Spontaneous mutations in GPCRs are 
causative of a number of diseases such as congenital nephrogenetic diabetes 
(vasopressin receptor), hyperfunctioning thyroid adenomas (thyrotropin receptor), 
familial male precocious puberty (luteinizing hormone receptor), and night blindness 
diseases (rhodopsin). In addition, different allelic forms of the melanocyte-
stimulating hormone receptor are responsible for different coat colour phenotypes in a 
variety of mammalian species. 
In summary, the diverse roles undertaken by the many members of this gene family 
(particularly in the central nervous system) led to speculation that there might be 
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found members restricted in expression to the hippocampus. These might be involved 
in the memory formation processes of this brain region. 
2.5: GPCR primer design 
The first set of primers designed to amplify members of this family were a gift from 
Dr. S. Morley (Centre for Genome Research) and were based upon those published 
by Libert et al. (ref. 31). By analysing the amino acid sequences of six GPCRs (131 
adrenergic, 132 adrenergic, a2 adrenergic, 5-HT la, muscarinic acetylcholine 1, and 
substance K receptors) they selected two conserved regions; one associated with 
transmembrane domain 3 and the other with transmembrane domain 6. To avoid 
excess degeneracy in the primers, not all possible codon variations were included for 
a particular amino acid; merely those most frequently occurring. Inosine residues 
were also included to reduce degeneracy. Also, Hindill and Sail sites were included 
in the primer sequences in order to facilitate cloning into plasmid vectors. 
The second pair of primers directed against this gene family were biased in sequence 
so that the products would contain members of the neuro-peptidelbio-active peptide 
receptor subset of GPCRs. Those members which formed the basis for the design of 
the primers included neurotensin, neurokinin A/substance K, substance P. bradykinin, 
bombesin, and angiotensin II receptors. The 5' primer was directed at a region of 
conserved sequence located in the second transmembrane domain whereas the 3' 
primer utilised the previously described region of homology in domain VI; albeit with 
a slightly different nucleic acid composition. Restriction sites for the enzymes Clal 
and XbaI were included in the primers. 
The precise primer sequences are listed in table 2a. As with all of the primers created 
for this approach, the following rationale was used: the conserved amino acid motif 
was chosen from a comparison of family members and then all possible codon 
variants encoding each amino acid were listed. In order to decrease the resulting 
degeneracy, codon usage in previously cloned family members was analysed in order 
to discount rare codon variants. Although this is a necessary step in the design of a 
competent primer, there is always the danger of a 'circular argument' ensuing; that is, 
by basing the primers so very closely on sequences already known, slightly divergent 
members might escape detection. This is especially true if the previously cloned 
members were obtained by the use of PCR primers designed in a similar fashion. 
Using the equation described in the Materials and Methods chapter, it is possible to 
estimate the melting and annealing temperatures for the primers. These are listed in 
the figure legends. 
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Table 2 a Table listing the degenerate PCR primers used to amplify members of the 
GPCR family and the conserved amino acid sequences from which they were derived. 
Conserved amino acid residues are shown above the degenerate nucleic acid sequence 
of the primer. Also shown (where included) are the 5' restriction sites which were 
intended to aid cloning of amplified products. For each primer an approximate 
annealing temperature can be calculated using the equation described in the Materials 
and Methods chapter. Because these primers are degenerate, there are a range of 
values. The GPCR primers are longer than the other listed PCR primers which may 
result in the annealing figures being an overestimation. Primer 1; 69-81°C, primer 2; 
81-870C, primer 3, 55-69°C, and primer 4; 61-810C. 
Table 2a 
Primer Sequence 
Amino Acid (N-C) SAL I L C V I A L D R V 
1 Nucleic Acid 5GTCGAC CTG TG(CIT) G(C/T)(CIG) AT(C/T) GO IT(G/T) GA(CIT) (C/A)G(C/G) TAG 3 
Amino Acid (N-C) - F I L C W L P F F I HIND Ill 
2 Nucleic Acid 3' MG (T/C)(GIA)(G/C) IAG AGO ACC GfiC G3 A(A/T)G A(AIT)G (T/G)A TTCGAA-3 
Amino Acid (N-C) XBA I N / s L A V / L A 0 / e L If 
3 Nucleic Acid 5GCTCTAGA T(G/C) A(G/A)(T/C) CT(G/A) GO (C/G)T(G/C/J) GC(C/A/T) GA(T/C/G) (C/T)T3' 
Amino Acid (N-C) - F A/v/f L//vu C W L P Y/L H/q/n CLAI 
4 Nucleic Acid 3' AA(A/G) (CIA)(A/G)(G/C) IA(G/C) AC(G/A) r 	ACC (GIA)A(CIG/T) GG(G/A) (G/A)(T/A)(G/C/A) (T/G)T AGCTA CC 5' 
2.6. GPCR PCR results 
Five slightly different approaches were used to amplify and clone members of the G 
protein-coupled receptor family from hippocampus cDNA. These were necessary 
because of the extent of degeneracy of the PCR primers used; this resulted in 
amplification products which contained only a small percentage of genuine GPCR 
species, the remainder comprising of misprimed artifacts. Another major obstacle was 
the inability to achieve large-scale cloning of the PCR products into plasmid vectors. 
In part, this was due to the small quantities of material obtained, but the failure to 
digest the terminal restriction sites efficiently represented the major cause. This is 
because certain restriction enzymes digest sites located at the ends of DNA strands 
poorly; Sall, the choice of Libert et al., being one of these. Therefore, a method which 
has been employed by some, but with little success here, is to blunt-end the PCR 
products with a suitable polymerase and ligate the products into extensive 
concatamers. In this way, restriction sites become flanked by long stretches of DNA, 
permitting their unhindered digestion (ref. 32). Invitrogen market a novel cloning 
system for PCR products; the 'TA Cloning System'. The operation of this kit relies on 
the observation that Taq polymerase adds a supplementary adenosine base overhang 
to the 3' end of many of the DNA strands that it synthesizes. Thus, a vector 
possessing 3' thymidine base overhangs is able to anneal and be ligated to these 
products. Because of the low efficiency of this process, a super-competent 
preparation of bacteria is used in the transformation step. This system of cloning was 
used in the majority of PCR cloning experiments described in the following pages. 
The first strategy involved the use of an amplification program very similar to that 
used by Libert et al. Twenty-five cycles of the program: 
93°C 	1.5 min  
55°C 2niin 
72°C 	4mm 
were performed. An aliquot of the reaction product was subjected to a second round 
of amplification and then electrophoresed on an agarose gel. The resulting 520 bp 
band (the expected size-range for products of family members varies from 500-1000 
bp) was cloned into the TA kit vector (pCR II). Of 5 insert-containing clones 
obtained, only one showed an extended reading frame from the primer sequence 
which encoded key residues consistent with it being a member of the GPCR family. 
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Clone (expt. 1) 	 GPCR Product 
11 	 1 alb adrenergic receptor (ref. 33) 
The second cloning attempt differed by the lowering of the annealing temperature to 
500C in order to increase the possibility of amplifying members of the family less 
homologous to the primer sequences, albeit at the risk of decreasing the specificity of 
the reaction. The reaction products were electrophoresed on a low melting point 
agarose gel so that products within the expected size-range could be cut out and 
purified. The purified DNA was subjected to a further round of amplification prior to 
cloning. As expected, the number of non-specific products was high, but two 
members of the GPCR family were identified. 
Clone (expt. 2) 	 GPCR Product 
4 	 Dopamine dl receptor (ref. 34) 
16 Cannabinoid receptor (ref. 35) 
The third strategy involved the creation of a pre-selected cDNA template. By using 
the 3' PCR primer instead of an oligo-dT primer in the reverse transcription of 
hippocampus mRNA, any cDNA which did not contain that sequence would not be 
present as a template for the PCR reaction. The subsequent PCR amplification further 
selects for GPCR members as there is a requirement for a site on the cDNA 
complementary to the 5' primer. This strategy proved to be very efficient in removing 
much of the background amplification products such that, out of 19 clones, 9 were 
genuine GPCRs. These are listed below. 
Clone (expt. 3) GPCR Product 
1 Rat testis GPCR (ref. 36) 
2 Fusion product* 
8, 12, 18 Adenosine al receptor (ref. 37) 
9 alb Adrenergic receptor 
13, 16 Dopamine dl receptor 
14 P2 Adrenergic receptor (ref. 38) 
*The fusion product contained in clone 2 was comprised of sequences from a GPCR, 
R334' (ref. 39) and from the dopamine dl receptor. The fusion event probably arose 
in the insert-to-vector ligation step. 
To extend the range of possible GPCRs amplifiable, a new set of primers were 
employed (see section 2.5). These were devised with a sequence bias that predisposed 
them to amplify GPCRs of the neuro- and bio-active peptide receptor subfamily such 
as the cholecystokinin and bombesin receptors: the activities of which may have 
important roles in the modification of synaptic transmission. At first, a lower 
stringency reaction (550C annealing temperature, two rounds of 30 cycle 
amplifications) was performed which yielded only 2/10 positive GPCR clones. 
Clone (expt. 4) 	 GPCR Product 
3 	 Rat testis GPCR 
8 Vasoactive intestinal peptide receptor 
(ref. 40) 
When the annealing temperature was increased to 590C, only one clone out of 20 
proved to be a genuine GPCR. 
Clone (expt. 5) 	 GPCR Product 
12 	 Endothelin 1 receptor (ref. 41) 
The final method used was 'nested PCR'. PCR products from a reaction, in which the 
the PCR primers used were the newly-designed pair, acted as a template for a 
secondary round of amplification using the same 3' primer coupled with the old 5' 
primer. Because the old 5' primer is complementary to sequences downstream of the 
new 5' primer, only those primary products which were genuine GPCRs should be 
able to act as template for the secondary amplification. The term 'nested' is applied 
because the second set of primers acts internally to the first set. One problem with 
this particular application is the fact that, due to there being a bias in the primers' 
affinities for subsets of GPCRs, the combination of such primers might result in an 
actual decrease in the scope of transcripts amplifiable. Out of 20 clones initially 
analysed, 14 were GPCRs as listed below. 
Clone (expt. 6) GPCR Product 
1, 2, 5, 12 Endothelin 1 receptor 
4, 6, 8, 9, 10 a lb Adrenergic receptor 
7 R334 receptor 
13 Adenosine a3 receptor (ref. 42) 
14,15 Dopamine dl receptor 
17 1 132 Adrenergic receptor 
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A further 520 colonies were gridded, transferred onto nitrocellulose filters, and 
probed with a mixed probe corresponding to the above clones. Those colonies which 
failed to hybridise (and were, therefore, none of the above) were sequenced but no 
new GPCRs emerged. 
This brought to an end the GPCR amplification attempts on hippocampus cDNA. In 
all, 10 members of this family were isolated, none of which were either novel or 
restricted to the hippocampus in expression. 
2.7: Introduction to metabotropic glutamate receptors 
The second candidate gene family which underwent degenerate PCR analysis was the 
metabotropic glutamate receptor family (ref. 43). Pharmacological experiments 
originally defined three types of glutamate receptors on the basis of antagonist 
binding specificities (Chapter 1); N-methyl- D-aspartate (NMDA), quisqualate/a-
amino-3 -hydroxy-5-methylisoxazole-4-propionic acid (Q/AMPA), and kainic acid 
(KA) receptors. Evidence for a fourth came from both the effects of another agonist, 
2-amino-4-phosphonobutyrate (L-AP4), and the realisation that glutamate could 
induce secondary messenger production (refs. 44-46). These data suggested that 
unlike the ion channel operation of the first three, the new type required the 
heterotrimeric G protein family to elicit electrophysiological changes; hence the name 
metabotropic glutamate receptors. 
The introductory chapter described the work which has been carried out to investigate 
the role of these receptors in the functioning of the brain, specifically in the processes 
of memory creation: this will not be discussed in any further detail here. 
In the search for the genes encoding these receptors, two groups screened clones in a 
Xenopus oocyte expression system and isolated identical clones which encoded a 
protein with the correct functional characteristics, subsequently named mGluRl (refs. 
47 and 48). Analysis of the nucleotide sequence of this cDNA revealed that the 
protein it encoded was topologically similar to other members of the GPCR 
superfamily, in that it possessed seven transmembrane domains, but had little in the 
way of direct sequence homology (fig. 2.2). The N-terminal extracellular domain is 
much larger that that of other GPCRs and contains weak homology at the amino acid 
level to the membrane-bound form of the sea-urchin guanylate cyclase and the G1uR 
B receptor. The carboxy-terminus region contains proline/glutamine- and 
glutamate/aspartate-rich stretches similar to those found in adrenergic and muscarinic 
acetylcholine receptors. 
The following years have seen the cloning of seven additional members of this family 
from brain tissue. mGluRs 2, 3 and 4 were cloned by using mGluRl cDNA as a probe 
in a low stringency screen of a brain cDNA library (ref. 49). mGluR5 was cloned 
using PCR primers directed against conserved amino acid regions in TM domains I 
and V to amplify members of the family from hippocampus cDNA (ref. 50). mGluR6 
was cloned by another low stringency library screen, this time using a rat retinal 
cDNA library (ref. 51). mGluR7 was cloned independently by two groups. Okamato 
et al. (ref. 52) used PCR primers based on TM domains HI and VI to amplify from 
brain cDNA whereas Saugstad et al. (ref. 53) used PCR products amplified from 
olfactory bulb cDNA (using primers against TM II and intracellular loop Ill) to 
screen an olfactory bulb cDNA library. From this latter screen, another novel mOluR 
(8) was cloned but its sequence has not yet been published. 
The table below summarises the agonist specificities and the signal transduction 
pathways used for each of the eight mGluR subtypes known. 
mGluRl 	 Quisqualate sensitive 	IPy'Calcium signal pathway 
mGluR5 if 
	
of 
mGluR2 	 trans-ACPD sensitive 	cAMP production pathway 
mGluR3 to 	 it 
mGluR8 	 it 
	
to 
mGluR4 	 L-AP4 sensitive 	 to 
mGluR6 91 	 it 
mGluR7 	 to 
	
of 
2.8: Metabotropic glutamate receptor primer design 
Among the five members of this family that were originally published, the amino acid 
sequences were relatively highly conserved which made primer design more 
straightforward. As before, the regions chosen corresponded to the transmembrane 
domains (fig. 2.1). The precise sequences of the primers are listed in table 2b. 
2.9: Metabotropic glutamate receptor PCR results 
Using the primers described, PCR amplification was performed both on rat 
hippocampus cDNA and an aliquot of the rat hippocampus cDNA library (created by 
igE 
Table 2 b Table listing the degenerate PCR primers used to amplify members of the 
mGluR family and the conserved amino acid sequences from which they were derived. 
Conserved amino acid residues are shown above the degenerate nucleic acid sequence 
of the primer. For each primer an approximate annealing temperature can be calculated 
using the equation described in the Materials and Methods chapter. Because these 
primers are degenerate, there are a range of values. Primer 1; 49-63°C, and primer 2; 
49-510C.  
Table 2b 
Primer Sequence 
Amino Acid (N-C) S G/S R E L S/C Y 
1 Nucleic Acid 5_ TC(A/C/G) (G/A)G(T/C) (C/A)G(GIA) GA(G/A) CT(C/T/G) (T/A)GC TA-3'  
Amino Acid (N-C) T M Y T T C 
2 Nucleic Acid 3'— T3 TAO ATG TG(G/A/T) T33 ACG_5 
J. 0. Mason and M. Richardson, Centre for Genome Research). The program used 
was based upon that used for the amplification of GPCR family members. 
950C 	 5mm 
930C 	 1.5 min  
520C 2mm 
720C 	 4 min 30 cycles 
Products at the expected size of approximately 520bp were observed from both 
amplifications. In addition, the cDNA-derived products showed bands at other sizes 
which were not removed by increasing the annealing temperature to 55°C. Of those 
aberrantly sized products sequenced, none showed any homology to the metabotropic 
glutamate receptors. 
The correctly sized products were pooled and cloned using the 'TA Cloning' strategy 
due to the absence of restriction sites at the S ends of the primers. Of the seven clones 
initially sequenced, one was mGluRl (clone 1), one was mGluR5 (clone 4), and five 
were mGluR3 (clones 3, 5, 8, 11 and 12). The remaining 12 clones were 'T-tracked'; a 
process of sequencing clones with respect to just one base so that a quick 
identification can be made. Eight clones corresponded to mGluR3, the rest were 
resequenced in full. Only one of these four (clone 10) represented a genuine member 
of the family; mGluR4. 
Because mGluR3 was represented most highly in the products, ways of increasing the 
abundance of other members were sought. One method attempted relied on the fact 
that only mGluR3 contained a Taq I restriction site within the PCR product sequence. 
Therefore, the PCR products were cut with this enzyme and then reamplified prior to 
cloning. No different mGluRs were identified using this approach. 
2.10: Introduction to heterotrimeric G protein a subunits 
The logical follow-up to the study of two G protein-coupled receptor families was the 
heterotrimeric guanosine triphosphate-binding proteins themselves (refs. 54-60). 
Additional to their described roles in neural functioning, there are also examples of 
members which exhibit restricted tissue distribution: these factors suggested that they 
would be a good candidate for a degenerate PCR approach. The members of the GTP-
binding protein superfamily, of which the a subunits are a subclass, mediate a wide 
range of cellular processes. They share the ability to carry out their various functions 
only when in the activated, GTP-bound, state. Hydrolysis of the GTP molecule into 
GDP, results in the cessation of this activity. Therefore, this family represents a 
molecular switch for a variety of cellular processes. The scope of their activities 
extends to signal transduction (heterotrimeric GP (x subunits and ras family), 
vesicular trafficking (RABs), proliferation/differentiation control (ras family) and 
protein synthesis regulation (elongation factors). As might be expected from 
molecules sharing such a function, regions of structural and sequence homology are 
found in common between all members. 
Region Gi (A or P) contains the amino acid motif:-
GX4 GK(S/T).. 
where X is any residue. It is thought to be involved in the binding of the a and I 
phosphates of the GTP molecule in the active form. 
Region G2 (B) contains a threonine residue which might chelate 
magnesium ions required for the GTP hydrolysis step. 
Region G3 (C or G') contains the amino acid motif:- 
DX2 GQ...... 
and is involved in the binding of the y phosphate of the GTP molecule. 
Region G4 (G) is defined by the amino acid motif:- 
... Z4  (N/T) (K/Q) X D ...... 
This region is known to bind the guanine ring. 
Region G5 (I or G") is characterised by the amino acid motif:- 
TCAtDT...... 
It is thought to play a role in the hydrolysis of the GTP molecule. 
The a subunit of the G proteins forms a heterotrimeric complex with the 13 and  y 
subunits when in the GDP-coupled state. This complex associates with a G protein- 
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coupled receptor (the precise type depending on the subunit composition; ref. 61). 
The a subunit is made competent to exchange the GDP molecule for GTP by the 
structural changes in the receptor brought about by ligand interaction. This activation 
results in the dissociation of a and 3/'y from each other and the receptor. The GTP- 
bound a subunit is then free to carry out the effector functions for which it is specific. 
Because one stimulated receptor can activate numerous G proteins, and these do not 
immediately hydrolyse their GTP cofactors, the original 'signal strength' of the 
ligand-receptor interaction can be amplified many-fold by the repeated triggering of 
downstream events, such as the production of secondary messengers. It must also be 
pointed out that the t3/y  subunits exist in multiple forms (at least four in the case of 1, 
and six in the case of y). These all have particular expression patterns and specific 
combinatorial preferences within the complex. Recently, it has become apparent that 
the dissociated 3/y complex can also function as a downstream effector (refs. 62-65). 
Much work has been undertaken to clone all a subunits and to define their 
localisations and precise functions. Early work centred on the susceptibility of certain 
physiological systems to pertussis toxin. This indicated that a receptor-initiated G 
protein pathway was involved. With the advent of molecular cloning techniques, the 
first a subunit was cloned (G(xs; refs. 66 and 67). Subsequent isolation of new forms 
has relied primarily on the use of degenerate PCR, with primers directed against 
conserved sequence motifs (fig. 2.3). 
Cholera toxin affects the Gas and Gat subunits by causing an ADP-ribosylation 
modification of an arginine residue (R201 in G(xs). This results in a decrease in the 
activity of the subunit and also, a decreased affinity for the 13/'y  subunits. 
Pertussis toxin also acts via ADP-ribosylation, but does so on a conserved cysteine 
residue present at the carboxy-terminus of those a subunits with a susceptibility to its 
effects. The result, a failure to interact with the relevant receptor, aided the 
assignment of function to this region of the protein. 
Other regions of the a subunit have been subjected to alterations to assess their roles. 
N-terminal cleavage causes a failure to interact with /y subunits. The ability of Gas 
to stimulate adenylyl cyclase falls by 90% when the amino acids L and R (positions 
282 and 283) are changed into F and T (the corresponding residues in the adenylyl 
cyclase-inhibiting a subunit, Gai). This is notable as there are almost no other effects 
observed on the function of the protein. 
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Figure 2.3 Diagram of the conserved regions within G protein a subunits. The five 
functional domains, Gl-G5, are shown (see text), two of which were used to design 
the degenerate PCR primers. Also featured are the insertions present in the Gas 
subunit. 
Figure 2.4 a The catalytic domain of the protein tyrosine phosphatases shown in 
diagrammatic form. Conserved amino acid sequence regions are highlighted in black; 
three of which were used to design the degenerate PCR primers. b Diagram 
illustrating the structures of the five principal classes of transmembrane PTPs (left) and 
five typical cytosolic PTPs (right). The diagonally hatched rectangles represent catalytic 
domains. Strongly stippled squares represent fibronectin type III (FN III) domains, 
cross-hatched circles represent Immunoglobulin-like domains (Ig), triangles represent 
MAM domains (see text), and the ellipse represents a carbonic anhydrase (CAH) 
domain. PTP 1C possesses 2 SH2 domains. PTP Megi possesses a cytoskeleton-
interacting domain. PTP PEST possesses a domain causing its rapid degradation. PTP 
61F contains a nuclear-localisation signal. PTP lB contains a domain which targets it 
to the endoplasmic reticulum. 
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To date, eighteen different a subunits have been cloned. Through sequence 
comparison, it has been possible to divide these into four groups. The following list 
arranges those published into their respective groups and also describes the roles that 
they play. 
Gs family 
Gas This a subunit typifies its group by coupling receptor activation to the 
stimulation of adenylyl cyclase (with a resultant rise in cAMP levels) and opening of 
certain calcium channels. The family is inhibited by cholera toxin, a process which is 
described below. There are at least four splice variants expressed in the brain (ref. 
68). 
Gaolf This closely related a subunit (88% amino acid identity) was originally 
identified as the olfactory tissue-specific G protein responsible for transducing 
odorant signals (see section 2.16; ref. 69). 
Gc,j family 
Gai 1, 2, and 3 are typified, like most members of this family, by their susceptibility 
to inhibition by pertussis toxin (refs. 70 and 71). They share 85% amino acid identity 
and are found at highest levels in the brain. Their downstream effects include 
inhibition of adenylyl cyclase, activation of phospholipases C and A, and the opening 
of potassium ion channels. 
GaO 1 and 2 also exist at high levels in neural tissue and have been seen to play a 
large role in growth cone functioning where they are activated (contrary to paradigm) 
by GAP-43 which is not a GPCR (ref. 72). 
Gat 1 and 2 are the 'transducins'; coupling the photo-activation of rhodopsin and cone 
opsin, respectively, to the activation of retinal phosphodiesterase (ref. 73). 
Gaz (also known as Gax) is another mainly neuronal a subunit (refs. 74 and 75). 
Unlike to other members of this family, it is not affected by pertussis toxin. It 
possesses a non-canonical GI domain with the 'GAGES' motif being replaced by 
'GTSNS'. 
Gustducin is a member of the Gal group and is localised to the papillae of the tongue 
where it is thought to mediate at least part of the taste response (ref. 76). 
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G,,q family 
Gq and Gall, like the rest of the group, are insensitive to the effects of Pertussis 
toxin, and act by stimulating PLC (ref. 77). They contain the G  motif GTGES'. 
Gal4 is expressed in a number of tissues but has not been well characterised (ref. 78). 
0a15 and 16 are restricted to B- and T-cell haematopoietic lineages, respectively and 
contain the 01 motif 'GPGES' (ref. 80). 
Ga12 and 13 family 
Gal2 is expressed in the brain among other tissues whereas Ga13 is entirely non-
neurally located (ref. 81). They share a separate grouping by virtue of their sequence 
divergence. They are both pertussis toxin insensitive. 
2.11: G protein a subunit primer design 
Degenerate primers were created against conserved amino acid motifs in the G 1 and 
03 domains as illustrated in fig. 2.3. The primer sequences are listed in table 2c. 
2.12: Gprotein a subunit cloning results 
The G protein a subunit family of genes were easier to amplify than members of 
other gene families due to the highly conserved nature of the domains against which 
the primers were directed. 
Hippocampus cDNA was taken through a PCR cycling program similar to those used 
before:- 
940C 	30 sec 
49°C 2.0 mm 
72°C 	4.0 min 	 30 cycles 
A clear doublet was seen when the PCR products were run out on an agarose gel. 
This agreed with the expected sizes of GP a products; approximately 550 bp for Gas-
derived products (due to the presence of an additional intervening stretch of amino 
acids; fig. 2.3), and approximately 510 bp for other members of the family. The 
products were cloned using the TA vector system resulting in 37 colonies with insert-
containing plasmids. Nine were sequenced, of which six encoded Gq and three 
Table 2 c Table listing the degenerate PCR primers used to amplify members of the 
a subunits of the G protein family and the conserved amino acid sequences from 
which they were derived. Conserved amino acid residues are shown above the 
degenerate nucleic acid sequence of the primer. Also shown (where included) are the 5' 
restriction sites which were intended to aid cloning of amplified products. For each 
primer an approximate annealing temperature can be calculated using the equation 
described in the Materials and Methods chapter. Because these primers are degenerate 
there are a range of values. Primer 1; 39-450C, and primer 2; 52-570C. 
Table 2e 
Primer Sequence 
Amino Acid (N-C) XHOI R/K L L L L G 
1 Nucleic Acid 5GGGGCTCGAG (AIC)A(G/C) ITG CTG C11 (C/T)T(G/T) GG_3 
Amino Acid (N-C) D V G G Q A XBA I 
2 Nucleic Acid CT(G/A) CAI ca CCG Git (G/T)C(C/T) AGATCTGGGG5 
encoded Gail. Subsequently, twenty-eight were 'T-tracked' (Materials and Methods 
Chapter) to identify further members that had been cloned. Of these, sixteen 
represented Gq and four Gail. The remaining eight, after sequencing in full, were 
shown to be Gas, Gaolf (twice; one clone truncated artifactually), and Gai3; the rest 
being non-specific amplification products. 
A second successful amplification, using a new batch of cDNA, was cloned into both 
TA vector and pBluescript' (using the restriction sites in the primers), such that 140 
colonies from the former and over 300 from the latter were obtained. These were 
gridded on plates, transferred onto filters, and hybridised with a mixed probe 
consisting of Gq, Gas, and Gai3 components. Non-hybridising colonies were 
sequenced but no novel members of the family were found. 
The same technique of negative selection was applied to a third set of amplification 
products which had been amplified from eDNA synthesized with the 3' PCR primer 
as the reverse transcription primer. Although the non-specific background products 
were more abundant, all the family members were found in an initial sequencing test. 
980 colonies were screened but, again, none of the non-hybridising colonies 
represented novel members: only non-specific products or G proteins which had 
failed to hybridise (probably due to the highly variable amount of DNA attached to 
the filters in a bacterial colony transfer) were sequenced. 
2.13: Introduction to protein tyrosine phosphatases 
The introductory chapter described the role of phosphorylation in the modulation of 
protein activity. Protein phosphorylation can occur on serine/threonine residues or on 
tyrosine residues; these two types mediated by separate families of kinases. Much 
work has been reported concerning the isolation and characterisation of these 
enzymes in numerous biological systems, including LTPILTD; where the alteration 
of phosphorylation states is critical for the early stages of synaptic efficacy 
modification. Just as there are two types of kinases with specificities for the identity 
of the residue to be phosphorylated, so there are two types of 'phosphatase' enzymes. 
The family of phosphatases that remove phosphate moieties from tyrosine (as 
opposed to serine/threonine) residues are known as 'protein tyrosine phosphatases' 
(PTPs) and will be discussed in this chapter (refs. 82-88). 
One important point is that PTPs should not be thought of as carrying out purely 
deactivation processes in the cell: several examples of PTPs eliciting/propagating 
stimulatory cascades have been described. CD45 is required for the T-cell activation 
response. It achieves this by dephosphorylating the carboxy termini of the non- 
receptor tyrosine kinases ick and fyn, which results in a kinase-dependent cascade 
leading to the activation of the cell. Precisely how CD45 is triggered into the active 
state is not yet understood, but it probably arises from interactions with T cell surface 
markers (such as the T cell receptor or CD4) as they bind their respective ligands. 
Purification of a protein tyrosine phosphatase activity (from human placenta) was 
first achieved by Charbonneau et a! (ref. 89). Partial amino acid sequencing yielded a 
surprising homology to two cytoplasmic domains of the leukocyte common antigen 
(LCA or CD45; ref. 90). This was confirmed by full-length cloning of the cDNA 
(named PTP 113; ref. 91). Subsequently, related domains were identified in leukocyte 
common antigen-related protein (LAR. ref. 92) and T Cell PTP (which was 
purposefully cloned on the basis of this homology; ref. 93). 
PTP lB and T Cell PTP are small cytoplasmic proteins which contain one copy each 
of the —250 amino acid homology domain (74% identity between the two). CD45 and 
LAR are 4-5 times larger and are transmembrane proteins. They each contain two 
homology domains (I and II) which are both located in the cytoplasmic portion of the 
protein. Protein sequence information indicated that the extracellular regions are 
involved in some form of ligand binding. Thus, like the tyrosine kinase family, the 
PTP family could be divided into receptor-like and cytoplasmic forms. 
It has been shown that the conserved domain is, in fact, the catalytic domain 
responsible for the phosphatase activity. Fig. 2.4a shows the catalytic domain in 
diagrammatic form with the conserved amino acid regions highlighted. A conserved 
cysteine residue in an eleven amino acid motif:- 
IIVHCXAGXXRS/TG 
seems to be critical for the phosphatase activity (ref. 94) by forming a thio-phosphate 
intermediate. 
More than thirty members of this family have been cloned to date and it is likely that 
many more will follow. The classes of cytoplasmic and transmembrane PTPs can be 
further subdivided because of the accumulation, throughout evolution, of additional 
functional domains which specify the precise role or subcellular localisation of the 
phosphatase activity. Fig 2.4b illustrates examples of these different forms. 
Receptor PTPs usually have two intracellular catalytic domains but hPTP 3 and D 
PTP10D have only one. A purpose for two catalytic domains has yet to be 
determined; it was originally thought that the second one was inactive but, at least in 
the case of CD45, catalytic activity has been found in domain II as well as I; perhaps 
there is some auto-regulatory function in the second domain (ref. 95). 
Five classes of receptor-like PTPs have been designated on the basis of functional 
analysis:- 
I - includes CD45 and related members which have extensive splicing 
in the extracellular domains. 
II - includes LAR/hPTP iIhPTP i and is distiguished by the presence 
of extracellular fibronectin type III (FN III) and immunoglobulin-like (IG) domains. 
This is an arrangement reminiscent of the cell adhesion molecule, NCAM, and thus 
these molecules are thought to act in a similar fashion. 
III - includes D PTP10D and D PTP 99A. They possess extracellular 
FN HI domains. 
IV - includes PTPs a and c made notable by the presence of only a 
very short extracellular domain which is heavily glycosylated. 
V - includes h PTP C (a.k.a. f3 and 18) and h PTP y. They are typified 
by the presence of an N-terminal carbonic anhydrase-related domain which is not 
catalytically active but probably plays a role in ligand-binding (section 2.16). A 
vaccinia virus protein (D8) has a related domain and is known to be a cell adhesion 
molecule. 
PTPs ji. and K are two of the few receptor-PTPs with known ligands (the function of 
these two phosphatases will be discussed later in the chapter) and the search for other 
ligands is an area which demands further study. In particular, it would be interesting 
to discover if there is a triggering of catalytic function by ligand-binding induced 
receptor dimerisation similar to that observed with receptor tyrosine kinases. 
Cytoplasmic PTPs show a wide variation in structures and resulting functions. PTP 
lB contains a C-terminal amino acid motif which causes it to be transported to the 
endoplasmic reticulum where it carries out its functions. Nuclear localisation is 
specified by another C-terminal sequence in the Drosophila PTP, D PTP 61F (ref. 
96), whereas a motif in the PTPs, PTP-PEST and PTP PEP, directs these proteins to 
be rapidly degraded (ref. 97). PTP MEG1 and PTP Hi contain a glycophorin-binding 
domain which is related to those in the proteins ezrin and talin (ref. 98). This 
presumably acts as a cytoskeleton-anchoring domain for these PTPs so that 
dephosphorylation activity can be focused on the proteins involved in the 
cytoarchitecture of the cell. PTP MEG2 contains a cellular retinaldehyde-binding 
protein (CRALBP) domain which may enable this PTP to interact with lipid moieties 
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(ref. 99). Again, reminiscent of the kinase cascade, there exist two PTPs (PTP 1C and 
SH PTP 2) containing SH2 domains (src homology domain 2), which are known to 
interact with phosphotyrosine moieties on other proteins (ref. 100). This may indicate 
that these proteins are involved in the deregulation of receptor protein tyrosine kinase 
activity. 
2.14: Protein tyrosine phosphatase primer design 
Three conserved regions in the catalytic domain were used to design degenerate PCR 
primers. These are shown in fig. 2.4a, and the precise sequences are presented in table 
2d. As can be seen, a number of primer sequence variations were used in some cases. 
The pair of primers which resulted in the amplification of the PTPs was the third set. 
2.15: Protein tyrosine phosphatase PCR results 
The successful amplification required the adoption of an entirely different PCR 
amplification protocol which, together with a third set of PCR primers, was a gift of 
K. Lee (Centre for Genome Research). The full protocol is described in the Materials 
and Methods chapter, but the key differences probably lay in the use of random-
primed cDNA synthesis (thus avoiding the requirement of oligo-dT-primed reverse 
transcriptase enzyme to pass through large 3' untranslated regions before entering 
PCR-amplifiable coding sequence) and the use of a different source of Taq 
polymerase. Agarose gel electrophoresis of the DNA products from the second 
attempt at the reaction revealed a strong signal corresponding to the expected product 
size-range. This material was cloned into the TA cloning vector and transformed into 
competent bacteria. 
Of the first seventeen clones sequenced, nine different PTP catalytic domains were 
identified:- 
Clone Sequence Identification 
1 PTP 	(domain I) 
3 PTP y (domain I) 
4 Novel sequence 1 
6 PTP 6 (domain I) 
7 PTP Hi (domain I) 
9 PTP a (domain H) 
11 PTP y (domain I) 
12 T Cell PTP 
EK 
Table 2 d Table listing the degenerate PCR primers used to amplify members of the 
PTP family and the conserved amino acid sequences from which they were derived. 
Conserved amino acid residues are shown above the degenerate nucleic acid sequence 
of the primer. Also shown (where included) are the 5' restriction sites which were 
intended to aid cloning of amplified products. For each primer an approximate 
annealing temperature can be calculated using the equation described in the Materials 
and Methods chapter. Because these primers are degenerate there are a range of values. 
Primer 1; 47-55°C, primer 2; 49590C, primer 3; 49530C, primer 4; 55650C, primer 
5; 63-65°C, and primer 6; 47550C. 
Table 2d 
Primer Sequence  
Amino Acid (N-C) SAL I or ECO RI K C - 0 V W P 
1 Nucleic Acid 5'C GTCGAC AA(A/G) TG(C/T). ill (C/G)A(A/G) TA(C/T) TtX3 CC-3' 
2 Nucleic Acid 5-GGGAATTC AA(A/G) TG(CIT) G(C/A)i CA(AIG) TA(C/T) T3 CC-3'  
Amino Acid (N-C) XHOI F W r M V/I W E/D/q 
3 Nucleic Acid 5GGGGCTCGAG TT(C/T) T3 III ATG (G/A)T(G/C) 103 (C/G)A_3 
Amino Acid (N-C) H C S A G A/I G BAM RI or XBAI 
4 Nucleic Acid - 	3_ 10 NG TC(G/A) CG(AIG/T) ca (C/T)(AIG)I CC(TIC/G) CCTAGGC_5 
5 Nucleic Acid 3_ GTO NX3 TCA CC(C/G/T) CC(CIG) Iii CCG AGATCTGGGG_5' 
6 Nucleic Acid 3_ GT(A/G) AC(GIA) TC(A/G) ca cXI (C/T)AC - CTAGG C_5 
22 PTP a (domain II) 
23 PTP P19 
24 Novel sequence 2 
25 PTP y (domain I) 
26 PTP P19 
27 Putative rat PTP Hi (domain I) 
28 PTP a (domain II) 
29 PTP 	(domain I) 
37 T-Cell PTP 
A mixed probe corresponding to equal parts of the two novel PTP PCR products was 
used to screen duplicate filter transfers (plating and transfer carried out by G. 
Stapleton; Centre for Genome Research) of a rat hippocampus cDNA library (created 
by Dr J. 0. Mason and M. Richardson; C.G.R.). This library consisted of 20 plates of 
50,000 plaques each, which gave a representation of i6  cDNAs. 
Six positive plaques were purified to homogeneity and analysed by sequencing (fig. 
2.6b/c for analysis of clones). Two clones (13.1 and 16b. l) corresponded to the first 
novel PTP, three (10.1, 16a.1, and 18.1) to the second, and one clone represented a 
mitochondrial sequence which showed some cross-hybridisation to the second novel 
PTP probe sequence. This was not studied further. The two novel PTPs were also 
used as probes for Northern hybridisation in order to obtain information concerning 
the expression of the transcripts in the brain and other tissues (fig. 2.8). 
MO 
2.16: Summary of the genes cloned by this approach 
G Protein-Coupled Receptors 
a lb Adrenergic 
32 Adrenergic 
Dopamine dl 
Adenosine al 
Adenosine a3 
Cannabinoid 
Endothelin 1 
R334 
Rat Testis GPCR 
VIP (discredited) 
Metabotropic Glutamate Receptors 
1 
3 
4 
5 
G Protein a Subunits 
ii 
B 
S 
Olf 
Protein Tyrosine Phosphatases 
P 19 
T Cell 
Hl 
a 
Novel PTP 4 
Novel PTP 24 
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In this section of the chapter the relative successes of each of the cloning attempts 
made on the four families will be discussed. As stated earlier, the aim of this 
approach was to discover gene-family members which were restricted in expression 
to the hippocampus. This was examined by using the cloned PCR products as probes 
on Northern blots of brain regions or, in the case of those that had been cloned and 
published previously, the literature concerning expression was consulted. 
The questions arising from these experiments are:- 
Were the primers able to amplify some hippocampus-expressed 
members and not others? 
What is the likelihood of there being other (unisolated) members of 
the gene family in the hippocampus? 
Are there within the amplified/published members any that show 
the required expression pattern? 
G protein coupled receptors 
The attempts to clone members of this family by degenerate PCR raise all three of the 
above questions. At face value there seems to be a lack of the 'classical' GPCR 
neurotransmitter receptors that would be expected (and are known to be present) in 
the hippocampus. This is probably due to the combined effects of their low 
expression levels and the biasing of the primer design (especially the second set 
which were not aimed at the neurotransmitter receptor subset of GPCRs). 
The ten identified members of this family can be subdivided into three functional 
groups. 
The classical neurotransmitter receptors were represented by five genes; otib 
adrenergic, P2 adrenergic, dopamine dl, adenosine al, and adenosine a3 receptors. 
The first two receptors in this list are present due to the many adrenergic afferents 
entering the hippocampus (for example those from the locus ceruleus and ventral 
tegmentum). Briefly, the otib receptor is localised post-synaptically and is known to 
couple ligand binding to activation of calcium channels. The P2 receptor is found 
post-synaptically as well as on some glia. It is thought to act by the stimulation of 
cAMP production. In addition, because of its affinity for adrenalin, as well as nor-
adrenalin, it is thought to play a role in the association of emotion/stress levels to 
learning and memory. 
The dopamine dl receptor is thought to play a role in diseases such as Parkinsonism 
and schizophrenia; with which the hippocampus is intimately linked. It is transcribed 
from an intronless gene and expression is seen in the cortex, thalamus, amygdala, 
septum, basal ganglia and low levels in the hippocampus. The adenylyl cyclase 
enzyme is stimulated in response to receptor activation. 
The two cloned adenosine receptors are known to mediate various effects on brain 
physiology such as sedation, vasodilation, gluconeogenesis, lipolysis, increases in 
potassium flux, and decreases in calcium flux. Both at and a3 receptors act by 
inhibiting adenylyl cyclase whereas a2 (not cloned in this study) acts through the 
reverse process. The localisation of at is not well characterised with only brain and 
thyroid confirmed to be sites of expression. a3, however, has been observed in the 
cortex, striatum, and olfactory bulb as well as testis, lung, kidney, and heart (where it 
can control the rate and extent of contractility). 
The cannabinoid and endothelin receptors are not classical neurotransmitter receptors 
and are probably localised outside of the synaptic cleft. 
CNS depression and analgesia are two effects of the administration of drugs of the 
cannabinoid family. The receptor causes the inhibition of the adenylyl cyclase 
pathway. Expression has been shown in the hippocampus, cortex, amygdala and 
ventromedial hypothalamus but not every neuron expresses the receptor and so, in the 
granule cell layer of the dentate gyms, for instance, punctate labelling is seen with in 
situ hybridisation. Recently, the endogenous ligand for the receptor has been 
identified as anandamide, a derivative of arachidonic acid (ref. 101). 
There are three members of the endothelin peptide family and the receptor for 
endothelin 1 was cloned here (although published studies have shown that endothelin 
2 can also stimulate this receptor to a small degree). A large N-terminal domain is 
found in these receptors; typical of peptide hormone receptors. Expression sites for 
this receptor subtype include the cortex and midbrain among other regions. The 
peptides themselves are some of the most potent vasocostrictors known and probably 
play a part in the regulation of blood flow in the brain. 
The final classification of cloned GPCRs is the group that possess unidentified 
ligands. Three of these 'orphan receptors' were amplified from hippocampus cDNA. 
R334 was originally cloned from a rat pituitary library and expression of a 7 kb 
transcript has been seen by Northern blot in the brain and testis. Within the brain the 
principal sites of expression are the piriform cortex and the lateral septal nuclei. 
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Comparison of its eDNA with other sequences seems to suggest that this is not a 
member of the classical neurotransmitter receptor subfamily. 
The 'rat testis GPCR' is reported to be observable by Northern blot only in the testes 
of sexually mature rats although it was originally cloned from cerebellum eDNA and 
was amplified here from the hippocampus. Further expression studies on brain region 
Northern blots seem to confirm the observation that this transcript is expressed at a 
level in the brain below the sensitivity limit of Northern hybridisation (data not 
shown). 
The third member of this group was originally published as the receptor for 
vasoactive intestinal peptide (VIP). VIP, as well as its long-established role in smooth 
muscle contraction, has been shown to have positive effects on the growth and 
survival of neurons in culture. The receptor is found principally in the presynapses of 
cholinergic neurons and acts by stimulating the activity of adenylyl cyclase. A 
transcript of 2.7 kb has been described in the brain, colon, heart, lung, kidney, spleen, 
and small intestine. However, a second group published a sequence which they 
claimed encoded the genuine VIP receptor (ref. 102). This gene showed substantial 
homology to the secretin/glucagon receptors which was expected, considering these 
peptides can act as VIP receptor agonists and antagonists. Secretin and glucagon were 
originally described as capable of binding to the first receptor, but this observation 
was not reproducible in other laboratories. Therefore, the true identity of the ligand 
for the receptor cloned here remains to be elucidated. Further analysis of the precise 
distribution of the mRNA for this receptor was performed by hybridising a brain 
region Northern blot with a probe derived from the PCR product (fig. 2.5a). The 
results indicate that this receptor is expressed at comparable levels in hippocampus, 
cerebellum, cortex, olfactory bulb, and the whole brain-minus-hippocampus. The size 
of the transcript matches that published in the original description of this gene. 
The GPCR family appeared a promising source of region-specific genes because of 
the large number of members cloned to date. The low number of family members 
obtained by the degenerate PCR approach, in this particular case, was probably 
caused by the diverse nature of the sequences together with their low expression 
levels. Many more receptors that are known to be expressed in the hippocampus 
should have been cloned. Outside of the hippocampus, the same primer sets were 
capable of amplifying a serotonin receptor (B Davies, CGR; personal 
communication) thus leading to the assumption that the expression level is a critical 
factor determining their presence or absence in these PCR products. 
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Figure 2.5 a Messenger RNA distribution of discredited VIP receptor within the 
brain as obtained by Northern hybridisation. The transcript size of 2.7kb matches that 
presented in the original publication. b Messenger RNA distribution of Golf  a 
subunit within the brain and other tissues. Ribosomal protein S26 was used as loading 
control for the Northern filter. (Hc; hippocampus, Ce; cerebellum, Cx; cortex, Olf; 
olfactory bulb, RoB; rest of brain, Ht; heart, Mu; muscle, Te; testis, Ki; kidney, Lu; 
lung, and Sp;  spleen.) 
Fig. 2.5a 
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VIP Receptor 
He Ce Cx OIf RoB 
Fig. 2.5b 
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Metabotropic glutamate receptors 
In total, four different members of this family were cloned. Seven members have 
been published and studied in detail with an eighth member as yet, unpublished. 
Expression data from these papers indicate that six out of seven show at least low-
level expression within the hippocampus. It seems to be a general characteristic of the 
mGluR family (with the exception of mGluR 6) that the expression profiles seen are 
relatively widespread within the brain. Therefore, any particular region seems to 
express a mixture of these receptors; maybe due to the multitude of different cell-
types within that region or because the individual receptor types are responsible for 
particular responses to the glutamate signal. For example, it is known that some 
mGluRs are found on the post-synaptic membrane, as expected for the normal 
transduction of the glutamate signal, while others are located in a presynaptic manner 
(autoreceptors) and cause negative feedback, limiting the amount of glutamate 
release. The table below illustrates the published expression profiles of the known 
mGluR transcripts. mGluRs 1, 3, 4, and 5 were cloned in a small, non-exhaustive 
search. 
1-cortex, hypothalamus, olfactory bulb, cerebellum, hippocampus. 
2-hippocampus, olfactory bulb, cerebellum, cortex, hypothalamus. 
3-'similar to mGluR4' 
4-olfactory bulb, cerebellum, low hippocampus. 
5-hippocampus, cortex, olfactory bulb, striatum. 
6-retina. 
7-cortex, thalamus, hippocampus, striatum, olfactory bulb, etc. 
From these data, it seems as if PCR products derived from mGluRs 2 and 7 should 
also have been isolated. Reasons for not cloning family members by degenerate PCR 
may include the low abundance of those forms in the hippocampus and possibly, 
divergence from the canonical sequence in the region used to design the PCR 
primers. With respect to mGluRs 2 and 7, only mGluR7 shows significant 
divergence; found at the 3' end of the downstream primer sequence. This may explain 
its absence from the PCR products (because of its relatively recent cloning, the 
sequence of mGluR7 was not used for primer design). An additional observation was 
that the low expression of mGluR4 in the hippocampus was reflected in the 
infrequency of its corresponding PCR product in the cloned and identified material. 
It seems likely that the majority of the mGluR subtypes in the brain have been 
identified. Of course, a receptor with a sufficiently different sequence might escape 
PCR amplification but would probably have been isolated in the low stringency 
library screening experiments described earlier. It is possible that a subtype expressed 
at a low level in a small brain region or one that is developmentally-/activity-
regulated might have escaped detection, but that would not prove useful for our 
purposes by virtue of those characteristics. 
Heterotrimeric G proteins; a subunits 
Five members of this family were amplified from hippocampus cDNA (Gail, i3, q, 5, 
and oil). Of these, the presence of the olfactory G protein a subunit was particularly 
surprising as this had been reported to be specifically expressed in the olfactory bulb, 
as explained in section 2.7. However, even though a specifically expressed 3' 
untranslated region exists, the coding region is widely expressed in the CNS. This 
was demonstrated here by using the PCR product as a probe on a Northern blot of 
various tissues (Fig. 2.5b). Prominent expression was observed in hippocampus, 
cerebellum, cortex, rest of brain (brain-minus-hippocampus), heart, and muscle. Brain 
expression of this gene existed in the form of three major transcripts of approximately 
2, 3.5, and 4 kb size. Published Northern data on olfactory epithelium expression 
indicates an additional transcript if 4.7 kb size which may account for the erroneous 
assignment of olfactory-specific expression (ref. 103). It will be interesting to see if 
this subtype, with its relatively high expression in the brain, will be found to play an 
important role in general CNS function. 
It was encouraging to note that of the members cloned, a representative was found 
from each of the a subunit subgroups ('s', 'i' and 'q') except for the '12' subgroup. 
However, within the subgroups, certain expected members (because of their reported 
expression in the nervous system) were absent. This could be explained by brain 
expression being limited to non-hippocampal tissue, or by the fact that the primers 
were not a good match for their sequences. For example, Gao, Gax, and Ga12 are all 
reported to be expressed in the brain. Analysis of the 3' end of the downstream primer 
of Gax showed that it diverged slightly from the primer sequence; this may explain 
its absence. 
Finally, it must be pointed out that G proteins could might not possess hippocampus-
specificity through restricted expression pattern. This is because a 'specificity of 
function' within the hippocampus might be achieved by the unique combination of the 
multiple forms of the three subunits that make up the heterotrimeric complex, and not 
by the expression of a spatially restricted form. Countering this, is the reported 
restricted expression of the transducin and gustducin a subunits to their respective 
tissues. These, however, are located in primary sense-detection tissues, and thus may 
have evolved to carry out these specialised functions. Is the hippocampus sufficiently 
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different, or demanding in function, to require a specific a subunit? This question 
will be returned to in the discussion (Chapter VI). 
Protein tyrosine phosphatases 
Recently, a survey of PTP expression similar to the one described here was published 
(ref. 104). Using degenerate PCR primers to amplify PTPs from mouse brain, eight 
different members were identified. Of six published, only one was cloned in common 
with this attempt (PTP ö). This could indicate (ignoring differences in experimental 
conditions) that each brain region expresses a distinct subset of PTPs such that when 
the whole brain is analysed, only those PTPs which are widely expressed at a 
sufficiently high level will be evident (i.e. regional PTPs expressed at a low level will 
not be well represented in whole brain). 
Due to the assignment of function to the non-catalytic domains of the phosphatases, it 
is possible to make an educated guess as to the cellular processes occurring in the 
hippocampus that might require particular subtypes. Interestingly, two-thirds of those 
cloned here belong to the receptor PTP class which seems to be largely involved in 
cell-cell interactions. This reflects the growing realisation (as discussed in the 
introduction) that cell-adhesion plays a large role in neuronal function, whether 
through development, maintenance of neuronal morphology, or activity-dependent 
changes of synaptic efficacy. However, the cytoplasmic PTPs that were cloned, and 
their putative roles in hippocampus activity, are discussed first. 
PTP P19 was originally cloned from P19 embryonal carcinoma cells and was 
reported to be highly upregulated in cultures which had been taken through a 
differentiation protocol designed to create neuronal lineages (retinoic acid induction; 
ref. 105). Apart from this information, nothing is known about the expression of this 
PTP in the brain. Therefore, it was used as a probe on a Northern blot. Extremely low 
level expression was seen in the cortex, olfactory bulb, and brain-minus-
hippocampus. No expression changes were observable after electro-convulsive 
stimulation (Chapter V). 
T Cell PTP is named after its original site of cloning. Expression of this gene has also 
been observed in brain, spleen, thymus, and placental tissues. Like PTP P19, the 
absence of defined domains renders the function of this protein unknown. 
PTP Hi has a domain in the N-terminal region of the protein which shows significant 
homology to regions in the proteins band 4.1, ezrin, and talin (ref. 106). In these 
proteins the domain is thought to act by localising them to the junctions of the 
cytoplasmic membrane and the cytoskeleton (such as focal adhesions). Members of 
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the src family of cytoplasmic tyrosine kinases are known to play a part in the 
functioning of focal adhesions, so it is interesting that a PTP might also be present; 
perhaps in a regulatory capacity. In the nervous system, such cytoskeletal-
cytoplasmic junctions occur at the 'post-synaptic density' to localise receptors and 
signalling molecules in direct opposition to the presynaptic bouton. In the 
hippocampus, there are high levels of one particular tyrosine kinase, fyn, which plays 
an important role in the modification of synaptic efficacy during LTP (Chapter I). 
This kinase also activates a more specific kinase known as focal adhesion kinase 
(FAK) which is widely expressed in neurons (ref. 107). It would be interesting to 
discover if there was direct interplay between these two kinases and PTP Hi in the 
creation, or stabilisation, of LTP. The PTP Hi PCR products obtained from the rat 
hippocampus show an amino acid sequence homologous to that obtained from human 
HeLa cells. In all probability this represents the ortholog. Expression patterns for this 
PTP have not been published. Therefore, an analysis of the expression was performed 
on Northern blots of brain region RNAs. Transcripts were detected in all tissues 
assessed (data not shown) and did not appear to be affected by electro-convulsive 
stimulation (Chapter VI). 
The following clones are derived from receptor PTPs. In the case of the two novel 
members this classification could only be made definitively for one of them (PTP 24) 
after the cloning of larger cDNAs as described. PTP 4 is also expected to belong to 
the receptor class by virtue of sequence homology and transcript size. 
PTP a (ref. 108) is a transmembrane protein with only a very small extracellular 
domain which is highly glycosylated. Its published expression pattern is the brain, 
kidney, and liver with lower levels elsewhere. 
PTP 'y (ref. 109) is a candidate tumour suppressor gene located on human 
chromosome 3pl4.2-p2i. Transcript sizes of 8.5 and 5.5 kb are seen in brain, lung, 
kidney, liver, heart, muscle, spleen, and testis (where there also exists a 3 kb product). 
In the brain, the expression of PTP y appears to be developmentally regulated. 
Postnatal expression is seen in the rat septal/thalamic nuclei, cortex and hippocampus 
but this becomes increasingly restricted to the hippocampus during maturation (albeit 
with low levels elsewhere in the brain). The protein is a member of the subset of 
PTPs which has one carbonic anhydrase-like (CAH) and several fibronectin type Ill 
(FN-III) domains at the N-terminal end of the extracellular region. 
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A second member of this subset is PIP C (aka RPTP 13; ref. 110). Expression of this 
gene has been localised to the brain; more specifically, to the dentate gyrus, 
cerebellum and ventricular region. Compared to y, there is a larger extracellular 
domain, but it still possesses the CAH and FN-III domains at the N-terminal. A recent 
paper (ref. 111) sheds new light on the function of the carbonic anhydrase-like 
domain. Using expression cloning techniques, a receptor for the CAH domain has 
been found and identified as 'contactin', a GPI-anchored neural cell-adhesion receptor 
which was previously known to play a role in CNS development by inducing axonal 
growth. Therefore, this represents one of the few proven examples of a PTP 
converting a signal (in this case, a ligand) into a defined cellular response. 
PTP 6 mRNA exists in multiple splice-forms that differ in their number of constituent 
extracellular domains (ref. 112). These domains are the immunoglobulin-like and 
fibronectin type III domains; the longest protein form consists of 3 Ig and 8 FN III 
domains. Overall, this receptor PTP is 62.7% identical to the LAR PTP described in 
the introduction. Expression is seen in the brain, B cells, kidney, and heart. 
Localisation of the PTP 6 transcript within the brain shows high levels in the 
hippocampus, thalamus, and piriform cortex. 
2.17: Further characterisation of two novel PTPs 
The complete characterisation of the two novel members of the PTP family was not 
fully carried out. This was due to the early realisation that their expression patterns 
did not match our requirements. In addition, because of their large transcript sizes and 
low expression levels, full-length clones for either PTP were not obtained from a 
screen of the rat hippocampus cDNA library. Nevertheless, some attempt has been 
made to interpret the obtained sequence data in terms of the functioning of these 
molecules in the hippocampus (fig. 2.6a for alignments of the novel PTP PCR 
products with corresponding regions from a selection of common PTPs). 
Sequencing of clone PTP 4 showed that it contained substantial homology to PTP 4 
(ref. 113). Soon after, another related PTP, K, was published (ref. 114). PTP t mRNA 
is found as a 5.7 kb transcript in the lung and, to a lesser extent, in the heart and 
brain. It has been localised to human chromosome 18 pter-q 11 by analysis of somatic 
hybrids. In a C-terminus to N-terminus direction, it consists of two catalytic domains, 
an unusually large serine/threonine-rich spacer region of seventy amino acids, a 
transmembrane domain, four FN III domains, one Ig-like domain and a 'MAM' 
domain. The MAM (A5/meprin) domain is an approximately 160 amino acid motif 
containing four cysteines which form disulphide bridges. It was originally described 
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Figure 2.6 a Alignment of the amino acid sequences derived from the novel PTP 
PCR products (PTP 4 and 24) with a selection of corresponding regions from other 
PTP family members. 'Cat. I' indicates that the sequence is from the first catalytic 
domain. Boxed residues are those which match the consensus/majority. In this list, 
PTP 4 showed most similarity to LAR PTP (54%), whereas PTP 24 showed most 
similarity to hPTP (30%). b Diagram showing the analysis of two cDNAs 
corresponding to PTP 4. The two clones (13.1 and 16b.1) are shown below a scale 
indicating their size. Below this is an indication of the extent of sequence data. At the 
bottom of the figure is a cartoon showing the expected domain structure of PTP 4. This 
was deduced from sequence analysis (solid regions) and comparison with PTPs p. and 
ic (dashed regions). c A similar analysis was performed on the three eDNA clones 
(10. 1, 16a.1, and 18.1) which corresponded to PTP 24. Clone 16a.1 has the site of 
the insertion indicated (see Appendix). 
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in the cell-surface proteins, A5 and meprin. There is some homology in the spacer 
region to the cell-adhesion molecule, cadherin. The corresponding region in that 
protein is responsible for interaction with the modulatory proteins, -catenin and 
plakoglobin, although no positive evidence is available for a similar interplay in t (or 
K). PTP K mRNA is found primarily as a 5.3 kb transcript in the kidney and liver with 
lower levels observed in the lung, heart, and brain. There does seem to be some 
modification of expression sites in the brain as maturation progresses, with an 
increase in olfactory bulb expression and concomitant decrease in cerebellar 
expression. Some evidence exists of cleavage of the extracellular portion (in the case 
of K, at least) by a protease, furin, although the function of the soluble product is not 
clear. Key experiments (refs. 115 and 116) involving the expression of these two 
PTPs in cells, or the attachment of their extracellular domains to beads, have shown 
that they function as cell adhesion molecules. Moreover, they are homophilic 
receptors; a i molecule will only bind to another t, and a K will only bind to another 
K molecule. This adhesion is mediated by the extracellular domains, as might be 
expected, with the precise specificity of binding being dictated by the MAM domain. 
Hence, chimaeric PTPs with a particular MAM domain will only interact with a like 
MAM domain-containing PTP (ref. 117). 
Two cDNAs which hybridised to PTP 4 were obtained from a screen of a rat 
hippocampus cDNA library (fig. 2.6b). The 5' ends of these terminate in the same 
region of the cDNA; that which corresponds to the N-terminal end of the first 
catalytic domain. The longer of the two clones was -3 kb. This indicates that 
approximately 2.5 kb of the upstream coding sequence remains to be cloned. By 
comparison with the protein structure of PTP t, there appears to be sufficient coding 
potential in the uncloned region of PTP 4 for it to possess a similar extracellular 
domain arrangement. An alignment of comparable amino acid sequences of p,, K and 
PTP 4 is shown in fig. 2.7a. 
The second novel PTP (clone PTP 24) shows homology within the amplified catalytic 
domain to a number of PTPs, most convincingly with hPTP 0 (ref. 118). Three 
cDNAs corresponding to this gene were obtained from the rat hippocampus cDNA 
library (fig. 2.6c). Two of these contain sequences at the 5' end which correspond to 
the region of the PTP protein immediately internal to the membrane-spanning region. 
In fact, the amino acid sequence encoded by the longer of the two clones contains a 
stretch of hydrophobic amino acids which is likely to be this region. Puzzlingly, this 
clone also contains an additional 83 nucleotides as an internal insertion (Appendix). 
If it had been found at the ends of the clone, a cloning artifact might be an 
explanation, but the fact that it is present internally seems to support it being an 
59 
Figure 2.7 a Amino acid sequence deduced from the two PTP 4 cDNA clones 
aligned with those from PTPs j.i and K. Boxed residues are those which are identical to 
the consensus/majority. PTP 4 shows 64-65% sequence similarity with t and K 
whereas between PTPs and K there is a similarity score of 76-77%. b Amino acid 
sequence deduced from PTP 24 cDNA clone 18.1 aligned with those from 3 
fibronectin type III domains from hPTP. PTP 24 shows 13-15% similarity to these 
sequences (similar to the equivalent comparison of domains 3 and 15). Despite the low 
score, several key residues are conserved. c Greater similarity scores are seen in the 
alignment of amino acid sequence deduced from the 5' ends of PTP 24 cDNA clones 
10.1 and 16a.1  with those from other PTPs. Similarity scores between PTP 24 and 
dPTP1OD or hPTPI3 (25-26%) are twice the amount of that between PTP 24 and LAR. 
Residues between positions 10-30 may constitute the transmembrane domain. 
Fig. 2.7a 
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alternative, or immature, spliceform. The presence of the insert affects the reading 
frame of the resultant protein such that it is shifted, causing a translation stop signal 
five codons after the insertion. Perhaps this represents a modification that is seen in 
some other receptors; the independent expression of the extracellular domain, which 
might act in a dominant negative fashion if direct coupling of receptor dimerisation to 
phophatase activity occurs. The third clone is substantially longer and would be 
expected to extend into extracellular domain-encoding sequence. Analysis of the 5' 
sequence from this clone showed it had significant homology to fibronectin III 
domains and thus it is probably part of the extracellular receptor domain. The 
presence of FN III domains in this gene also fits with the homology to hPTP 0 which 
possesses 16 such domains. hPTP 3 is also distinguished by the presence of only one 
catalytic domain. Whether PTP 24 possesses one domain remains to be directly 
elucidated, but the sequence information from the 2 kb clones seems to indicate that 
there would only be enough 3' coding information for one catalytic domain. In 
addition, approximately 4kb of sequence is known to exist upstream of the region 
encoding the transmembrane domain, lithe average coding sequence for a fibronectin 
III domain is assumed to be 270 bp, then there is a potential capacity for at least 14 
FN HI domains in PTP 24. 
Expression data was collected for these two novel PTPs by using them as probes on 
Northern blots (fig. 2.8). 
PTP 4 demonstrates a major transcript size of approximately 5.5kb (compare jt; 5.7 
kb, and i; 5.3 kb) and is principally localised to the CNS with peripheral expression 
seen in lung and testis. PTP 24 exhibits transcript sizes in the CNS (not cerebellum) 
of approximately 6kb, whereas in the rest of the tissues a transcript size of 4 kb or 5 
kb is seen. Overall, PTP 24 is less restricted in expression than PTP 4. 
No change in expression was seen in either PTP as a result of electro-convulsive 
stimulus (Chapter V for more information). 
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Figure 2.8 Northern expression analyses of the two novel members of the PTP 
family. Positions of the two major species of ribosomal RNA are marked 
approximately. (Olf; olfactory bulb, He; hippocampus, Ce; cerebellum, Cx; cortex, 
RoB; rest of brain, Ht; heart, Lu; lung, Ki; kidney, Sp; spleen, Te; testis, Mu; muscle, 
and Li; liver.) 
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Chapter III 
Chemical Cross-Linking Subtraction 
3.1: Introduction to the methods available for directly identifying specific gene 
expression 
Although degenerate PCR amplification has many advantages and has had notable 
successes with respect to the isolation of tissue specific genes, it suffers from the fact 
that, at best, the choice of gene family is an educated guess. Ideally, in order that a 
search is not unduly limited, tissue-specific genes should be isolated using techniques 
which operate purely on the basis of the presence or absence of a particular transcript in 
the tissue of interest without any prior subjective biasing in favour of certain genes. At 
present, there exist three techniques which attempt to fulfil this ideal; 'differential 
screening', 'subtractive hybridisation', and 'differential display'. Each has its own 
benefits and disadvantages and specific situations in which it would be the optimal 
choice. These are discussed below. 
Furthermore, the study of brain region specificity presents difficulties in its own right 
which seem to push the operating capabilities of these techniques to the limit. These 
problems, which were also discussed in the introductory chapter, will be returned to 
later. 
The following two techniques originated 15 years ago when it was realised that the 
intrinsic complementarity of nucleic acids, which had been utilised in Northern and 
Southern hybridisations and cDNA-niRNA reassociation kinetics, could be exploited in 
the comparison of transcript expression in different tissues. 
Differential screening 
One requirement for this approach is that a cDNA library of the tissue in question be 
created before any experimental step is taken; a relatively labour-intensive procedure. 
However, because any resulting genes may have to be characterised by cloning full-
length transcripts, the initial work is rewarded at a later stage. If 'tissue X-specific' 
genes are required, a cDNA library is created from tissue X mRNA. This is plated out 
such that plaque density is relatively low compared to a conventional library screen. 
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Duplicate representations of each plate are made on nitrocellulose filters. A probe 
derived from a tissue X cDNA template is hybridised to one set of filters and, in 
parallel, a probe derived from a comparable tissue, 'Y', is hybridised to the second set 
of filters. 
The relative strength of hybridisation to a given plaque when probed with X or Y gives 
an indication of the corresponding transcript's abundance in that tissue. Hence, if the 
filter-bound plaque DNA gives a positive signal by autoradiography in the X probing 
but not by the Y probing, it can be assumed that the expression of the transcript 
corresponding to the plaque is much higher in, or specific to, tissue X. 
As with other techniques that will be described below, there are certain problems with 
differential screening which can affect its efficiency. Because the specific activity of a 
transcript species within the cDNA probe will be directly proportional to its abundance 
within that tissue, rare transcripts will probably fall below the level of efficient detection 
by this procedure. Therefore, tissue-specific genes of low abundance will be missed 
and transcripts might be erroneously assigned tissue X-specificity if expression in 
tissue Y is below the threshold. Technical problems centreing on the representability of 
the probe and the comparabffities of the duplicate screens often complicate interpretation 
of the final plaque differentials. However, differential screening has often been 
combined with subtractive hybridisation to increase sensitivity. 
Subtractive hybridisation 
This is, in effect, the inverse procedure to differential screening. The selection for 
expression in one tissue and not the other is achieved through solution hybridisation: 
specific/enriched genes that emerge from the procedure can be cloned and analysed 
directly. Typically, if tissue X-specific transcripts are required then X cDNAs (the 
'tester' or 'tracer') are hybridised in solution to a 10- to 20-fold excess of tissue Y 
mRNA (the 'driver'). Depending on the choice of subtraction protocols, there will be a 
method of discarding excess mRNA together with the mRNA-cDNA hybrids, leaving 
just unassociated cDNA (which is cloned). Theoretically, the reassociation kinetics of 
the hybridisation step should ensure that the only X cDNA species to remain 
unassociated to Y mRNA are those which have no complementary counterpart in the Y 
mRNA; i.e. they are specific to, or highly enriched in, tissue X. 
The precise protocols used for subtractive hybridisation have been modified extensively 
since its original description. The key steps of preparation of the nucleic acid pools, 
hybridisation, removal of hybrids, and analysis of the products have all been subject to 
alterations in an attempt to improve the efficiency of the technique. However, the 
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abundance of transcripts and the representabilty of the tracer and driver are still crucial 
factors in the subtraction process. 
Differential display 
This involves the comparison of electrophoresed subsets of PCR-amplified cDNA 
(refs. 1 and 2). RNA is extracted from different tissue types or one tissue in different 
states. This is reverse transcribed using a primer such as:- 
5'- [anchor]-(T) 12-1  5-XY-3' 
where 'anchor' is any defined sequence, 'X' is any of the bases A, C, or G and 'Y' is 
any of the bases A, C, G, or T. Unlike conventional reverse transcription, only a 
subset of transcripts can be initiated by any one such primer (1/12 of the total assuming 
equal base usage). A PCR reaction is performed on this material using an arbitrary 10-
mer oligonucleotide together with a primer identical to the anchor sequence. To create 
an amplifiable product, there has to be complementarity between the arbitrary primer 
and a region on the cDNA near to the 3' end of the transcript; again, this selects a 
further subset of transcripts from the total. The resulting amplified and radiolabelled 
products are electrophoresed on a polyacrylamide gel so that the spectrum of PCR 
products derived from one tissue can be compared to that in another by looking for 
changes in band intensity at a equivalent sizes. The two factors determining the 
successful application of this technique are, first, the display spectrum from a sample 
should be reproducible and, second, the differences between two samples should 
represent genuine expression differences and not amplification biases/incomparable 
representation. By using different combinations of reverse transcription primers and 
arbitrary PCR primers a complete expression profile can be approached. Many 
variations have been applied by different groups (ref. 3) but the overall strategy remains 
the same. 
The major limitation to this technique is that cDNA fragments corresponding to rare 
transcripts will not be visualised by autoradiography due to their low abundance. In 
many situations this is irrelevant (ref. 4), but in the context of brain region-specific 
expression it might prove a problem. An advantage is that because PCR is involved, the 
availability of large amounts of starting material is not a requirement. 
3.2: Historical application of these techniques 
Numerous applications of these three techniques to a wide variety of biological systems 
have been described over the past 15 years. Early approaches were straightforward 
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differential screens with the focus more on proving that transcriptional differences 
existed rather than identifying molecules. Shiosaka and Saunders (ref. 5) looked at 
transcription in leukaemic and normal lymphocytes and obtained several cDNA clones 
which appeared to be upregulated in the former. More recent attempts such as Anderson 
and Axel's screen for transcriptional differences in neural crest derivatives (ref. 6) and 
Oberdick's screen for cerebellar purkinje cell-specific cDNAs (ref. 7) resulted in the 
cloning of specific genes but, in all likelihood, these experiments were limited to the 
detection of medium abundance transcripts. Beadling et al. (refs. 8 and 9) have tried to 
circumvent this problem by artificially boosting transcriptional changes in IL-2-
stimulated T cells by the inclusion of translational inhibitors; thus preventing feed-back 
deregulation of induced genes by their protein products. 
Subtractive hybridisation by itself, or in tandem with differential screening, has been 
the most frequently used approach in recent years. One of the earliest examples of its 
use was Sargent and Dawid's analysis of expression in the Xenopus gastrula (ref. 10) 
which used hydroxyl-apatite columns to remove hybrids between gastrula cDNA and 
placental mRNA, allowing the cloning of gastrula-enriched cDNAs. The resulting 
library was differentially screened with cDNA obtained from the gastrula and other 
developmental stages to confirm that many were gastrula-specific. The cloning of the T 
cell receptor (ref. 11) and the myoblast determining factor, MyoD, (ref. 12) were 
achieved in an almost identical fashion by comparing expression in T and B cell lines 
and myoblasts and fibroblasts, respectively. Modifications since then have been 
primarily alterations in the precise details of the protocols either to increase sensitivity 
or reduce technically difficult/laborious steps. 
Because subtraction requires large quantities of driver mRNA, it is impractical in some 
biological systems. Therefore, one approach (refs. 13-15) has been to convert tester 
and driver tissues into cDNA libraries, from which unlimited mRNA can be made by in 
vitro transcription from RNA polymerase initiation sites within the vector. Drosophila 
head-specific genes and a floor-plate-specific gene (F-Spondin) have been cloned in 
this manner. Another approach to this problem is to convert the two 'tissues' into pools 
of PCR-amplifiable cDNA; this has been used by Duguid et al. in the search for scrapie 
infection-responsive genes (refs. 16 and 17) and by Wang and Brown (see next 
chapter). The extent and rate of hybridisation can be increased in some cases by the use 
of the 'phenol emulsion reassociation technique' (PERT) by which, through a still-
unexplained phase-boundary effect, hybrids form more readily. Travis et al. (ref. 18) 
applied this to the transcriptionally complex monkey brain for the isolation of cortex-
enriched genes. 
Separating hybrids from non-hybrids has been facilitated by a wide selection of 
techniques. Driver nucleic acid can be modified by photobiotinylation (refs. 19-21) or 
by the addition of magnetic beads (refs. 22 and 23) and the resulting hybrids and 
excess driver removed by streptavidin/phenol-chioroform or magnetism, respectively. 
Alternatively, hybrids can be enzymatically destroyed by double-stranded DNA-specific 
exonucleases (ref. 24). 
As detailed in the introduction, with respect to gene expression, the brain is the most 
complex of all tissue types. Have subtraction techniques performed as well in the brain 
as in other systems, and have examples of brain region-specific expression been found? 
Rhyner et al. (ref. 25) isolated several forebrain-enriched clones in a subtracted library 
screen using subtracted forebrain cDNA as a probe and claimed that some were present 
at an abundance level of 0.0005% (differential screening alone has a sensitivity down to 
an abundance of approximately 0.05%; ref. 26). However, the very fact that this probe 
has had abundant sequences removed by the subtraction procedure will increase to 
detectable levels the specific activity of cDNAs corresponding to rarer mRNA species: 
this does not mean that they are specific. To control for this, the subtracted library 
should also have been differentially screened with subtracted probes from other brain 
regions. The same group have also, more satisfactorily, examined changes in gene 
expression in the forebrain after sleep deprivation (ref. 27). Several clones showed 
altered expression levels, albeit by only a factor of two or less. The isolation of cerebral 
cortex-specific genes in the monkey (ref. 28) by the use of subtracted probes proved to 
be equally challenging with an initial isolation of 163/60,000 clones showing cortical 
enrichment that later proved less conclusive by Northern hybridisation assessment. A 
maximum of two-fold enrichment was seen over other brain regions. The protocol 
relied solely on cerebellum mRNA as the driver in the subtraction, hence, the 
probability that a cortex-specific gene would have been obtained was decreased. Much 
less was demanded of a subtraction carried out to enrich for brain-specific sequences 
(ref. 29). In the completed library 55% of the clones showed brain-specificity or high 
enrichment, but when it is considered that a random selection of brain clones carried out 
by Milner and Sutcliffe (see Chapter I) revealed that approximately 30% were restricted 
to the brain (admittedly, the search for other sites of expression was not exhaustive), 
the result is not so impressive. Kato (refs. 30 and 31) screened 950 rare cDNAs from a 
mouse cerebellar cDNA library. By in situ hybridisation, 130 appeared to show some 
restriction to brain regions and, of these, 5 were identified as being cerebellum-specific; 
4 granule cell-specific and one purkinje cell-specific. Perhaps this work (in conjunction 
with that of Oberdick) reveals that the cerebellum is sufficiently different in structure 
and function to require specific transcription. 
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In comparison, more success has been observed when subtractive technologies have 
been employed in the search for genes induced by neuronal activity: a description of 
such experiments is to be found in Chapter V. 
In conclusion, subtractive techniques have met a severe obstacle in the form of brain 
transcriptional complexity that has resulted in limited success in the search for region-
specific expression. 
3.3: Chemical cross-linking subtraction 
The first subtraction method used to search for hippocampus-specific genes was based 
on a technique devised by Hampson, Pope, Cowling, and Dexter (ref. 32). In short, a 
subtracted probe is synthesized which can be used in a differential screen to select for 
tissue-specific gene expression. 
Potentially, the removal of excess driver and driver-tracer hybrids by the traditional 
methods described in the introduction can be inefficient or result in the loss of much 
tracer material required for cloning or probe synthesis. 'Chemical cross-linking 
subtraction' (CCLS) circumvents the need for physical separation of this material from 
unhybridised cDNA. This is made possible by use of the reagent diazirydinyl 
benzoquinine (DZQ) in reducing conditions to irreversibly cross-link -GC-
dinucleotides in one strand of the duplex with opposing -GC- dinucleotides in the other 
strand (refs. 33 and 34). 
Fig. 3.1 shows a representation of the reaction that occurs at a -GC-/-GC- dinucleotide 
site on the mRNA/cDNA hybrid when the the cross-linking agent is added in reducing 
conditions. The reactive groups on DZQ react with each of the four bases forming 
covalent bonds which prevent the separation of the two strands. This compound has 
been used as an antitumour drug, although the reaction pathways that cause its in vivo 
tumouricidal effects are probably different from the one described here. 
The post-subtraction nucleic acid material is purified and used directly as template for a 
random-primed probe synthesis reaction. Only uncross-linked cDNA can act as a 
template for the 'Sequenase H' enzyme (product of United States Biochemicals) in the 
probe synthesis reaction; thus, the probe is enriched for sequences not found in the 
driver mRNA. This particular enzyme is employed because it cannot use RNA as a 
template, has no exonuclease activity, and will not displace a presynthesized strand 
from template cDNA. One advantage of such a technique is that if hybridisation 
between cDNA and RNA is only over a short length of the cDNA (for example, due to 
repeat elements, alternative splicing, or a tract of one particular nucleotide) then a probe 
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Figure 3.1 Cartoon illustration of the structure of the diaziridinylbenzoquinone 
(DZOJ cross-linking agent and the manner in which it irreversibly interacts with 
guanine (G) / cytosine (C) dinucleotides in complementary nucleic acid strands. 
Fig. 3.1 
31 1' 
Is 
N 
HO 	
DZQ 	
NH+ 	0 
0=< N6,x 	 , 
, NH+ 	 OH  
N'  
If 
5' 
3, 
can still be made from the unhybridised regions. A more traditional technique would 
remove such hybrids completely. 
In the original paper describing the technique, an enrichment factor (defined as the 
abundance of a particular transcript's component in a probe after subtraction, divided 
by the same transcript's abundance before subtraction) of 240-300 fold was quoted for 
an anitozolomide-induced transcript from RJKO cells. Extrapolating from information 
concerning probe hybridisation sensitivity limits mentioned in the introduction to this 
chapter, a transcript originally present at an abundance of 0.00017-0.00021% would be 
detectable by this method. 
CCLS has been recently used in the investigation of genes induced by the tumour 
suppressor p53 (ref. 35). A library created from p53-induced cDNA was screened with 
a subtracted probe (induced cDNA subtracted with normal mRNA). Of 99 clones that 
appeared to be differentially expressed, 45 were genuine. 28 of these encoded the same 
transcript; subsequently dubbed 'WAFi'. Although the authors state that the 
subtraction causes a one hundred-fold enrichment for WAF1, they also admit that the 
transcript constitutes 0.4% of the mRNA post-induction. Because this is such a high 
figure (coupled with the non-neuronal nature of the tissue), tthe subtraction procedure 
was not taxed by this experimental system. 
3.4: Application to the identification of hippocampus-specific transcripts 
Previous work in this laboratory has focused on the application of a differential 
screening technique to the identification of specifically expressed genes. This involved 
the probing of duplicate filter lifts of a rat hippocampus cDNA library (constructed by 
J. 0. Mason and M. Richardson in the laboratory) with either hippocampus or 'rest of 
brain' (brain minus hippocampus) cDNA probes. Differentially hybridising plaques 
were selected and studied further as described (0. Stapleton; thesis, 1994 and ref. 36). 
Not all plaques were studied in depth, so a technique was required which would be able 
to select the best candidates for further analysis. A combined subtraction and 
differential screening approach was used as a means to this end. 
A subtracted hippocampus probe for use in the differential screening process was 
created by the method of chemical cross-linking. The precise protocol is described in 
the Materials and Methods chapter, but briefly, 0.38 tg of hippocampus cDNA was 
mixed with 20 ig of non-hippocampus brain tissue mRNA and hybridised for 20 hrs. 
The resulting material was cross-linked and aliquots taken for probe synthesis 
reactions. In an attempt to quantify the success or otherwise of the subtraction process a 
'spike' was added to the hippocampus cDNA. A —270 bp fragment of the SV40 
67 
polyadenylation sequence was chosen as the spike because it is not found in brain 
mRNA. This was transcribed in vitro and then reverse transcribed such that single-
stranded cDNA resulted. Enough of this material was added to the hippocampus cDNA 
such that it constituted one ten-thousandth of the total cDNA content. This figure was 
chosen because the quoted enrichment factor of this subtraction protocol would ensure 
that only its post-subtraction signal would be of suffient specific activity to generate 
detectable hybridisation. Another efficiency assay carried out was the monitoring of a 
ubiquitous transcript (actin, in this case) which should be reduced in specific activity 
after the subtraction procedure. 
The probe was used on a 'mini-library' created by pooling the plug suspensions of the 
436 remaining positive plaques obtained by the original differential screen. Because 
each plug consisted of multiple bacteriophage species (estimated at 10-20) due to 
particle diffusion and the relatively high plating density of the screen, the total library 
was made up of approximately 9000 cDNA species. This was plated onto 5 bottom 
agar plates such that there were in the order of 8000 plaques per dish; thus giving an 
approximate 4.6 times representation. 
Duplicate transfers of this library were made on nitrocellulose filters which were probed 
with an aliquot of the subtracted hippocampus probe or with a cDNA probe derived 
from rest of brain mRNA. By comparison of the images of hybridised plaques on X-
ray film, it was possible to select 44 plaques which appeared differential: they showed 
hybridisation to the subtracted probe but not with the rest of brain probe. 
Filters spotted with SV40 polyadenylation sequence DNA and actin DNA were 
hybridised at the same time as the differential screen. It was evident from the lack of 
hybridisation signals that the subtracted probe had not been enriched to a degree 
whereby the SV40 spike was detectable above background hybridisation. The actin 
signal appeared to be slightly diminished (data not shown). 
These plaques were individually replated at low density in order that a 'secondary 
screen' could be carried out to reveal well-isolated differential plaques that consisted of 
a single cDNA clone. Because of the failure to replicate some differential signals in this 
screen, the number fell to 36 cDNA clones. 
Due to the nature of the bacteriophage vector used in the construction of the library 
('Lambda Zap II'; Stratagene), it was possible to rescue the cDNA clone in the more 
manipulatable form of 'pBluescriptll' plasmid by 'in vivo excision' from plaque plug 
suspensions using a 'helper' bacteriophage strain and a bacterial line; SOLR (see 
Materials and Methods chapter). In addition, the construction of the library had been 
carried Out in such a manner that the cDNAs were mostly cloned in one orientation in 
the vector. The initial sequencing of the clones was performed using the T7 primer 
because, as the vector was in the KS configuration, this resulted in sequence 
information being obtained from the inherently more informative 5' end of the cDNA 
clones. Table 3a lists the 36 clones with information concerning insert size (estimated 
from restriction digests of the clones) and sequence identification. The clone numbers 
are prefixed by 'sub' to indicate that they came from this screen. Those that gave 
polyA+ or repeat motifs with T7 sequencing were subjected to T3-primed sequencing. 
In all, 13 of the 36 clones were assigned positive identifications on the basis of their 
sequence data and these are discussed below. 
Of these 13 clones, 10 different transcripts were represented (super-oxide dismutase-2 
(SOD-2) appeared twice and synaptosomal-associated protein-25 (SNAP-25) three 
times). The clones can be split up into three categories as follows:- 
Mitochondrial genes (cytochrome b, clone sub8, clone sub25, and 
cytochrome c oxidase III). 
Metabolic genes (fructose-1,6-bisphosphate aldolase A, and 
glyoxalase- 1). 
Others (SNAP-25, a novel Zn-finger transcription factor family 
member, SOD-2, and inhibitory insulin-like growth factor binding protein 4). 
The first group represents clones which obviously cannot be differentially expressed as 
every cell must possess a complete complement of these genes to be functional. The 
question then arises how they appeared as differentials. One possibility which might 
explain this anomaly is that if the concentration of a cDNA is over a certain threshold, it 
might escape complete subtractive removal despite the presence of driver sequences at 
10-20 times concentration. This doesn't explain how the 'rest of brain' probe signal 
was under-represented causing a differential to exist. Localised differences in the 
efficiency of filter hybridisation could possibly be responsible for this. 
The second group, the metabolic enzymes, might possibly be expressed at different 
levels in different regions of the brain in order to satisfy different biochemical 
requirements. Among organs, the brain is particularly metabolically active, and within it 
some regions may be more active than others; especially in certain situations. This has 
been demonstrated by PET scans of the brain performing specific tasks. 
Table 3 a The analysis of all of the subtraction clones is summarised in this table. 
R>H indicates that the rest of brain (RoB) abundance was greater than the 
hippocampus (Hc) abundance as observed by Northern expression data. 'mito. 
indicates that the sequence is mitochondrial in origin. A dash indicates that the 
expression was not examined. 
Table 3a 
Clone Number Secondary 1)111. Insert Size (kb) '11 Sequence T3 Sequence hR Northern 
1 2 3 tandem repeat_elein.nts poly A - 
2 3 1 SNAP-25 - - 
3 3 	- -- 	0.5 line/132 element repeat - 
4 2   0.5 - inito.gene (cytochr. B)  
5 	- 2  2  Aldolase - - 
6 2 - 	1 line element - - 
7 
8 
2 
2 
0.1 
-0.7 
lineelement 
polyA 
- 
mito.gene 
- 
- 
9 
11 
1 
2 
1 
1.2 
EST 
no homology 
- 
- 
equal 
R>H 
12 2 2 no homology - R>H 
13 1 0.5 poly A no homology equal 
14 2 1 line element - - 
16 2 1 prob. B 	element - - 
18 3 4.5 zinc finger homology line clement equal 
19 3 - repeat no homology - 
20 3 0.1 repeat no homology - 
21 4 0.2 no homology poly A equal smear 
22 2 0.8 SNAP-25 - - 
23 3 0.1 sameas3 - - 
24 3 0.5 mito. D-loop poly A equal 
25 2 0.2 poly A mito. gene - 
26 2 1 repeat - - 
27 2 1 poly A poly A equal smear (Apa I) 
28 5 0.2 SOD-2 poly A - 
29 2 1 glyoxalase I - - 
30 2 2.3 poly _A poly A equal smear (A pa I) 
31 2 0.1 no homology - R>H 
32 2 0.1 cytochn ox. III - - 
33 3 3 poly A poly A equal smear 
35 2  1 SNAP-25 - - 
38 3 2 repeat - - 
39 2 2 repeat - - 
41 3 0.5 rat homol. inIGF-BP - - 
42 3 3.5 no homology - equal smear 
43 3 1.5 SOD-2 - - 
Aldolase A (ref. 37) is a constituent enzyme of the glycolytic pathway. Therefore, it is 
unlikely to be expressed in an absolutely polarised fashion in the brain, although it 
could have relatively higher expression in the hippocampus because of this brain 
region's high metabolic rate. Another factor which could explain its failure to be 
subtracted will be discussed in the analysis of this and subsequent subtractive 
experiments. It can be appreciated that by the synthesis of different splice-forms of a 
transcript (each with different stabilities, cellular localisations, or encoded functions), 
great diversity can be created from a small number of genes. Alternative transcripts are 
seen as a result of differing transcription start-sites, differing polyadenylation sites, and 
the incorporation of different exons. This presents an alternative possibility in the 
search for hippocampus-specific transcripts; perhaps the specificity might not reside in 
the absolute expression of a gene, but in its structural composition resulting from 
processing undergone by the immature transcript. Aldolase A 
has been described as existing in three transcript forms which arise from alternative 
transcript initiation sites. Forms I, II, and III possess successively more upstream 
sequence as ascertained from primer extension experiments. The cDNA clone (sub5) 
that was obtained from this screen has a 5' end which corresponds to 5' untranslated 
sequence that could be derived from either mRNAs II or III. In an attempt to examine 
whether one of the Aldolase A transcripts is expressed preferentially in the 
hippocampus, a probe derived from sub5 was used on a Northern blot of brain regions 
(fig. 3.2). No obvious differences were seen in the expression levels or the transcript 
sizes caused by these splice-forms (admittedly, the small differences in size of the three 
forms of Aldolase A transcript might not be discernible by Northern blot). 
The other metabolic enzyme cloned was the rat form of human glyoxalase- 1 (-80% 
identity at the nucleic acid level: ref. 38). This is an enzyme which catalyses the 
transformation of methylglyoxal and glutathione into S-lactoylglutathione, a reaction 
whose significance is not entirely understood, but which probably plays a part in the 
detoxification of glyoxal derivatives as well as the metabolism of cellular a-
ketoaldehydes. High expression is seen in tumours and in undifferentiated cells. 
Therefore, it seems that the expression of this gene can be regulated to some extent in 
different circumstances, but whether there is tissue-specific expression has not been 
examined elsewhere. The clone isolated from the screen (sub29) has a 5' end which 
starts at the beginning of the mRNA open reading frame and probably extends to the 
transcripts 3' end. This was used as a probe on a Northern blot (fig. 3.2) which 
revealed no tissue specificity within the brain. 
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Figure 3.2 Tissue expression patterns of clones obtained from the subtraction. The 
panels on the left-hand side of the page show the virtually ubiquitous expression of 
sub 18 (ethidium-stained gel below to indicate RNA loading comparability). The right-
hand panels show the brain region distributions of other 'sub' clones (Aldolase A, 
Neuraxin, Glyoxalase-1, and Superoxide Dismutase-l). Note the smearing effect in 
some cases caused by the presence of repeat sequences within the probes. 
Fig. 3.2 
Sub 18: Novel Zinc-Finger Transcript 
Aldolase A 
He Ce Cx Olf RoB 
Glyoxalase-1 
Neuraxin 
He Ce Cx Olf RoB 
S.O.D.-2 
He Ce Cx RoB HI Mu Te Ki Lu Sp 
It was the final group which represented the type of transcript which, at face value, 
might be most likely to be differentially expressed. 
SNAP-25 was identified (ref. 39) as a major protein component of synaptosomal 
preparations of hippocampus tissue. Its presynaptic localisation in selected brain 
regions has made it the focus of studies into the mechanisms responsible for 
neurotransmitter release. The 25kD protein that results from translation of the message 
does not seem to be membrane spanning but instead has an amino terminal helix that 
may permit association with the membrane. Its structure suggests that it may 
coordinately bind metal ions. Recent work has gone some way to defining the cellular 
functioning of SNAP-25. It appears to associate with another protein, syntaxin, such 
that together they mediate the docking and priming of synaptic vesicles at the 
presynaptic membrane by binding a vesicular protein, synaptobrevin (ref. 40). In terms 
of the relevance to these studies, the expression pattern is probably not suitable for 
further experimentation. High levels of expression are seen in the hippocampus 
(especially in the CA3 and dentate gyrus regions), but there is also expression in 
neocortex, piriform cortex, anterior thalamic nuclei, pontine nuclei and the granule cell 
layer of the cerebellum. Northern analysis does not show any evidence for different 
splice-forms. Of the three clones isolated, sub2 and sub35 are identical, commencing 
immediately downstream of the ORF start, whereas sub22 starts upstream but does not 
seem to be long enough to encode the full —2 kb transcript. This is probably the result 
of internal EcoRl/NotI sites or cDNA fragmention prior to ligation to the lambda ZAPII 
vector. Coincidentally, this gene was the only one cloned in common with the initial 
differential screen (G. Stapleton; as above). The high levels of expression reported in 
the hippocampus might explain the failure to remove this cDNA during the subtraction 
process. 
A novel zinc-finger protein (subl8) was isolated as a 4.5 kb clone. When sequenced 
from the 5' end, it appeared to correspond to an ORF containing the stereotypical 
cysteine and histidine residue pairs responsible for the coordinate binding of a zinc 
metal ion. The sequence shows some frame-shifting in this region which does not 
simplify the interpretation of the resulting amino acid sequence. This could be due to 
the cloning process, although it must not be ruled out that this clone is a pseudogene. 
However, the observation of a transcript on a Northern blot argues against this (fig. 
3.2). At the nucleic acid level, sequence similarities of 52% and 62% are obtained 
between the novel transcript and the most closely related members of this family (h-plk 
and znf20x, respectively; ref. 41). Fig. 3.3 shows the best fit amino acid sequence of 
the novel clone (deduced by comparison with other members of the zinc-finger 
transcription family and therefore to be treated with caution) aligned with the related 
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zinc-finger genes (see Appendix for all sequence obtained). Homologies over this 
region at the amino acid level are 45% and 52% . The role of transcription factors is to 
regulate the expression of other genes. The cloning of a hippocampus-specific 
transcription factor would go some way in the comprehension of the mechanisms that 
dictate this brain region's identity and profile of gene expression. Unfortunately, the 
comprehensive analysis of the distribution of this transcript seems to suggest that it is 
widely expressed. Because the full-length sequence was not be used as a probe due to 
the presence of repeat sequences, hippocampus- specific regions of the transcript could 
possibly have been absent from the actual probe fragment. However, no alternative 
transcript sizes were observed on the Northern blot. 
NPYKCEECGKXFXYSSXLNX - HXRX Majority 
I 	 I 
10 20 
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Figure 3.3 Alignment of 'best-fit' amino acid sequence of sub 18 with two closely 
related zinc-finger proteins. Note conserved cysteine and histidines. 
Two separate clones were identified corresponding to the enzyme superoxide 
dismutase-2, which is a manganese-containing protein responsible for the deactivation 
of oxygen free radicals (ref. 42). These radicals are highly toxic and mutagenic to a cell 
and so must be removed with high efficiency (ref. 43). They occur as by-products of 
the action of cytochrome P-450s in the respiratory chain of mitochondria; the cellular 
compartment where this protein is found. Because the excitational activity of neurons 
results in those cells being subject to 'oxidative stress' efficient mechanisms have to be 
present to counteract the harmful nature of by-products such as superoxide and other 
free radicals. Left alone, these highly reactive species can mutate DNA (especially that 
in the mitochondrion, which can be 15 times more oxidised in aged humans) and 
damage cellular machinery. The originally published sequence for this gene identified 5 
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exons present in a region of genomic DNA almost 10 kb in length. Ref. 42 describes 
the presence of 5 differently-sized SOD-2 transcripts on a liver tissue Northern blot. To 
prove that the heterogeneity was due to the use of different polyadenylation signals, 
they used successively more downstream (3') genomic fragments as probes on these 
Northern blots. As expected, the increase in fragment distance from the translated 
region of the clone resulted in the hybridisation to fewer and fewer bands; those bands 
being of increasing size. Therefore, a SOD-2 transcript can be generated by the 
utilisation of any one of a number of polyadenylation sites culminating in differing 
transcript sizes. Two clones corresponding to this gene were identified here. Sub43 (2 
kb in size) commences at the 5' end of the final exon (5) and sub28 commences 
approximately 800 bp downstream of this exon. It was a possibility that one or both of 
these clones were selected because of the precise polyadenylation site used. For 
instance, the hippocampus, in comparison with other brain regions might use a distal 
site such that this region of the cDNA would only be found in this brain region. This 
hypothesis was tested by the use of clone sub43 as probe on a brain region Northern 
blot. The result was not entirely conclusive because of the presence of repeat sequences 
within the probe, but there seem to be only two transcripts which show virtually 
ubiquitous expression (fig. 3.2). 
Inhibitory insulin-like growth factor binding protein-4 was the final clone to be 
identified on the basis of sequence homology (ref. 45). In general, this family of 
proteins binds to TOP, prolonging its cellular half-life. In cell culture, this binding can 
either be stimulatory or inhibitory to the growth-promoting effects of the IGFs. In the 
hippocampus there are numerous growth, neurotrophic, and survival factors that play 
roles in the development and function of this brain region. IGF-1 has recently been 
shown to stimulate oligodendroglial myelination of CNS neurons and may be used as a 
future therapeutic agent for demyelinating diseases such as multiple sclerosis (ref. 46). 
A model whereby IIGFBP modulates this activity in a positive or negative manner 
could be postulated. The paper describing the cloning of this particular gene showed 
Northern expression data demonstrating that its transcript was present in cortex and 
hypothalamus amongst other tissues and organs. The cDNA identified in the screen 
(sub4l) has a size of approximately 500 bp and by sequence analysis of the clone's 5' 
end, seems to represent the 3' portion of the published transcript. It seems likely, 
therefore, that this does not represent an alternatively spliced form. 
Most of the clones that were analysed by the database-searching program FASTA 
(GCG 7 and 8. Wisconsin DNA analysis package) did not show meaningful 
homologies to any known genes. In addition, a sizable fraction of the clones contained 
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repeat element sequences, repetitive sequences, or polyadenylation stretches at both 
ends. Such repeats included the typical B1/LINE elements (e.g. sub/6/14) as well as 
more unusual repeats (subl9/20/26 possessed 1CT]n  and  [AC]n  dinucleotide repeats 
and seemed to be identical). It is not certain whether the transcripts which contain these 
repeats were genuinely differentially expressed or merely isolated because such repeat 
domains are intrinsically refractory to subtraction. 
The presence of repeat regions in these transcripts made their expression analysis 
difficult. In many cases the result of Northern hybridisation with a library-derived clone 
as probe was non-specific hybridisation at all molecular sizes in both hippocampus and 
rest of brain RNA lanes. In a largely unsuccessful attempt to alleviate this problem, 
restriction digests were carried out on a number of these clones in an attempt to obtain 
subfragments which would be more suitable for use as probes on Northern filters. 
Table 3a lists those clones that were used as probes on these Northerns together with 
the expression patterns obtained. These experiments were carried out in many cases by 
using small strips of nitrocellulose filter onto which had been blotted hippocampus and 
rest of brain RNA (as described in the methods section) in denaturing conditions. It 
must be noted that these Northern strips were not intended to provide definitive 
expression data, but were a fast and efficient screen for those clones selected. In several 
cases, a more extensive survey of expression was performed (see fig. 3.2). 
All clones for which expression data is available (table 3a) displayed either repeat-
indicating smears or an expression pattern that indicates that the probe sequence was 
represented equally in all tissues (or, in three cases, more expression in the rest of brain 
than in the hippocampus). 
3.4: Discussion  of the results of this subtraction experiment 
This subtraction did not yield hippocampus-specific cDNAs. There are three 
hypotheses that can be made as to the reasons for this failure which will be dealt with in 
turn. 
Firstly, the subtractive enrichment might not have been accomplished to the required 
degree. The failure to detect the spiked cDNA by hybridisation indicated that this 
subtraction's efficiency was not as great as the one published. However, because the 
brain is transcriptionally complex and hippocampus-specific gene expression might 
only occur in rare transcripts, the assumption that the enrichment factor would be as 
high as that quoted in the original publication of this protocol was probably over-
optimistic. The cloning of 'housekeeping genes' such as the metabolic enzymes is a 
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failure to some extent, but several groups trying differential screening-based 
approaches have reported that these high-abundance transcripts are never fully removed 
from a subtracted probe (R.S.P. Beddington, personal communication). RNA as a 
driver is always vulnerable to enzymatic degradation, especially in this example where 
the hybridisation time was 20 hours. Sufficient degradation of the driver pool would 
result in the failure to subtract adequately. 
Secondly, in the introduction it was stressed that this subtraction would allow 
hippocampus-specific regions of a transcript (possibly due to alternative splicing) to 
contribute towards the final probe unlike traditional subtraction protocols. Because the 
rest of brain probe in the differential is not discriminatory, it will hybridise to the 
'common' regions of a cDNA clone even if it has tissue-specific segments, thus, 
obscuring the differential nature of such a transcript. 
Lastly, the mini-library used in this screen was made from positives obtained from a 
theoretically less sensitive procedure. Hence, flaws in the original selection and the 
failure to detect low abundance, yet specific, transcripts could not be corrected by the 
CCLS procedure. 
It was with this possibility in mind that the decision was made to carry out a small-scale 
probing of the original unselected rat hippocampus cDNA library (one tenth of the 
library because of the lower plating density necessitated by a differential screening 
method). 92,000 plaques were transferred to duplicate filters and screened with a 
subtracted probe and 'rest of brain' probe as before. From this, 12 differentials were 
selected and subjected to sequence and Northern blot analysis. Six transcripts of 
unidentified sequence were used as probes on Northern blots (data not shown) but 
these did not show any hippocampus specificity. Two clones were positively identified 
from database searches as neuraxin (ref. 47) and the llOkD subunit of 
phosphatidylinositol-3-kinase. The clone for neuraxin was over 4 kb in size with a 5' 
end corresponding to the start of the 3' untranslated region of the published sequence. 
Because this published sequence did not amount to more than 600 bp in the 3' 
untranslated region, there existed the possibility that this might represent an alternative 
splicing or polyadenylation site use. This was tested by using the clone as a probe on a 
Northern blot (fig. 3.2). As can be seen, despite the presence of repetitive sequences 
within the probe which cause the streaky appearance, there are no hippocampus-
specific transcripts visible. 
The results of this limited experiment seem to suggest that the low efficiency of the 
subtractive enrichment is the key restriction to the application of this technique to the 
isolation of hippocampus-specific genes. 
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Chapter IV 
Application of a Second Subtraction Technique to the Search for 
Hippocampus-Specific Genes 
4.1: A novel subtraction technique 
The chemical cross-linking protocol for subtraction described in the previous chapter 
has advantages over many approaches. These include the relative ease of the 
procedure, the ability to identify subtle changes in the arrangement of a transcript and 
the high enrichments reported to be obtainable. However, in the context of the search 
for transcripts restricted in expression to the hippocampus it did not prove effective. 
The two fundamental criteria for the selection of an alternative approach were that it 
should result in a much greater extent of enrichment for appropriate transcripts and 
that the resulting subtracted material should be directly analysable (as opposed to 
being used as a probe to screen a cDNA library) so that, if there are particular regions 
of a transcript that are specific, only those will remain. 
A 'Gene Expression Screen' technique published by Z. Wang and D.D. Brown (ref. 
1) seemed to fulfil the above criteria. The technique they described was applied to the 
isolation of genes whose expression was altered in tadpole tail tissue after treatment 
with thyroid hormone; the physiological signal in maturing tadpoles for the resorption 
of the tail. 16 different up-regulated genes (including thyroid receptor 0) and 4 down-
regulated genes were obtained from this screen. 
It is necessary to go into some of the technique's experimental details so that there is 
a framework for the interpretation of the results The full protocol is described in the 
Materials and Methods chapter and a flow chart of a modified form of the protocol 
(section 4.7) can be found in fig. 4.3 a and b. The seven features responsible for the 
increased performance of the subtraction are as follows:- 
1) The two mRNA extracts from the tissues to be compared (whether they be different 
tissues, as in this case, or the same tissue before and after a particular treatment) are 
76 
converted into double-stranded cDNA, thus avoiding the problems accociated with 
the manipulation of RNA. 
Each cDNA pool is divided in two. One half is digested with the restriction 
enzyme Alul and the other with Alul and RsaI combined. These enzymes, by virtue 
of their four base-pair recognition sequences, cleave DNA frequently; on average, at 
256 base-pair intervals. This results in most cDNAs being split into several smaller 
fragments which can behave independently of each other in the subsequent 
subtraction. Wang and Brown describe these fragments as 'alleles' stressing the 
similarity of this technique to genetic screens. In those instances where alternative 
transcript regions may be preferentially expressed, corresponding cDNA fragments 
should behave independently of the ubiquitously expressed regions. This would also 
have the benefit, as in the case of the chemical cross-linking protocol, that the entire 
length of a specific transcript is not removed if a part of it contains repetetive 
sequence or sequences refractory to enrichment. In addition, if there is a transcript 
that is differentially expressed in the two pools then all cDNA fragments derived from 
it should be represented in the final subtracted material. This presents a way of 
verifying that a transcript is genuinely differentially expressed. 
Oligonucleotide linkers were ligated onto the cDNA fragments from each pool in 
order that the cDNA material could be amplified using a PCR primer complementary 
to the linker. A potential drawback to this step is that, in order to be amplified 
efficiently and representatively, the cDNA fragments must be below a certain length. 
Thus, the frequency of AluI/RsaI restriction sites in a given transcript is critical. 
Wang and Brown estimate from an analysis of Xenopus cDNA sequences in a 
database that 75% of the nucleic acid material originally present would be represented 
in an amplified pool. However, because the two pools undergo comparable treatment, 
a fragment that does not amplify efficiently in one pool should behave similarly in the 
other pool. This means that, even if the PCR amplified pools are not a genuine 
representation of the niRNA expression from which they were derived, they should be 
equivalently 'flawed' such that the relative expression levels of a randomly selected 
cDNA fragment in the two pools should remain faithful to the relative levels of 
expression in the mRNA pools. This is vital if false positives/negatives are to be 
avoided. 
The subtraction process itself is carried out in tandem. If the two tissue pools are, 
for example, 'X' and 'Y', one subtraction will operate to identify X-specific cDNAs 
and the other to identify Y-specific cDNAs. As in a typical subtraction, nucleic acid 
from one pool (the 'tester' or 'tracer') is hybridised for a set time period with an 
excess of nucleic acid from the other pool (the 'driver'). The driver material is treated 
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prior to hybridisation with photobiotin; a chemical that binds to the cDNA in the 
presence of light and which irreversibly associates with the protein streptavidin. Thus, 
the excess driver together with the tracer/driver hybrids are removed by streptavidin 
binding in conjunction with phenol-chloroform extractions, leaving only the 
unhybridised (subtracted) tracer cDNAs in the aqueous phase. 
Six rounds of subtraction are carried out in this protocol which are divided into 
three sets of long and short hybridisations. Wang and Brown state that short 
hybridisations favour the removal of those cDNA species which are common to both 
pools and present at relatively high abundance. Such species are usually refractory to 
subtraction because of their quantity. Their removal here is due to the number and 
duration of hybridisations together with the nature of the driver (see below). The long 
hybridisation steps permit the subtraction of all species present in both pools, 
including those of low abundance. 
As the subtraction procedes, the long hybridisation drivers are created from 
material from the equivalent subtraction stage of the other pool (e.g. stage 4 X tracer 
cDNA is hybridised to an excess of stage 4 Y driver cDNA and vice versa). Thus, 
successively more competent drivers are used to subtract away rare sequences. Using 
the starting pools throughout as drivers for the long hybridisations would result in the 
plateauing of the effectiveness of the subtraction procedure in later stages. The short 
hybridisations, however, always use the starting pools as drivers. It is those pools 
which contain the greatest percentage of the high abundance cDNAs; the target 
species of the short hybridisation steps. 
In order to generate sufficient material for subsequent subtraction steps after each 
hybridisation, the tracer is subjected to PCR amplification using a primer 
complementary to the linker. If the driver sequences are not fully removed from the 
tracer during the post-hybridisation extractions they could go on to be amplified, 
negating the previously achieved enrichment. To avoid this possibility, the driver 
cDNA is subjected to complete digestion with the restriction enzyme EcoRI. There is 
an EcoRI site in the linker sequence. Hence, cleavage at this site removes the linker 
sequences from the driver cDNA resulting in material which is unamplifiable 
thereafter. 
4.2: The application of this technique to study hippocampus-specific transcription 
In the application of the protocol described below, the two PCR-amplifiable cDNA 
pools were synthesized from hippocampus and rest-of-brain (RoB; as defined 
previously) mRNAs, respectively. The resulting PCR pools seemed to be of 
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comparable quality with respect to the spectrum of product sizes as judged by the 
intensity of staining of the cDNA material resolved on an agarose gel. Sufficient 
starting material was subjected to procedures (described in the Materials and Methods 
chapter) resulting in the creation of drivers and tracers from both pools. The 
subtraction steps were carried out on both pools. General observations were that the 
average cDNA size of the pools diminished as the subtraction proceded (probably due 
to PCR bias) and certain cDNA species emerged as the subtraction proceded. These 
species became visible as discrete bands within the background of the other cDNA 
products when electrophoresed in an ethidium bromide stained agarose gel (see fig. 
4.4a). The occurrence of such bands was to plague all attempts at subtraction using 
this technique. They do not seem to be merely due to the accumulation of pool-
specific cDNAs as the subtraction procedes, but appear to be either refractory to the 
subtraction process or preferentially amplified. Attempts to explain this phenomenon 
will be made later in this chapter. 
The amplified cDNAs from the 6 hippocampus subtraction stages and the 4 RoB 
subtraction stages were subjected to several tests to examine the efficiency of the 
subtractive process. All cDNA stages were electrophoresed in agarose gels and 
blotted onto filters. These filters were hybridised separately with three different 
probes. The first probe was synthesized from the sixth (final) hippocampus 
subtraction stage and was intended to show that there had been a steady enrichment 
for these sequences in the hippocampus pools and that these sequences were not 
present in the RoB pools at any stage (fig. 4.1a). The results seem to prove the former 
point in that there is very little hybridisation to the starting hippocampus pool but 
increasing amounts to the subsequent enrichment stages. However, there was a 
considerable degree of hybridisation to the final RoB subtraction stage. This can be 
interpreted as the result of contamination from hippocampus driver material from 
later subtraction stages which has been amplified together with the RoB tracer cDNA. 
It is also possible that the final RoB stage material contaminated the hippocampus 
tracer (stage 4). This suggests that the described precautions (driver cDNA digestion 
and multiple steptavidin binding/phenol-chloroform extractions) did not work as 
efficiently as expected in these particular subtraction steps. A counter-probing; to test 
if stage 4 RoB material was present in the hippocampus pools was also performed 
(data not shown). This gave a positive result demonstrating that cross-contamination 
had occurred. The final hybridisation was carried out using a probe derived from the 
starting RoB sequences (fig. 4.1a). As can be seen from the autoradiograph, higher 
abundance RoB sequences (as represented by this unsubtracted material) were 
effectively removed from the hippocampus material by stage 4. The RoB lanes do 
show diminishing hybridisation to this probe (as ubiquitous sequences are removed) 
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Figure 4.1 a The efficiency of the subtraction procedure as monitored by probing 
subtraction stages with enriched hippocampus (H 6) or initial RoB (R-) cDNA 
material. The results indicate that as the subtraction progressed RoB material was 
removed and hippocampus material enriched. Cross-contamination is revealed by the 
hybridisation of the H 6 probe to the R 4 cDNA material. b Bacterial colonies 
containing the subtracted hippocampus material were transferred to nitrocellulose 
filters. Shown here are three probe hybridisations (H, R 4, and H 6) to a region of 
one such filter. The purpose of the probings was to identify contaminating cDNAs and 
to select hippocampus-specific clones (see text). 
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but to a lesser extent than the corresponding hippocampus stages; as might be 
expected from a probe which is derived from RoB cDNA. 
4.3: Results from this subtraction 
cDNA from the final subtracted hippocampus stage (H 6) was cloned into the plasmid 
vector pBluescriptll (KS) and transformed into competent bacteria. The resulting 
colonies were gridded onto two plates and transferred onto filters for hybridisation. A 
probe derived from the final subtracted material was hybridised to these filters in 
order to select for those clones strongly represented in that material. Twenty such 
colonies were selected and plasmid DNA isolated for the purpose of sequencing. 
Table 4a lists these twenty clones and describes the results of the restriction, 
sequencing, and expression analyses performed on clones selected for their high level 
hybridisation to the probe. 
Clone Insert Size (bp) Hyb. Intensity Seq. Homology cDNA Southern Northern 
3 800  None - All lanes 
5 250 * None - - 
6 510 ** - H. 	R. - 
9 400 *** None - - 
10 650 * - - All lanes 
13 250 *** - - All lanes 
14 - None - - 
19 500 1 17-mer repeat I R.-specific None 
20I - None 	I - - 
iarne 'ea i-4irst screen or tirst sulMraction. see text tor Uetails. Ilyb. intensity,  
represents an approximate comparative guide to hybridisation strength on the filter. 
Dashes indicate that information was not obtained. 
Expression of the clones was assayed in two ways. Firstly, by probing 'cDNA 
Southerns' which were made by electrophoresing and blotting the starting PCR-
amplified pools onto filters. These give a representation of the distribution of the 
cloned cDNA as it was initially presented to the subtraction procedure. This technique 
is useful as a quick screen of clones because large amounts of nucleic acid can be 
electrophoresed in each gel lane, thus providing an abundant target for any probe. The 
second method was simply to use the cloned cDNA fragments as probes on brain 
region RNA Northern blots. These provide a more accurate analysis of brain 
expression, but require longer exposure times. 
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As can be seen from the table, this route to the selection of subtracted clones did not 
yield any that were hippocampus-specilic. One clone (19) showed what seemed to be 
a specificity for the RoB cDNA pool when used as a probe on a cDNA Southern. 
When the same probe was used on a Northern blot, no discernible signal was 
observed. Sequencing of this clone revealed that it possessed six successive 17-mer 
nucleic acid repeat motifs which could be translated into three 17-mer amino acid 
repeats in one reading frame. Its unexpected presence in the final hippocampus 
subtraction stage can be explained only in terms of contamination of this cDNA 
material by RoB sequences; thus, it was present in the material cloned into the vector 
and in the screening probe used for the selection of candidates. Nevertheless, it does 
provide proof that some pool-specific enrichment and selection has occurred. 
4.4: A second screen of the subtracted material 
A more rigorous screen was performed on a larger number of colonies derived from 
the same material (560 colonies gridded onto 4 plates). In addition to the filters being 
probed separately with the first and final subtracted hippocampus stage material, 
duplicate filter lifts were probed separately with the second and fourth stages of the 
RoB subtraction (fig. 4.1b). Thus, in essence, a differential screen was performed on 
these colonies with the intention of discounting those clones which had come through 
the subtraction either as a result of a failure in the removal of ubiquitous sequences or 
by cross-contamination of the pools. 
Probing with the final subtracted hippocampus stage not only permits a selection of 
those colonies which are recombinant, but also allows an estimate of the abundance 
level of each clone in the final subtracted material. Comparing this screen with that 
using the initial hippocampus cDNA material illustrates the extent to which sequences 
have been enriched during the subtraction process. Of the 560 colonies gridded out, 
only approximately 15 contained inserts which were of sufficient abundance in the 
initial pool to be detected when this material was used as a probe. 
Probing the colonies with cDNAs from stages 2 and 4 of the RoB subtraction was 
performed in order that colonies might be screened out if they represented either 
clones which had escaped subtraction despite being present in both initial pools or 
clones that were the result of cross-contamination and amplification of the two cDNA 
pools as the subtraction progressed. Probing with stage 2 RoB cDNA was intended to 
examine the first of these possibilities as it had not been through sufficient subtraction 
steps to entirely remove ubiquitous sequences or to be contaminated with a cDNA 
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present at high abundance from the hippocampus stages. Of the 560 colonies, only 11 
showed significant hybridisation to this probe showing that relatively few clones were 
derived from material that had escaped subtraction. 
4.5: Cross-contamination of the cDNA pools occurred during the subtraction 
It can be appreciated that cross-contamination of the pools as the subtraction process 
progresses would substantially decrease the likelihood of a successful outcome. A 
pool-specific cDNA species should be enriched as the subtraction procedes. If it 
contaminates the other tissue's cDNA pool then two problems arise. Firstly, the other 
pool now contains this sequence and so if a differential screen is performed then this 
will appear not as a specific clone but as a ubiquious cDNA which has escaped the 
subtraction process: probes derived from both pools will detect it. Secondly, 
contamination of a pool with a cDNA which is genuinely specific to the other pool 
will have the effect of negating the enrichment of that sequence in subsequent 
subtraction steps: the two pools average out the expression differences instead of 
accentuating them. This was the reason for the screen using stage 4 RoB as a probe on 
the cloned hippocampus stage 6 cDNA. 15 out of 560 clones were hybridised to this 
probe of which 4 were additional to those seen on the stage 2 RoB probing. Assuming 
that the majority of the cross-contamination occurred in the later stages (as the 
information presented in Fig. 4. la seems to suggest) then these represent cross-
contamination. Therefore, contamination is seen to a certain degree but the damage to 
the efficiency of the subtraction as a whole is not determinable from this approach. 
The exact direction of contamination is uncertain without further analysis of those 
clones as they could have arisen from RoB sequences contaminating the hippocampus 
material prior to cloning or from the hippocampus sequences contaminating the RoB 
material prior to its use as a probe; both events have the same outcome. 
4.6: The clones obtained from this screen show contradictory expression analyses 
Five colonies were selected on the basis of hybridisation to the hippocampus, but not 
RoB, probings and these are listed in table 4b. The striking feature of this subtraction, 
also seen in subsequent subtractions, is that there is a considerable discrepency 
between the expression profiles obtained by the cDNA Southern approach and those 
obtained by conventional Northern hybridisation (fig. 4.2a). 
Figure 4.2 a These three clones (3a, 4a, and 5) display hippocampus- specificity at 
the level of the cDNA Southern (smaller panels: H; hippocampus pool, R; rest of brain 
pool) which disappears upon Northern expression analysis (larger panels). b An 
experiment to discover if the subtraction procedure is able to remove high abundance 
cDNA material. The lower panel shows the ethidium- stained DNA before (bef.) and 
after (aft.) subtraction at various size-marker spike concentrations. The top panel 
shows this DNA blotted onto a filter and probed with size-marker DNA. The results 
indicate that the subtraction is very efficient, even after one round. 
Fig. 4.2a Fig. 4.2b 
Clone 3a 	 Clone 4a Clone 5 
i-I 	R HcCeCx Roll H R HcCeCxRoB H R HcCeCxRoB 
rA 
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'Is  'S. 
Clone Insert Size (bp) Hyb. Intensity Seq. Homology cDNA Southern Northern 
3a/5a 400  Rib. Prot. S25 H. Specific All Lanes 
4a 550 ** None H. Specific All Lanes 
0 380 ** None H. and R. 
I 
- 
5b 250 ** None H. Specific All Lanes 
I awe 'en econa screen ot first sut)tractlon. 
Four clones (3a (identical to 5a), 4a, and 5b), together with one (5) from a screen not 
presented here, showed hippocampus-specificity when used as probes on the cDNA 
Southerns. However, when the same probes were used on Northern blots, the results 
indicated that they were ubiquitously expressed throughout the brain regions 
represented. What was the reason for this difference? cDNA Southerns are 
representations the two cDNA pools as they begin the subtraction. The five isolated 
clones only hybridised to the hippocampus pool and therefore can only have been 
present in that pool at the start of the subtraction. Hence, the conclusion that must be 
drawn from these contradictory results is that the initial synthesis of the PCR-
amplifiable cDNA pools cannot have been truly representative of the actual mRNA 
distribution in the case of the RoB cDNA pool synthesis. Because there was no direct 
cloning and selection for those cDNA species which had been enriched in the RoB 
subtraction, it is not possible to tell if there was a similar failure in the representation 
of the hippocampus cDNA pool (with respect to a different subset of sequences). 
Typical of this failure was clone 3a which, upon sequencing, was identified as the 
ribosomal protein S25; not a gene that would be expressed in a brain region-specific 
manner. 
Regardless of the failure to enrich for genuinely hippocampus-specific sequences, the 
results do show that when a cDNA species is present in one pool, and not the other, 
the subtraction process is sufficiently thorough to enrich for those sequences. In this 
example, the fault lies not with the efficiency of the subtractive process, but the 
failure to create truly representative PCR-amplifiable cDNA pools from the native 
mRNA. This representation failure has two features which may contribute to a better 
understanding of the processes that lead to it. Firstly, it was restricted to particular 
cDNA fragments, as not all probes exhibited specific expression on cDNA Southerns, 
and secondly, the difference in representation of these cDNA fragments on the cDNA 
Southerns was extreme. A typical observation was that there would be almost 
complete restriction of the cDNA fragment to the hippocampus cDNA pool, as 
analysed by cDNA Southern. If the failure to create the initial PCR-amplifiable 
cDNA fragment pools was of a stochastic nature, then it might be expected that there 
would be a two- or three-fold variation in the levels of any cDNA between the two 
pools; this was not the case. Therefore, in the search for a root cause for the failure to 
achieve comparable RoB cDNA representation, features have to be found which make 
specific sequences refractory to cDNA synthesis or amplification with respect to one 
pool and not the other. The final section of the next chapter attempts to rationalise 
these problems in light of results from subsequent subtractions and experiments. 
4.7: A solution to the problem of cross-contamination 
In two subsequent cDNA subtraction experiments attempted; one to identify 
hippocampus-specific transcripts and the other to identify activity-related genes in the 
hippocampus (see next chapter), a modification to the subtraction protocol was made 
to prevent the occurrence of pool cross-contamination (fig. 4.3 a and b). This was 
prompted by the publication of a paper (ref. 2) which described similar problems to 
those above. The proposal made in this paper was that by creating each tissue's cDNA 
pool using a different linker set, they could be made to act independently of each 
other during PCR amplification. Thus, if tissue X cDNA tracer became contaminated 
with tissue Y driver in one round of subtraction, the subsequent PCR step would only 
amplify X cDNA material because of the specificity of the PCR primer used. The two 
sets of linkers and primers used in these subtractions are listed in the Materials and 
Methods chapter. 
4.8: Certain cDNA species accumulate erroneously as the subtraction procedes 
After each round of subtraction the amplified products from the two cDNA pools 
were electrophoresed on an agarose gel in order to monitor their quality and average 
size. As the subtraction progressed certain bands grew stronger in intensity until they 
represented a large percentage of the nucleic acid present in the pool (fig. 4.4a). Their 
abundance threatened to lower the efficiency of the subtraction because they reduced 
the concentration of genuinely enriching cDNAs. Also, the final subtracted material 
prepared for cloning primarily consisted of these species, hindering the cloning of 
specific sequences. It was presumed that these major species did not in themselves 
represent enriching cDNAs as they were often present in the same distribution in both 
tissue pools. 
Several explanations were postulated as to their origin and failure to subtract. Based 
upon these, efforts were made to counteract their accumulation. 
The first explanation was that these species accumulated as the subtraction progressed 
because they were intrinsically more amplifiable than the other cDNA species. In this 
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Figure 4.3 a The subtraction protocol: cDNA pool synthesis and subtraction 
mechanism. a) tissue X mRNA converted into double-stranded cDNA b) restriction 
digestion and ligation of linker sequences c) amplification and denaturation of 
tracer/tester d) hybridisation to excess of denatured and biotinylated driver cDNA. 
Separation of excess driver and tracer-driver hybrids from single-stranded tracer. This 
material is enriched for tissue X-specific sequences. b The subtraction protocol: 
repeated and reciprocal subtractions. The long hybridisations, short hybridisations, and 
PCR steps are indicated for each cDNA pool. The numbers by these steps indicate the 
name of the subtracted cDNA material at that point. Curved lines feeding into the 
hybridisation steps indicate the identity of the driver cDNA used. Only four subtraction 
stages are shown here, as was used in the later subtraction experiments. 
Fig. 4.3a 
AAAAAAAAAAA 
Alul 	 RsaI 	 Alul 
__- 
S 
Enriched cDNA 	 Discarded hybrids/driver 
LONG 
HYB. 
SHORT 
HYB. 
PCR 
LONG 
HYB. 
Yi 
SHORT 
HYB. 
PCR 
SHORT 
HYB. 
PCR 
LONG 
HYB. 
SHORT 
HYB. 
Fig. 4.3b 
'X' eDNA 
situation, because of the large number of cycling steps between the cDNA synthesis 
and the cloning of the subtracted material (approximately 102), there exists ample 
opportunity for a hypothetically advantaged cDNA to increase its relative abundance 
through such a mechanism. There are a number of problems with this explanation. 
Firstly, the subtraction steps should actually reduce the relative abundance of these 
species as they are not specific to one pool. Any advantage that these cDNAs 
possessed with respect to amplification should have been countered by subtraction. 
Secondly, if an amplification advantage exists it would have to be marginal otherwise 
the amplification products would be swamped by these species after the initial 30 
cycles. For example, if these hypothetical species have an initial abundance of 0.5% 
and possess a 5% amplification advantage over normal cDNAs, then after 102 cycles 
they will represent 72.5% of the cDNA (0.5 x 1.05102).  This is probably an 
underestimation of the actual abundances of these bands at the initial stages as some 
were visible before any subtraction took place. Thirdly, it is hard, on the basis of our 
knowledge of PCR, to come up with a mechanistic description of preferential 
amplification. Disadvantages to amplification are known, such as large cDNA size, 
skewed base composition or secondary structures. However, the abundant species do 
not seem to be excessively small: DNA fragments of 4kb have been amplified using 
these cycling conditions, so size does not seem to be a major factor. Nevertheless, the 
failure to find a precedent for preferential amplification does not discount this theory. 
The second explanation was that these cDNAs were initially present at a 
concentration above a threshold for their effective and complete removal: even with 
an excess of driver the kinetic constraints would prevent complete removal of that 
cDNA from the tracer. This does not explain their accumulation over the course of the 
subtraction. This might happen if, through synthesis artifacts or natural distribution, 
the two initial populations contained unequal levels of these high abundance cDNAs. 
In that unbalanced situation, one pool might, by being above the threshold value, 
dominate over the other in subtracting that cDNA. In that case the pattern of 
accumulating bands would not be identical in the two pools when electrophoresed. It 
is hard to imagine a situation where the efficiency of mRNA into cDNA pools could 
be sufficiently different between the two pools; and with respect to just a few 
molecular species. 
The third explanation centred on the fact that these species appeared to be resistant to 
subtraction. Because only a few cDNA species behaved in this way, any explanation 
must be based on the nature of the sequences of these particular cDNAs. The 
subtraction process itself relies on the complementarity of DNA strands; those that 
hybridise to the driver sequences will be removed from the pool. Therefore, it was 
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hypothesised that cDNAs that could not hybridise to complementary sequences in the 
driver, but could, nevertheless, be amplified by PCR would accumulate in the 
observed fashion. It was presumed that the failure to hybridise was due to self-
complementarity within the cDNA strand such that cDNAs in both the tracer and the 
driver which contained such sequences would form internal secondary structures 
preventing the formation of double-stranded hybrids. Even though the formation of 
such secondary structures is a unimolecular process (and, therefore, occurs extremely 
rapidly in solution), there would still be an energetic advantage for such strands to 
form double-stranded hybrids in a bimolecular reaction (due to the increased extent of 
hydrogen bonding). The subtraction protocol requires the use of two different 
hybridisation time-periods; two hours or twenty hours. Even though kinetic equations 
have not been calculated, it may be the case that short hybridisation steps favour the 
unimolecular reaction but long steps permit the formation of the correct duplexes. 
Thus, the use of short hybridisation steps might favour the accumulation of such 
unsubtractable material. 
4.9. Two experiments designed to test these hypotheses 
If certain DNA species were present at a concentration that prevented their efficient 
removal then these species would accumulate throughout the subtractive process. An 
experiment was designed to test the efficiency of the subtractive hybridisation 
technique when confronted with cDNAs of a high percentage abundance. A 1 kb 
DNA marker ladder (Gibco BRL) used to estimate the size of DNA fragments 
electrophoresed on agarose gels was converted into a PCR amplifiable form by the 
addition of the linkers that were used to create the cDNA pools. Ladder fragments 
with the same linker type as used in the creation of the hippocampus cDNA pool were 
added at defined percentage abundances to a 'background' of the hippocampus cDNA 
pool. Therefore, in the three experiments the ladder constituted 5, 0.5, and 0.05% of 
the total DNA content of the respective pools. Similar ladder fragments possessing 
the rest-of-brain cDNA pool-type linkers where added to a rest-of-brain cDNA 
'background' to the same final percentage abundances. The subtraction was performed 
so that hippocampus (plus set percentage of ladder) tracer was hybridised to rest-of-
brain (plus equivalent set percentage of ladder) driver in a short (two hour) 
hybridisation period. The resulting subtracted tracer was analysed for the percentage 
of ladder DNA remaining. 
The results suggested that the ladder was completely removed at all initial starting 
concentrations upto 5% of the starting material (fig 4.2b). Thus, the subtractive 
process works very efficiently, even during short hybridisation steps. In the light of 
this experiment, it seems unlikely that the initial abundance of a given cDNA can 
affect its ability to be subtracted. There are two potential caveats to this experiment. 
Firstly, in each case the tracer and the driver contained equivalent percentage 
quantities of the ladder; one possibility mentioned above was that the initial starting 
quantities in the cDNA pools could be sufficiently imbalanced as to cause the failure 
to subtract in one direction. Secondly, the 5% maximum limit imposed on this 
experiment might be below the threshold at which a species fails to subtract 
efficiently. As can be seen in the figure, at 5% the bands of the ladder are just visible 
through the background of hippocampus cDNA so this percentage may be under that 
seen with the major bands. 
One particular region of electrophoresed hippocampus cDNA material enriched in 
accumulating unsubtracted material was purified and cloned into pBluescriptll for 
sequence analysis. All eight clones sequenced (table 4c) were identified from the 
database. Their sequences were analysed for the existance of secondary structure 
using the 'Fold' program of the Wisconsin GCG8 DNA analysis package. 
Clone Identification 
mb4 16S rRNA fragment (mito.) 
mb6, mb15 Cytochrome c oxidase I (mito.) 
mb9 Human EST (muscle) 
mblO Cytochrome b 
mbl 1 Gs (3' untranslated region) 
mb12 28S rRNA fragment (cytoplasmic) 
mb19 Birepeat 
mb20 Mouse EST (testes) 
lanie 4C leennues 01 eight clones obtained trom chINA material co-migrating with 
an unsubtracted band. 
The sequences for cytochrome c oxidase I and cytoplasmic ribosomal RNA 28S 
showed the greatest degree of secondary structure (the others also possessed 
significant amounts). Diagrams showing the putative secondary structures of these 
two clones are shown in figs. 4.4b and c, respectively (their cDNA sequences are 
listed in the Appendix). The genuine secondary structures of these two clones may be 
very different, as these are only derived from a computer prediction. However, the 
extent to which these sequences possess regions of self-complementarity cannot be 
ignored. 
Even though these clones were isolated from DNA co-migrating with the 
unsubtractable material, it is not certain that they were the unsubtractable cDNAs 
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Figure 4.4 a Typical appearance of electrophoresed and ethidium- stained cDNA 
pool. Note the presence of the major eDNA species after two rounds of subtraction, 
especially in the R 2 lane. b Proposed secondary structure of a section of major band 
clone mb6 (cytochrome c oxidase) as determined using the 'Fold' program of the 
Wisconsin GCG7 DNA analysis package. c Proposed secondary structure of a 
section of major band clone mb12 (28S rRNA) determined as before. Full sequences 
of mbs 6 and 12 are to be found in the Appendix. 
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themselves. To confirm that these behave in the hypothesised manner they would 
have to be seeded into a cDNA pool and their accumulation monitored relative to 
control species: this experiment was not carried out. The secondary structure 
explanation for the accumulation of these species is still not definitively proven. 
4.10: Attempts to remove unsubtractable material from the cDNA population 
Based on the sequence analysis of the putatively unsubtractable material together with 
the physical characteristics that may give rise to their behaviour, two protocols were 
designed and applied with the aim of discriminating between cDNAs on the basis of 
their secondary structure. These are described below. 
It is a property of nitrocellulose membrane that only single stranded nucleic acid is 
able to bind to its surface. Therefore, if suitable conditions are created, this could act 
as a selection device for the cDNA material. The cDNA pools (resuspended in TE 
buffer/lOOmM NaCl) were denatured by boiling so that all species were present in the 
single-stranded state. The cDNA solution was allowed to cool to room temperature 
slowly; thus permitting the formation of secondary structures where possible. The 
solution was then applied to a small section of membrane which was then subjected to 
gentle washing steps with the same buffer solution to remove unbound cDNA from 
the surface. The membrane was then boiled in a small volume of water to remove 
bound DNA. This was then ethanol precipitated and used as a template for the 
standard subtraction PCR reaction. Thoeretically, only single-stranded cDNA 
molecules could become reversibly bound to the membrane whereas those exhibiting 
a large degreee of secondary structure would be washed off. The amplified material, 
however, showed no improvement in quality with respect to the percentage of the 
putatively unsubtractable cDNAs. Perhaps the single-/double-stranded nucleic acid 
discrimination of nitrocellulose membrane is not as absolute as this technique 
requires. 
A second protocol designed to separate the cDNAs on the basis of their secondary 
structure relied on the resistance of these stuctures to enzymatic activity. Again the 
cDNA pool was denatured by boiling and allowed to slowly cool to room temperature 
in order to permit the formation of secondary structures. The relevant primers and 
reaction constituents were then added to this material (at a temperature of 160C) such 
that a second-strand synthesis reaction could be carried out using the Kienow subunit 
as the polymerase enzyme. The rationale behind this reaction was that only cDNAs 
that were single-stranded along their entire length could be converted, in these 
conditions, to double-stranded DNA molecules. A region of secondary structure 
within a cDNA would hinder the progress of the Kienow enzyme at this temperature 
and would not be converted into the double-stranded form. Si Nuclease enzyme was 
added to the products in order to digest any single-stranded DNA present in a 
partially double-stranded molecule. Such a molecule would become unamplifiable 
after this digestion. The remaining double-stranded material was subjected to the 
normal subtraction PCR amplification. This protocol did not produce a substantial 
improvement in the quality of the cDNA pools. Explanations for this include the 
creation of double-stranded (re-annealed) forms of the unsubtractable material in the 
slow cooling step which would not be removed by the subsequent steps. The presence 
of such species is made all the more likely by the fact that they exist at a high 
concentration in the initial pool. 
For the following two subtractions, the most sucessful (but not completely so) method 
of preventing the unwanted species from accumulating was the extra care taken to 
ensure that as much ribosomal RNA material was removed from the purified mRNA 
as possible. Hence, two rounds of mRNA selection on oligo-dT cellulose columns 
were performed. This had the effect of creating initial cDNA pools which appeared 
devoid of any discrete bands; previous preparations using a less stringent mRNA 
purification method had resulted in cDNA pools which contained high abundance 
bands (possibly derived from ribosomal RNA) in a background of the other cDNA 
species. 
4.11: The revised subtractive hybridisation protocol used in an attempt to isolate 
hippocampus-specific transcripts 
Using the more efficient mRNA purification protocol and different linker 
combinations for the two cDNA pools, a second attempt at the Wang and Brown 
subtraction system was carried out. 
The tissue samples used to create the pools were derived from sham-treated brains 
(see next chapter for a fuller description). As before, cDNA pools corresponding to 
hippocampus and the rest-of-brain were synthesized and amplified. The subtractive 
hybridisation steps were performed as set out in the Materials and Methods chapter 
except that only four rounds of reciprocal subtraction, instead of the normal six, were 
completed prior to the cloning step. This was due to the appearance, once more, of 
unsubtractable material which manifested itself as prominent bands in the background 
of the cDNA pools when electrophoresed. 
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It was possible to clone the final stage (H 4) subtracted hippocampus DNA into the 
bacteriophage vector, Ml3tg 130, by the use of the XbalI restriction sites in the linkers 
of the cDNA fragments. Duplicate filter lifts of the resulting M13 plaques were taken 
through a differential screen for two purposes. Firstly, to gauge the extent of the 
expression specificity of a given clone and, secondly, as a negative selection against 
the unsubtractable cDNA-containing clones which were present in the fourth round 
hippocampus subtracted material. With this in mind the probes used in the screen 
were synthesized from fourth round subtracted hippocampus cDNA (H+4)  for the 
positive screen, and a mixture of new and old rest-of-brain cDNA pools (R and R 4) 
for the negative screen. The differential filter probings were compared and only 
plaques which were H+4  positive and R-/R-4 negative were selected for further 
analysis. 
Fig. 4.5a shows a comparison of the differentially screened filters and table 4d 
describes the eighteen most studied clones obtained from this screen. As before, the 
clones were sequenced to find homology to the GenBank/EMBL database of DNA 
sequences. PCR-amplified cDNA inserts from the M13 clones were also used as 
probes for expression analysis. Both cDNA Southerns and Northern blots of brain 
regions were used for this purpose. 
The same expression discrepencies between these two methods were seen, just as they 
had been for the previous attempt at hippocampus-specific cDNA subtraction. 
According to expression data from the cDNA Southerns, many of these clones 
represented transcripts which were very highly enriched in the hippocampus and, in 
two cases, appeared to be almost specific to this region (fig. 4.6). Northern analysis, 
however, contradicted these results in most cases (fig. 4.5b). 
The sequences of four clones (H4M 10, 27, 33, and 37) showed homology to 
sequences in the database. 
H4M 37 showed homology to a human expressed sequence tag (EST) originally 
described in the large-scale sequencing of brain cDNAs (ref. 3) 
H4M 33 showed identity over its entire length to the rat 5-hydroxytryptamine la 
receptor (ref. 4). This receptor is coupled to the inhibition of adenylyl cyclase activity 
upon agonist stimulation. The cloning of this receptor is interesting in two ways: 
firstly, neurotransmitter receptors are generally low abundance transcripts (showing 
that the subtraction procedure is relatively sensitive) and, secondly, because this 
transcript shows a restricted distribution. The predominant sites of expression in the 
brain described in the paper include the hippocampus, septum, and thalamus with 
Figure 4.5 a Final subtraction stage hippocampus cDNA cloned into M13 
bacteriophage vector, transfected, plated, and transferred onto duplicate filters. One 
region of a set of duplicate filters is shown here to demonstrate the results of the 
differential screen. Only plaques which were exclusively hybridised by the H probe 
were analysed further. b The brain expression distributions of two clones (H4M29; 
no homology and H4M1O; hippocalcin) by Northern hybridisation. Ribosomal protein 
S26 is included as an RNA loading control. 
Table 4 d Analysis of the clones that emerged from the second attempt at 
hippocampus subtraction. Insert size is given in base pairs. Hybridisation intensity is 
an approximate assessment of relative hybridisation strength. Dashes indicate that no 
expression experiments were carried out. 
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Table 4d 
11+4 M13 Clone Insert Size Hyh. Intensity Seq. Homology eDNA Southern Northern 
6 300 ** No Homology H.>>>R. - - 
10 500 ** Hipplcin H. Specific H.>>Cx>R.>>Ccr. 
19 350 * No Homology H.>>R. - 
21 300 ________________ No Homology H.>>R. - 
22 500 ** No Homology H.>>R. - 
23 - * Linkers - - 
24 250  Linkers - - 
25 330  No Homology H.>>R. - 
26 - * Linkers - - 
27 220 * NHE-1 - - 
28 250 * No Homology H>R. H.=Cx>Else 
29 300 * No Homology H.>>R. Ce.=Cx.>H. 
31 - * Linkers - - 
33 300 * 5-HT1a Receptor - - 
34 - *** Linkers - - 
35 150 * No Homology H. Specific All Lanes Equal 
36 100 * Linkers - - 
37 	1 250 ** hEST T04934 H.>R. - 
lower levels of expression seen in some mid- and hind-brain structures. The 
implications for such a distribution on the sensitivity of the subtraction will be 
discussed later. 
Clone H4M 27 showed identity to the sequence for the rat Na/H exchange-i protein 
(ref. 5) which seems to be expressed in most tissues studied to date. Its function is to 
mediate the exchange of sodium and hydrogen ions across the cell membrane; a 
process which is important in a variety of ways, including pH balance and absorption 
efficiency. Its effect on pH balance has been studied in isolated hippocampal neurons 
but it is not known whether it exists in other brain regions also. 
The fourth identified clone, H4M 10, is identical to a sequence, hippocalcin (ref. 6). 
This protein is a member of the recoverin family of calcium-binding proteins and is 
described as being "...exclusively expressed in (the) pyramidal layer of the 
hippocampus...". cDNA Southern analysis concurred with the hippocampal specificity 
(fig 4.6) but this was not so pronounced when the clone was used as a probe on 
Northern blot of brain regions; expression was also seen in lesser amounts in the 
cortex and cerebellum (fig. 4.5b). 
4.12: Dilution of brain regions within the RoB pool might lead to false positive clones 
The expression patterns of hippocalcin and the serotonin receptor point to an 
explanation for their enrichment in the subtraction. The subtraction is performed 
using cDNA pools derived from hippocampus mRNA and RoB mRNA. The second 
of these is a mixture of mRNAs obtained from all of the non-hippocampal brain 
regions. As such, there are two factors which dictate the representation of a given 
transcript within this pool; the abundance of that transcript and the percentage of the 
brain that expresses it. Hence, the representation of a cDNA in the remainder-of-brain 
pool is an average of its abundance throughout this region as a whole. For example, a 
transcript might be present at equivalent abundances in the hippocampus and the 
hypothalamus but when used a probe on a cDNA Southern of the two pools would 
look much higher in the hippocampus than remainder-of-brain because the 
hypothalamus makes only a small contribution to the latter pool. Hippocalcin is 
probably the best example of this; the Northern blot shows that the transcript is 
present in the cortex, but the non-hippocampal brain tissue lane shows very low 
expression as the cortex signal only represents a small part of it. This 'dilution effect' 
makes a subtraction of this kind more difficult to achieve but it cannot be used as an 
explanation for all of the false-positive clones obtained here. H4M 35 seems to be 
specific according to cDNA Southern but is ubiquitously expressed as analysed by 
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Northern blot (data not shown). Other explanations have to be found to account for 
such discrepencies (see Chapters V and VI). 
Although not described in any detail here, a second screening was attempted on a 
larger selection of clones. In this case the negative probings were native cDNA probes 
derived from cerebellum, cortex, anterior mid-brain, and posterior mid-brain. This 
was used to avoid both the problems associated with the dilution effect and failure to 
achieve complete representation of transcripts in the amplified cDNA pools. No 
specific clones were isolated. 
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Chapter V 
Long-Term Activity-Dependent Modification of Gene Expression in 
the Hippocampus 
5.1: Introduction 
Functional distinctions for the hippocampus are plentiful and this raises the possibility 
that the hippocampus might only exhibit transcriptional individuality when carrying 
out its principal role; that of memory formation. The experiments described elsewhere 
in this thesis failed to distinguish this region from others at the level of transcription 
and were carried out using cDNA obtained from unstimulated tissue (or sham-treated 
tissue, in the later experiments described in Chapter IV) dissected from rats caged in a 
cognitively undemanding environment. As the hippocampus is the brain region 
required for the creation of certain types memories then perhaps specific gene 
expression might be induced in rats when they are subject to a situation demanding 
the increased activity of this brain region (such as swim maze training or introduction 
to a novel and complex environment). This might be one explanation why searches 
for hippocampus-specific genes up to now have been fruitless. The introductory 
chapter referred to experiments showing that rats housed in enriched environments 
seem to undergo structural changes in hippocampal synaptic morphology, although 
little work has been done to investigate the gene expression changes in such animals. 
The role of neuronal gene-induction has been extensively studied in lower organisms 
such as Aplysia and Drosophila. This has revealed that there are defined stages in the 
process that leads to the consolidation of modified behaviour. These phases are 
distinguished from each other by their susceptibilities to pharmacological disruption. 
5.2: Long-lasting LTP requires de novo transcription and translation 
Synaptic excitation of sufficient strength can result in de novo gene expression. The 
introductory chapter described the effects of transcription and translation inhibitors on 
the consolidation of STP into LTP. These experiments prove that the memory 
formation process is not simply the result of protein phosphorylation or the triggering 
of certain biochemical cascades, but requires the synthesis of new proteins. 
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5.3: Activity-dependent gene expression in the brain 
How might newly-expressed gene products contribute to the potentiation state of a 
neuron? To answer this it has been necessary to clone genes whose expression 
changes after hippocampal stimulation procedures (ref. 1). Previous attempts to 
isolate activity-dependent transcripts have had two main features. First, much of the 
work has concentrated on a narrow time-window immediately following the particular 
stimulus paradigm used. Second, for reasons explained below, stimulus protocols 
have been chosen for maximal potentiation effect. The choice of the time post-
stimulation when brain expression is monitored has generally limited the genes 
isolated to a particular functional group; the immediate early gene family (refs. 2-4). 
Such genes undoubtably play an important role in medium-term potentiation events 
(and in initiating the long-term events). 
The following section briefly describes the results from published experiments 
designed to isolate transcripts which show responsiveness to neuronal activity. 
High frequency stimulation of the perforant pathway to the dentate gyrus granule cells 
leads to a rapid induction of one particular lEG transcription factor, zif/268 (also 
known as egr-1, NGF1-A, and box 24). Other EEG transcription factors such as c-fos, 
c-jun, and junB are induced to a lesser extent and not consistently. The activation 
characteristics of zif/268 are typical for lEGs in that its mRNA accumulates from 15 
minutes after the stimulus, reaches a maximum before one hour, and then returns to a 
base-line level after approximately three hours. The protein product persists for eight 
hours after the stimulus. Two results point to a close relationship between zif/268 
upregulation and the induction of LTP (ref. 5). First, upregulation of its mRNA seems 
to be critically dependent on whether the stimulatory signal was above a certain 
threshold and second, the induction is prevented by the NMDA receptor antagonists 
MK801 and CGS-19755. These characteristics closely match the induction 
requirements of LTP. Interestingly, maximal electroconvulsive shock stimulation to 
the brain induces the expression of this gene even in the presence of NMDA receptor 
inhibitors; implying that the effects on memory seen after this technique may be, in 
part, NMDA R-independent. However, recent work has shown that ketamine (a 
NMDA receptor blocker) can reduce the amnesic effects of electroconvulsive 
stimulus (see below) when administered prior to stimulus. The effect of volatile 
anaesthetics on LTP and zif/268 induction appears to be variable (ref. 6) but 
completely prevents the other lEG transcription factors from being upregulated. Thus, 
it seems likely that different mechanisms operate to cause the transcriptional 
activation of the different members of the lEG family. The activity-dependent entry 
of calcium into the post-synaptic cell is the likely trigger for events that lead up to the 
induction of these genes, but the precise mechanisms have yet to be elucidated. 
2D gel electrophoresis of the proteins produced in Aplysia neurons before and after 
the induction of long-term sensitization (or serotonin administration) revealed the 
presence of two products which remained at elevated levels for some time. These 
were identified as BiP (a heat shock-related protein involved in protein trafficking at 
the endoplasmic reticulum; ref. 7) and caireticulin (a calcium binding protein; ref. 8). 
The functional significance of their upregulation is not yet known, but expression of 
members of the heat shock protein family is often observed upon cellular stimulation 
in a wide range of biological processes, probably to aid the correct folding of nascent 
proteins. 
Ever since the detection of increased protease activity in post-stimulation 
hippocampus perfusate, there has been great interest in the function of these enzymes 
in the brain. A differential screening experiment designed to isolate genes upregulated 
soon after metrazol-induced seizures produced five 'brain activity-dependent' (BAD) 
genes. One of these encoded an extracellular serine protease, tissue-plasminogen 
activator (tPA; ref. 9), which exhibits a classical NMDA receptor-dependent lEG 
expression profile under a variety of activation protocols. Metrazol-induced seizures 
caused widespread upregulation, kindling (experimental epileptogenesis) caused 
bilateral hippocampal upregulation, and perforant pathway stimulation only affected 
ipsilateral hippocampus. Thus, an estimate of the comparative strength and range of 
these stimuli can be made from these data. The role of protease activity in neural 
tissue has been proposed to be one of synaptic remodelling; by reducing the rigidity 
of the extracellular matrix and the adhesivity of cell adhesion molecules, synapses can 
alter their structure, divide, or form entirely new connections. A tPA null strain of 
mice has been generated by targeted disruption of the gene locus. These mice exhibit 
altered blood clotting response (ref. 10) and possible resistance to excitotoxicity (ref. 
11). Unpublished information (abstract: IX International Neurobiological 
Symposium, Magdeburg, 1995 and personal communication, E. R. Kandel) on the 
hippocampal function in these mutant mice seems to show that they lack conventional 
LTP. This is the first 'knock-out' experiment which has targeted an activity-
dependent gene in the brain and the putative phenotype appears to suggest that 
mutations of this type may be more informative than the disruption of constitutively-
expressed genes. Recently, another activity-inducible serine protease gene has been 
discovered. Neuropsin (ref. 12) expression seems to be restricted to the limbic system 
(hippocampus and amygdala; see Chapter VI). 
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The proposed presynaptic glutamate receptor GR33 shows a degree of NMDA 
receptor-dependent upregulation in dentate gyrus granule cells for a few hours after 
high frequency stimulation (ref. 13). Because of the location of the encoded protein in 
the presynaptic (axonal) processes of these cells, an upregulation could have an effect 
on the post-synaptic CA3 neurons. In this way, activation of gene expression in one 
section of the hippocampal network could have a knock-on effect on the excitability 
of the next section (by acting as a negative feedback control on the release of 
glutamate neurotransmitter). This kind of process is not Hebbian (nor is the 
potentiation exhibited by synapses between dentate gyrus and CA3 neurons) as it 
does not require the simultaneous activity of the post-synaptic neuron to evoke a 
change in potentiation. It would be interesting to see if the same sort of upregulation 
was seen upon CA 1 LTP stimulation; a region displaying Hebbian LTP. 
Kindling has been shown to have an down-regulatory effect on ligatin (a membrane-
bound protein) gene expression (ref. 14). This lasts for up to four months and 
represents one of the longest-lasting gene expression shifts observed in the brain to 
date, even though the change in the level of expression is small. 
LTP induction in the CAI region of the hippocampus has a positive effect on the 
transcription of two neurotrophins, brain-derived neurotrophic factor (BDNF) and, to 
a lesser extent, neurotrophin 3 (NT-3) (ref. 15). These are growth and survival factors 
and may play a part in the avoidance of excitotoxicity and the creation of new 
synaptic connections. This is especially evident in the dentate gyrus region which 
exhibits mossy-fibre sprouting in response to certain electrical stimuli. 
Recent advances in molecular biological techniques have permitted the isolation and 
analysis of mRNA from a single neuron (ref. 16). In this way, it has been possible to 
examine individual cellular responses to stimulation. Stimulated CAI neurons show 
significant but modest increases in a-CaMKII, zif/268, and GABA 131 expression and 
comparable size decreases in the levels of mRNAs encoding PKC 131, BDNF, TRK, 
and muscarinic acetylcholine receptor 3 mRNA; all sampled at 30 minutes to 3 hours 
after stimulation. 
In another experiment, a subtractive hybridisation was performed to enrich for dentate 
gyrus genes upregulated six hours after intraperitoneal injection of kainate (ref. 17). 
The resulting enriched library was used in a differential screen to further select these 
genes. Of 1000 clones studied to date, 52 show some degree of upregulation. Many of 
the previously described lEGs and activity-regulated genes were represented in this 
screen, together with several novel cDNAs. Two of these, cpg-1 and cpg-2 (candidate 
plasticity genes), were described in more detail. Cpg-1 is possibly related to the 
neurotrophin family and shows preferential expression in the dentate gyrus after 
perforant pathway stimulation. Unlike cpg-2, it is activated in an NMDA-dependent 
fashion. Sequence information on cpg-2 is not yet available. 
Perhaps the most interesting experiment from the point of view of the work presented 
in this thesis was the isolation of pentylenetetrazole seizure-induced genes by 
differential screening. This was made technically easier by the co-administration of 
cycloheximide, a treatment known to attenuate the down-regulation of immediate 
early genes. The precise methodology of the differential screening process (the 
screening of duplicate lifts of an activated hippocampus cDNA library with control 
cortex and activated hippocampus cDNA probes) had the dual outcome of revealing 
both hippocampus-enriched and immediate early activity-dependent genes. Three 
clones were described in differing detail in this paper; c-fos, a 'clone predominantly 
expressed in the hippocampus' (see Chapter VI), and an activity-regulated gene 
(arg3. 1; ref. 18). The last of these exhibits a typical lEG activation time-course within 
the granule cells of the dentate gyrus but, interestingly, its mRNA is localised to the 
soma and dendritic processes of these cells. Only a limited number of neuronal 
transcripts have been shown to undergo this sort of trafficking throughout the cell 
(refs. 19-21). These include MAP2, a CaMKII, and the inositol trisphosphate 
receptor. 
Pulse labelling of activated fragmented synapses shows that between 8-10 mRNAs 
are capable of being rapidly translated (in a transcription-independent fashion) at the 
synapse. These may be the transcripts that are important in the consolidation of LTP 
and which are affected in the translation inhibitor experiments described above. The 
data indicate that these mRNAs may be stored in the synaptic region until required. 
This has important implications for one of the tenets of LTP theory; that of 'synapse 
specificity'. This states that only associatively activated synapses can become 
potentiated. Events at a subset of synapses have to be communicated to the nucleus 
for transcriptional changes to ensue. The problem of accommodating the concepts of 
'synapse specificity' with activity-dependent gene expression comes when these 
transcription or translation products have to be returned to the relevant activated 
synapses where, presumably, they act to stabilise synaptic potentiation. A 
'potentiating' synapse must somehow present an identity signal to the protein and 
mRNA trafficking systems that it is a suitable site for such modification. It is not 
clear at the moment whether there is a distinction between constitutively expressed 
dendritically localized transcripts, which might (upon activity-dependent translation) 
form the basis of this signal, and those transcripts which travel to the activated 
synapse later (such as arg3. 1), which may be part of the consolidatory process. The 
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analysis of potential targeting signals of these transcripts would be a useful approach. 
Arg3. 1 has an unconfirmed homology to the cytoskeletal protein spectrin, and may 
therefore, play a role in activity-related synaptic remodelling. 
5.4: Stimulus paradigms employed for gene expression induction 
Because techniques such as subtractive hybridisation and Northern blots have low 
sensitivity limits, non-physiological stimulation of the hippocampus is usually 
required to permit observation of activity-dependent changes in gene expression. It is 
a property of the in vivo hippocampus that when it is active (for instance when the 
animal is exploring a novel environment) fewer neurons fire than when at rest. This 
observation is known as 'sparse coding' (ref. 22). The functional implication of this 
highly restricted activity is a 'computational' benefit arising from the lack of 
processing interference; in fact, this has been adopted by neural network designers as 
an efficient model. However, the implications for the molecular biologist are that 
during hippocampal activity only a small number of neurons will exhibit 
transcriptional changes: these will be diluted by the uninduced majority. With this in 
mind, stimulus paradigms have therefore been adopted which maximise the 
percentage of transcriptionally active neurons. Inevitably, a compromise has to be 
struck between the proportion of the hippocampus driven into the expressing state and 
the artficiality of the stimulatory method. It has to be borne in mind that the genes 
whose expression is changed because of a particular inductive regime may not be 
those which participate in the normal memory creation process. Certainly the gross 
result of intraperitoneal injection of kainate (ref. 17) is violent seizures which can be 
fatal: this would be expected to induce gene expression changes in its own right 
which may be in response to the drug's toxicity rather than the induction of 
potentiation. Nevertheless, much of the investigation of LTP from a pharmacological 
or electrophysiological stand-point has faced similar concerns over the abilty to infer 
the mechanisms of the natural process from experimental intervention. 
There is a danger that a gene can be ascribed a hippocampus-specific expression 
pattern (and hence, a role in learning in memory) purely because the stimulus 
paradigm used selectively activates that part of the brain; for example, perforant 
pathway stimulation. The brain expression pattern of induced tPA is very different 
depending on the precise stimulus used. Therefore, the assessment of induced 
expression should be performed after a wide variety of stimuli (including, if possible, 
a 'natural context' behavioural activity such as swim maze navigation) before the 
induced expression of a gene can be described as both restricted to the hippocampus 
and linked to its function. 
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5.5: Electroconvulsive stimulus (ECS) : depression treatment, LTP model, and 
stimulatory paradigm 
The aim of the subtraction described in this chapter was to isolate genes which are up-
and down-regulated in response to electrical activity in the hippocampus. The choice 
of the stimulus protocol was electroconvulsive stimulation (ECS) which has 
characteristics that make it suitable for this experiment (ref. 23). These include the 
longevity of the induced potentiation changes and the lack of spontaneous epileptic 
episodes in the rats (in contrast to kindling). 
Electroconvulsive therapy (ECT) is a treatment for chronic depressive illness in 
humans which can be used as an alternative or complement to drug treatment. 
Patients who receive this therapy sometimes suffer from anterograde amnesia for a 
few weeks after the end of the course of treatment. A similar effect has been seen in 
rats which have undergone the analogous procedure, ECS. In vivo electrophysiology 
has permitted the greater understanding of these side-effects. It appears that after a 
defined number of ECS shocks have been administered there is a semi-permanent 
increase in the general potentiation level of neurons in the hippocampus (amongst 
other regions). This results in the inability to induce additional LTP (by artificial 
means) to the same extent as can be induced in control animals (ref. 23). It is 
observed that this effect attenuates after 30-40 days in these animals: a time-scale 
similar to that of the human side-effects. Perhaps this can explain the amnesic side-
effects reported by the patients; hippocampal synapses are uniformly potentiated to 
such an extent (saturated) that genuine memory-forming potentiation cannot occur. 
ECS has been used in an attempt to tighten the link between LTP and spatial learning. 
Several studies have described efforts to induce total LTP saturation in the 
hippocampus by means of bilateral perforant pathway stimulation along the entire 
length of the hippocampus. Rats treated in this way have then been assayed for 
hippocampal function in a variety of behavioural tests; the aim being to prove that 
hippocampal LTP saturation prohibits subsequent learning. It seems likely that the 
highly variable results published from such experiments can be explained in terms of 
the failure to elicit ubiquitous and maximal stimulation within the hippocampus (ref. 
24) Moreover, network models of hippocampal function predict that the amount of 
memory deficit observed would not follow a linear relationship with the extent of 
LTP saturation. The relationship is likely to be sigmoidal in that a threshold saturation 
level has to be attained before the onset of any hippocampal deficit, but when this is 
achieved the effects of any further saturation are substantial (ref. 25). In this way, the 
adoption of electroconvulsive stimulation as a means to ensure complete saturation 
has led to the reproducibility of behavioural deficits. 
Very little is known about the precise mechanisms responsible for the anti-depressive 
effect of the treatment. One feature of note is that approximately 5-6 ECS shocks are 
required to elicit the maximum induction of potention in rats: this matches the number 
of ECT treatments necessary to produce the most beneficial and sustained anti-
depressant effects in human patients. An understanding of the gene expression 
changes that accompany ECS in rats may go some way to explaining how this 
particular treatment acts and possibilities for novel treatment approaches. 
5.6: Molecular studies of ECS illustrate its similarity to conventional LTP -inducing 
procedures 
Several groups have begun to investigate the molecular biology of ECS, generally 
examining the transcriptional changes of candidate genes that might be involved in 
the etiology of depression. One of the very first attempts (ref. 26) was published in 
1979 and concerned the immunoelectrophoretic detection of several neural markers 
(synaptin, Dl, D2, D3, and 14-3-2). After a course of EC stimuli, increased levels of 
the markers synaptin and 14-3-2 (which was tentatively suggested to be enolase 
enzyme) were detected in the frontal and occipital cortices. The advent of more 
sophisticated molecular biological techniques has revealed expression changes at the 
level of transcription. In a recent paper (ref. 27), levels of CRH mRNA in the 
paraventricular nucleus and levels of TH mRNA in the locus coeruleus were assayed 
after 1, 3, 7, and 14 EC stimuli. The results show that TH is upregulated after one 
stimulus whereas CRH requires 7 to induce maximum transcriptional change. The 
raised levels of these two mRNAs persist for three weeks in the case of CRH and 
eight weeks for TH. Such long-term changes in gene expression have been rarely 
documented in the literature concerning brain gene expression. 
It may be that ECS represents an efficient tool to investigate expression changes that 
follow LTP because of the large-scale and widespread potentiation that occurs. 
Admittedly, the relationship between the anti-depressive actions, the potentiation 
saturation effects, and the UP induction properties of ECS is not yet understood. 
Nevertheless, the ECS-induced gene expression changes that have been reported are 
similar to more standard excitation protocols. For example, the immediate early gene 
transcription factors have been shown to be upregulated within the first few hours 
after an EC stimulus. A subtractive and differential screening approach (ref. 28) was 
used for the identification of early response genes induced by maximum 
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electroconvulsive shock (MECS). One gene identified was mitogen-inducible cyclo-
oxygenase (COX-2/prostaglandin synthase 2) which is a constituent enzyme in the 
synthesis pathway responsible for the production of thromboxane and prostaglandin; 
two modulatory compounds thought to have wide-ranging effects on neurons. Again 
the activation profile is typical of the lEG family with an expression peak at 30 
minutes and a return to base-line at 8 hours. This gene is upregulated 
developmentally, in the post-natal brain, and in response to stress. Recently, the 
targeted disruption of this gene has been reported (ref. 29). The phenotype shown by 
mutant mice includes the presence of kidney abnormalities and a susceptibility to 
peritonitis. No attempts were made to address possible cognitive deficits. A second 
gene isolated from this screen has been identified as a member of the small GTP-
binding protein family (ref. 30). Rheb is most closely related to rasl and rap2 at the 
sequence level. Its transcriptional induction following maximal electroconvulsive 
stimulus is approximately 2-5-fold above basal levels. The time-course of 
upregulation follows the typical immediate early gene pattern, with the maximal 
increase observed 4 hours after stimulation. In addition, a novel member of the 
EGR/NGF transcription factor family, egr3, has been cloned from subtracted ECS-
treated brain cDNA by the same group (ref. 31). As with all of these IE genes, a 
return to baseline expression levels is seen within 24 hrs. Other genes shown to be 
upregulated by ECS include neuropeptide Y(ref. 32), nerve growth factor, basic 
growth factor, a lb (but not la) adrenergic receptor, 5HT1a, and 5HT2a receptors 
(ref. 33). 
5.7: The study of long-term gene expression changes 
The study of activity-dependent gene expression changes described in this chapter 
was performed using mRNA extracted 72 hours after the final stimulus in a series, as 
opposed to the majority of experiments which are concerned with relatively 
immediate changes in gene expression. Our aim was to obtain genes whose 
expression levels in the hippocampus remain altered for long periods of time in 
response to ECS. Such genes might be responsible for the consolidation or the 
maintenance of synaptic efficacy changes. However, it is important to note that 
though the effects of ECS extend far beyond the 72 hour time-point, it is not certain 
that these effects are mediated by a continued change in gene expression (even though 
some genes are upregulated for this period, as mentioned in section 5.6). The 
potentiation/saturation at these later time-points could be mediated by early 
synthesised proteins that persist in their roles of synaptic restructuring or signal 
transmission modification. 
Section 5.8: The ECS regime and the subtraction process 
All experiments involving ECS were carried out in collaboration with Drs. Ian Reid 
and Caroline Stewart (then based at the Biomedical Sciences Division, Aberdeen 
University, and now at the University of Dundee). They were responsible for carrying 
out the full ECS regime on the experimental animals. 
To maintain comparability, only male Fisher rats of approximately four months of age 
were used. The electroconvulsive stimulation procedure involved the rats being 
divided into two groups; ECS and Sham. Both groups were subjected to light 
halothane anaesthesia prior to the attachment of electrodes to the ears. Only rats in the 
ECS group received the EC stimulus (see Materials and Methods section) which 
induced tonic/clonic seizures lasting approximately 15 sec Sham rats were subjected 
to the same degree of handling but were not stimulated. This protocol was repeated on 
alternate days such that, by the end of the program, the ECS rats had received 10 
shocks each (6 shocks are normally considered adequate to elicit maximal 
electroconvulsive stimulation). 72 hrs after the final stimulation, the brains of these 
rats were removed and dissected into subregions. 
cDNA derived from hippocampus mRNA was used to create two PCR-amplifiable 
cDNA pools (from Sham and ECS rats) as described in the Materials and Methods 
section. These formed the starting material for the subtractive hybridisation process as 
well as DNA material for use in cDNA Southern hybridisation experiments. 
The subtraction was limited to four reciprocal rounds of hybridisation for the reasons 
described in the previous chapter. Stage four ECS (E 4) and Sham (S 4) cDNA pools 
were cloned into a bacteriophage M13 vector (tgl3l) in order to create small libraries 
of the final subtracted products. These libraries were plated, transferred to 
nitrocellulose filters and taken through a differential screening process using 
particular cDNA stages as templates for the various probes. E+4  filters were screened 
with probes derived from stages E and S-/S-4.  4 filters were screened with probes 
derived from stages S 4 and E+/E+4. Differentially hybridising plaques were picked 
and purified to isolation. 
Plaques only hybridised by E 4 probe were designated ECS up-regulated clones 
(ECU clones) whereas plaques only hybridised by S 4 probe were designated ECS 
down-regulated clones (ECD clones). The cDNA inserts of the ECU and ECD 
plaques were isolated and studied by sequence and expression analysis as described 
below. 
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5.9: Sequence analysis of clones 
The majority of ECU and ECD clones were subjected to sequence analysis and used 
to search the GenBankIEMBL databases for homology using the FASTA program of 
the GCG8 Wisconsin DNA analysis package (tables 5a and 5b). 
Most clones lacked database matches, although the number might be reduced upon 
more extensive sequencing of the clones or examination of corresponding full-length 
cDNAs. It was also notable that very few of the putative down-regulated clones were 
identified by sequence homology. This might be in part due to the lower average 
abundance of these clones (see section 5.10): lower abundance transcripts are less 
well represented in any database. 
Three sequences showed a high degree of homology to human expressed sequence 
tags (ESTs) which are short regions of sequence obtained from the automated analysis 
of cDNA libraries. Because brain cDNA libraries have been frequently subjected to 
this kind of analysis, it was likely that at least some clones would exhibit homology to 
EST sequences. 
The other identified clones are described below. 
Aconitase 
Clone ECU 6, while being only 40 base pairs in length, possessed 100% identity, 
when hypothetically translated, to pig heart aconitase (ref. 34). Aconitase is unusual 
in that the protein it encodes has two very different functions. First, it is a 
mitochondrially located enzyme which catalyses one stage in the citric acid cycle. As 
such it is an enzyme containing a [4Fe-S] cluster cofactor which is responsible for the 
redox conversion of its substrate, citrate, into isocitrate. The iron-sulphur part of this 
enzyme is itself very sensitive to disruption by free radicals that accumulate during 
hyperoxic shock or NO release. Second, the aconitase enzyme with a deactivated and 
dissociated iron-sulphur core behaves as an entirely different protein (dubbed the iron 
regulatory protein, IRP) which acts by binding mRNAs encoding iron metabolism 
enzymes (ref. 35). 
NF- YB 
Clone ECU 9 corresponds, at the 5' end, to the published sequence of NF-YB (ref. 
36). NF-YB protein product, when complexed to that of NF-YA, forms a transcription 
factor (NF-Y/CP- 1ICBF). This factor, along with other factors such as CP-2 and NF- 1 
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Table 5 a ECS up-regulated (ECU) clones including sequence homology information 
and expression pattern by cDNA Southern and Northern hybridisation. b ECS down-
regulated (ECD) clones including sequence homology information and expression 
pattern by cDNA Southern and Northern hybridisation. 
Table 5a 
ECU Clone eDNA Southern Sequence Homology Northern Results 
2 E>>>>>Sh No Homology All lanes 
6 E>>>>>Sh Aconitase - 
8 E>>>>>Sh No Homology (=14/24) - 
9 E>>>>Sh NF-YB Tr. Fact. All lanes 
10 - Phosducin-Like Protein (I) - 
11 - No Homology Smear/band in all lanes 
12 E>>>>>>Sh Phosducin-Like Protein (2) All lanes 
13 E>>Sh B-Catenin - 
14 - No Homology (=8/24) - 
15 E>>Sh Hu.ESTT50042 All lanes 
16 - No Homology - 
17 - No Homology All lanes 
18 - B-Catenin - 
19 - No Homology - 
20 - No Homology - 
21 E>>>>>Sh No Homology (=26/35) - 
22 - No Homology - 
23 - No Homology - 
24 - No Homology (=8/14) - 
25 - No Homology - 
26 - No Homology (=21/35) All lanes 
27 - No Homology - 
28 - No Homology - 
29 - No Homology - 
30 - B-Catenin - 
31 - Hu.ESTZ40081 - 
33 - No Homology - 
34 - No Homology - 
35 - No Homology (=21/26) All lanes 
36 E>>>Sh Guanine-Nucleotide Rd. Fact All lanes 
37 - No Homology All lanes? 
38 - No Homology (fusion prod.) No signal 
39 - No Homology - 
40 - B-Catenrn - 
Table 5b 
ECD Clone cDNA Southern Sequence Homology Northern Results 
1 Sh>>E - - 
2 Sh>>>E No Homology - 
6 Sh>>>E No Homology No signal 
7 Sh>>>E No Homology - 
9 Sh>>>E - - 
10 - No Homology - 
12 - bEST F07937 - 
14 Sh>>>E No Homology - 
24 Sh>>>E - No signal 
25 - No Homology No signal 
26 - No Homology All lanes: not baseline 
28 - No Homology - 
35 - No Homology - 
38 - No Homology - 
40 - No Homology - 
50 - No Homology - 
54 - No Homology - 
60 - No Homology - 
bind to the DNA sequence CCAAT; a motif present in the promoters of many 
eukaryotic genes, and studied in detail in the promoters of the major 
histocompatability class II genes (ref. 37). Other promoter examples include herpes 
simplex virus thymidine kinase, mouse MHC I, mouse albumin, interleukin-4, 
thrombospondin 1, tryptophan hydroxylase, rat aldolase B, and mouse a and 13 
globins. When the two constituent genes were originally cloned and sequenced, it was 
postulated that together they possess a zinc finger-like structure with each member 
protein containing amino acid motifs (CXXC in NF-YB and HXXH in NF-YB) 
which may act together as a zinc ion chelator, as in other examples of this family. In 
non-CNS mouse tissue NF-YB transcripts of 1.2 and 3.4 kb have been described. 
Differences at the levels of splicing and polyadenylation sites were proposed to 
explain the different forms but only the cDNA which corresponds to the smaller 
species has been obtained and sequenced to date. Clone ECU 9 was used on 
Northerns created from both base-line and Sham/ECS brain RNA. Only one transcript 
was observed at a position in agreement with it being of over 5 kb in length. ECU 9 is 
approximately 600 bp in length and when sequenced from the 5' end shows identity 
with a region of the published sequence commencing 280 bp upstream of the 
polyadenylation site. Near to the published polyadenylation site this homology 
abruptly ends (fig. 5.3). The remainder of the ECU9 sequence (300 bp) possesses 
three potential polyadenylation signal sequences, of which the third one is utilised. 
Hence, this gene could exist in at least four polyadenylation forms (two published, 
one used here, and one other putatively defined by its polyadenylation motif; see 
Appendix for sequence analysis of ECU9). To confirm that this clone does not 
represent an artifactual fusion event which might have occurred during cDNA pool 
synthesis or subtracted material cloning, a 180 bp PCR product encompassing the 3' 
end of the sequence was used as a probe on another Northern; exactly the same 
transcript size was observed. Even though ECU9 possesses a slightly longer 3' 
untranslated region, an additional 4 kb must be located in the 5' untranslated region to 
account for the larger transcript size. It is possible that this transcript size is brain 
specific as it was not detected in other regions in the original publication. To function 
as a transcription factor, both subunits have to be present. The presence of NF-YA 
protein in the brain has been demonstrated. With respect to NF-YB, expression has 
not been described in the brain (ref. 38). 
Phosducin-like protein 
Two clones, ECU 10 and ECU 12, emerged from the subtraction as the most highly 
expressed and upregulated genes at the level of cDNA Southern analysis. Sequencing 
of these clones revealed that they were homologous to the same gene, 'phosducin-like 
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protein' (PhLP; ref. 39), but were derived from differently spliced transcripts. 
Signalling pathways downstream of G protein-coupled receptors rely on the 
participation of both the a and the 13/y components of the heterotrimeric G Proteins 
(see Chapter II for examples). In addition to the actions of the a subunit, these seem 
to be mediated by the interactions of the 3/y complex with proteins containing a 
pleckstrin homology' (PH) domain (refs. 40 and 41). Members of the growing family 
which contain this domain include 3-spectrin, ras-GRF (also isolated as an 
upregulated clone), 3 adrenergic receptor kinase (see Chapter II), protein kinase C jt, 
phospholipase C y, Btk tyrosine kinase, and the syntrophins (a protein family 
associated with dystrophin). However, it must be noted that not all 13/7 complex-
binding proteins contain this domain (e.g. the potassium channel GIRK1 and adenylyl 
cyclase II). 
In a screen for genes upregulated by alcohol administration to cells in culture, a clone 
was obtained which exhibited sequence homology to phosducin, especially at the C-
terminal end (65% overall at the amino acid level), which was therefore dubbed 
'phosducin-like protein' (PhLP). Its expression is increased by a factor of two upon 24 
hour exposure to 100 mM ethanol. Phosducin, itself, was first isolated from retinal 
cells by virtue of its transducin 13/y complex-binding function and it has been shown 
to play a role in the negative modulation of that signalling pathway. Sequence 
homology to 13-ARK demonstrated that the 13/7-interacting region of phosducin was 
localised to the N-terminal region of the protein (refs. 42 and 43). This was confirmed 
in a binding assay. Interestingly, this N-terminal region contains residues with 
significant homology to the C-terminal portion of the canonical pleckstrin homology 
domain. Thus this protein possesses a '1/2 PH domain' which has been shown 
elsewhere to be sufficient for the protein interaction. 
During the initial characterisation of the PhLP cDNA clones, the authors saw 
considerable heterogeneity of sequence at the 5' end of the transcript. This was due to 
the existance of at least four 5' exon combinations as illustrated in fig. 5.3. One of 
these splice variants creates a transcript which, when translated, produces a longer 
protein product than the others. Moreover, the additional amino acid sequence of this 
extended protein contains the typical residues of the 1/2 PH domain, making it able to 
bind to 13/y complexes. Thus, by alternate splicing, the cell is able to regulate the 13/y 
complex-binding potential of the resulting protein. Spatial restrictions on the 
expression of some of the transcript types has been reported. It would also be 
interesting to discover if the splicing choice was activity dependent. 
The two clones isolated by this subtraction corresponded to the heterologous 5' region 
of the PhLP cDNA (see fig. 5.3). ECU 10 was derived from a transcript containing 
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exons 4 and 5 that would give rise to the longer (PH-containing) protein product, 
whereas ECU 12 was derived from exons 3 and 5 
/3-Catenin 
Four ECU clones showed sequence identity to 3-catenin at its 3' end. Three clones 
(ECUs 13, 18, and 30) were of 120 bp length, whereas a fourth (ECU 40) consisted of 
a sequence that overlapped with the others but extended an additional 370 bp further 
in the 5' direction. 
Adhesion between cells is a fundamental process in many biological systems. The 
ways in which neurons (specifically, their synapses) are attached to each other has 
been the subject of much recent research; especially in the light of data that suggest a 
role for cell adhesion in plasticity events that underlie memory formation (see 
introductory chapter). Cell adhesion is mediated by a large number of diverse protein 
families. One such family, the E-cadherins, forms homotypic cell-cell interactions in 
the presence of calcium ions. In epithelial cells, these adhesion molecules are 
restricted in localisation to the zonula adherens on the lateral surface of the cell where 
they are associated with two main proteins (ref. 44). These proteins, a-catenin and 13 
-catenin, seem to function in the regulation of cadherin-mediated cell adhesion. 
catenin, in particular, is regulated by the signalling pathways of two proto-oncogenes, 
wnt and src (ref. 45). Src non-receptor tyrosine kinase activation brings about a 
decrease in cellular adhesion whereas wnt- 1 activity has the reverse effect. 13 catenin 
(and y  catenin/plakoglobin) show a high sequence conservation at the amino acid 
level to a Drosophila protein, armadillo, which has been shown, in this organism, to 
participate in both of these signalling cascades (ref. 46). 
ras-GRF 
The final clone identified by sequence homology (ECU 36) was shown to be the 
guanine-nucleotide-releasing factor for the ras monomeric G protein (ras-GRF; ref. 
47). The product of this gene is responsible for the conversion of the inactive guanine 
dipho sphate- bound form of ras into unbound ras. This can then bind guanine 
triphosphate in a reaction catalyzed by the ras activation protein, ras-GAP. This 
process is, in turn, regulated by ras-GAP's activation by a variety of cell-type specific 
stimuli, usually emanating from receptor tyrosine kinase ligand binding. The 
importance of the ras-GRF function is that it is responsible for the rate-limiting step 
in the ras activation cycle and therefore dictates the intensity of the ras response to 
stimulation. 
5.10: Expression analysis by 'cDNA Southerns' 
Many of the clones that were isolated as differentials from the subtraction were used 
as probes on cDNA Southerns (the initial, pre-subtraction cDNA pools 
electrophoresed and blotted onto filters) as a quick assay for the efficiency of the 
subtraction. In comparison to the other subtractions that had used this technique, it 
was clear that the majority of clones that had emerged from the differential screening 
step exhibited a striking bias of distribution according to this assay. As this is a test of 
how well the subtractive process had performed with respect to the ability to select 
cDNAs which had a skewed starting distribution, the subtraction seemed to work 
more efficiently than before. Figures 5.1 and 5.2 list the results of a selection of 
cDNA Southerns. 
Several observations concerning the nature of the hybridisations were made. Firstly, 
from the results of the screen, there seem to be fewer cDNA sequences which appear 
down-regulated. Moreover, the general abundance of these species together with their 
degree of down-regulation was less than that for the up-regulated genes. Secondly, 
some of the expression differences are extremely pronounced such as those for PhLP, 
the 8/21 family of clones, and NF-YB, whereas others are less so. Thus, the 
subtraction appears to able to isolate differentially expressed genes present at a 
variety of abundances. Thirdly, in the case of the up-regulated clones, several 
repetitions of cloning were observed (for example, -catenin, PhLP, and the 8/21 
family) and while the expression level by cDNA Southern did not always correspond 
to the number of times a perticular sequence was cloned, there was some agreement. 
The fact that some clones were appearing multiple times can be used to argue that the 
total number of up-regulated clones enriched in this subtraction is not far in excess of 
those which were picked in this study. Fourthly, the precise pattern of hybridisation to 
the cDNA Southern was notable in a few examples. In the creation of the cDNA 
pools, the three factors which should determine the sizes of fragments derived from a 
parent transcript are; the distribution of the restriction sites used to digest the cDNA, 
the 5' extension by the reverse transcriptase enzyme, and the length of fragment that 
can be efficiently amplified by PCR. If a clone that emerges from the subtraction is 
used as a probe on the cDNA Southerns two patterns of hybridisation (or 
combinations thereof) would be expected; either discrete bands in the case of defined 
restriction fragment sizes, or smears in the case of 5' fragments which terminate at a 
random spread of positions. The predominance of the latter may indicate that 5' ends 
were more extended in one pool than in the other leading to false positives (see below 
section for a fuller explanation and counter-argument). The presence of incomplete 
digestion of the pre-amplification cDNA has been observed at the level of sequencing 
107 
Figure 5.1 cDNA Southerns probed with ECS up-regulated (ECU) clones obtained 
from the subtraction. S represents the sham cDNA pool and E, the ECS cDNA pool. 
Also shown is a cDNA Southern probed with a 700 bp fragment of the 8/21 family 
(see section 5.14). 
Figure 5.2 cDNA Southerns probed with ECS down-regulated (ECD) clones 
obtained from the subtraction. S represents the sham cDNA pool and E, the ECS 
cDNA pool. Also shown are cDNA Southerns probed with a candidate plasticity gene 
(cpg-1) and a loading/representation control, ribosomal protein S26. 
Figure 5.3 a Cartoon representation of the transcript sizes observed for NF-YB. 
1.2 kb and 3.4 kb transcripts have been described in the literature and a 5.5 kb 
transcript was observed in brain Northerns carried out here. Directly underneath is a 
representation of the structure of the 1.2 kb transcript (solid lines, ORF; open reading 
frame) and the additional mRNA required to create the larger transcripts (dashed lines). 
Clone ECU 9 contains an additional novel 3' untranslated region of NF-YB. b 
Possible exon combinations of a phosducin-like protein transcript. Under each is 
shown the resultant open reading frame for translation. Regions corresponding to the 
sequences of ECU 10 and 12 are indicated. Note that the exon combination -4-5- will 
give rise to a longer protein product upon translation. 
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and may cause a complication in the hybridisation pattern analysis of these clones. 
Fifthly, closer inspection of some of the cDNA Southerns shows that the expression is 
not entirely restricted to one pool. In some cases, the hybridisation pattern between 
the two pools differed with respect to the size of the cDNA fragments which are being 
hybridised (e.g. in the case of ECU 13; 0  catenin). This may indicate that the 
differentials are not genuine but the result of different extents of restriction digestion 
during the two cDNA pool syntheses. 
5.11: Expression analysis by Northern hybridisation 
Total RNA corresponding to selected brain regions was obtained from a second batch 
of rats taken through the Sham/ECS procedure. Northern blots were created from this 
material in order to obtain a more accurate assessment of the expression level changes 
of the subtraction clones after ECS. 
Fig. 5.4 shows Northern filters hybridised by a representative selection of the 
subtraction clones. The striking feature of these is that the differences between Sham-
and ECS-treated tissues, as seen on cDNA Southerns, are not maintained at the 
Northern hybridisation level. For a complete list of the Northern results see tables 5a 
and Sb. 
Several general observations can be made about the Northern hybridisation results. 
First, only a few ECD clones showed detectable expression by this method which 
suggests that these clones are, on average, expressed at a lower level than ECS clones. 
Second, although not a quantitative observation, the relative hybridisation strength of 
any given EC clone on a cDNA Southern did not always correlate with its expression 
level by Northern. The most extreme example of this discrepency was ECU 9, which 
gave one of the strongest signals by cDNA Southern, but displayed very weak 
expression on a Northern blot. One potential explanation for such a result is that 
preferential amplification (see Chapter IV) has actually occurred in the case of ECU 
9, leading to a falsely high abundance level in the original and subtracted ECS cDNA 
pools. 
5.12: Hypotheses for the discrepencies seen between cDNA Southern and Northern 
expression analyses 
The failure to corroborate the expression patterns of the clones on cDNA Southerns 
with expression on Northern blots was a feature of the previous subtraction, described 
in Chapter IV (carried out simultaneously). From a naive stand-point, the results from 
Figure 5.4 Northern expression analysis of a selection of up-and down-regulated 
clones fromn the subtraction. Tissue RNA lane abbreviations are 0; olfactory bulb, Hc; 
hipoocampus, Cx; cortex, Ce; cerebellum, Bs; pon s/medulla/brain stem, and El; else 
(brain minus O/Hc/Cx/Ce/Bs i.e. thalamus/striatum etc.). Expression comparisons 
between Sham and ECS-treated rat brains are shown for the clones listed on the right-
hand side of the page. The bottom of the page shows a typical ethidium- stained 
Northern gel to show comparable RNA loading: it can be seen that the olfactory bulb 
lane is slightly overloaded in every case. 
Fig. 5.4 
Sham 	I 	ECS 
Ow 	 I ECU 2 
ECU 12 
N 
 
ECU 15 
ECD26 
ECU 11 
ECU 35 
'p ECU 36 
Ethidium 
Bromide 
Staining 
sequencing of the clones appear to conflict with the notion that they are merely 
artifacts. The genes that have been identified do not seem to be the result of 
inefficiency in the subtraction process: if that were the case then it might be expected 
that highly expressed, mitochondrial, housekeeping, or ribosomal transcripts would 
have been cloned in greater numbers (as they were in the experiment described in 
Chapter In). Moreover, the cloning of several independent cDNA fragments from the 
same gene (for example, -catenin, PhLP, and, possibly, the ECU8/21 family of 
clones) seems to suggest that they are genuine. However, several possible 
explanations for the failure are listed below. Section 5.13 describes the results from 
experiments which were designed to test these theories. 
The mRNA which was used for the creation of the cDNA pools prior to the 
subtraction, and the RNA extraction which formed the basis for the Northerns, were 
derived fron different batches of rats; taken through the ECS procedure at different 
times. All possible efforts were made to ensure that these rats underwent identical 
protocols to ensure their comparability but, because of their different origins, there 
may have been inconsistencies between them at the level of transcription. 
During the various steps that were carried out, there could have been a stochastic 
failure with respect to one pool to convert some mRNAs into PCR-amplifiable DNA 
strands. Thus those sequences would appear to be enriched in the other pool. 
Stochastic processes would present more of a problem if the amount of nucleic acid 
material present in the pool synthesis steps was very low; approaching single 
representation with respect to some transcripts. The PCR-amplified material would 
not be a good representation of the true expression profile in such a case. 
The polyadenylation extent of a transcript is known to play an important role in its 
stability. In addition, specific examples of polyadenylation changing in response to a 
stimulus have been well-documented and assayed (for example, tPA; ref. 48). If the 
polyadenylation of a given transcript fell below a certain threshold length then it 
might not be purifiable using an oligo-dT cellulose column (see Materials and 
Methods chapter; mRNA extraction). Reverse transcription was performed using 
oligo-dT primers which would also affect the efficiency of conversion to cDNA for 
such a transcript. Hence, it could be postulated that up-regulated clones are derived 
from transcripts which are raised above a threshold polyadenylation state by ECS and 
down-regulated clones by the reverse process. The Northern expression data would 
not easily reflect this difference as total RNA (no selection for polyA+ RNA) was 
used. 
Differential splicing is a process which has been shown to be altered in a tissue-
specific and developmental stage-specific manner (ref. 49). If ECS causes a change in 
the splicing arrangement of any transcript then this could result in the conflicting 
expression seen. If a gene had the restriction sites necessary to create cDNA 
fragments of amplifiable size present in one transcript splice-form (present as a result 
of ECS) but not in the other, then it could be represented in one pool and not in the 
other. This bias in the pools would be absolute, and sequence-specific. Out of all the 
genes expressed in the hippocampus, only a few might exhibit this splicing and fewer 
still the correct arrangement of restriction sites. This selectivity matches that seen in 
the probable number of clones that came out of this procedure. Features of this 
hypothesis include the presence of other regions of the transcript in both pools; those 
which are not constrained by the specific splicing/digestion/amplification parameters. 
In addition, if the subtracted clone corresponded to a region of the transcript where 
the upregulated exon was spliced to a constitutive exon, then its use as a probe on a 
Northern blot would result in hybridisation to both normal and upregulated 
transcripts, masking the upregulated nature of the splice-form from which it was 
derived. 
This kind of argument can be extended into more general situations. For example, 
if the average length of reverse-transcribed cDNA is sufficiently different between the 
two pools, then additional 5' sequences will be present in one pool compared to the 
other; especially if extension of the cDNA synthesis in a 5' direction exposes relevant 
restriction sites. The size of the transcript would also play a part in the bias as long 
mRNAs would be especially susceptible to incomplete reverse transcription according 
to this model. 
Alternatively, it became clear upon sequencing many of the clones that the restriction 
digests used to divide transcripts up into small amplifiable fragments had not gone to 
completion. If one pool had been digested to a greater extent (i.e. consisted of smaller 
cDNA fragments) than the other then it is likely that it would have a better 
representation than the other pool because of the size constraint on PCR. Because 
both of these processes are stochastic, the differences between one pool and the other 
would very likely not be absolute. 
A variant on this theme is based on the experimentally-created differences between 
the two cDNA pools; that of the linker sequences ligated onto the ends of the cDNAs. 
These were chosen for the purpose of distinguishing cDNA members of one pool 
from the other in order that cross-contamination would not occur. However, the use of 
separate primers for the amplification of the pools raises the question of whether these 
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amplifications can be considered equivalent. An example of a situation that would 
expose these primer-based differences would be if a certain cDNA which was too 
large to be amplified by the PCR contained within it a sequence complementary to the 
3' end of one primer but not the other. PCR of this cDNA using one primer set might 
result in a product that was within the size range of the amplification process. 
Because the corresponding cDNA in the other pool is amplified with a different 
primer sequence, no PCR product would result. Only the final six or seven bases of 
the primer need to be complementary to the cDNA sequence for PCR priming to 
occur. This process is sequence-specific and absolute; as required for an explanation 
of the observed results. 
Although harder to explain mechanistically, it may simply be the case that the 
presence of one linker set on a particular cDNA fragment renders it more or less 
amenable to the PCR amplification process. 
5.13: Testing the explanations for the expression discrepency 
Different origins of the tissue samples. 
The first explanation raised the possibility that the subtraction results were correct but 
there was a failure to replicate the stimulatory or preparative conditions in the second 
batch of rat RNA used in Northern analysis. This possibility was tested by the use of 
RNA samples obtained from a third set of rats. In addition, this batch contained RNA 
samples derived from rats which had not been subjected to the Sham or ECS regimes; 
denoted 'baseline'. These were included to confirm that expression levels in the Sham 
hippocampi truly represented a control level. A probe derived from ECU10 was used 
as a probe on a Northern blot created from this material. The results were identical to 
those obtained from the second batch of RNA (data not shown). Moreover, no 
differences were observed between baseline and sham hybridisation signals. 
Brain sections obtained from the original set of rats were used for in situ hybridisation 
experiments. Expression changes seen in these sections should be directly comparable 
to that of the cDNA pools as they were derived from the same batch of rats. The 
individual results will described in a section 5.14 but the overall result was similar to 
the Northern data in that no expression changes were observed. 
Stochastic failures 
The observed patterns of hybridisation of the clones in question exhibit certain 
features which seem to suggest that stochastic failure is not a viable explanation. Not 
all sequences exhibit expression differences between the Sham and the ECS pools; for 
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example, SNAP-25 (data not shown) and ribosomal protein S26 show virtually 
equivalent distributions in the two pools. In addition, clones have been isolated which 
are virtually exclusive to one pool or the other. Together, this suggests that neither 
pool was vastly inferior (with respect to representational quality) to the other. It might 
be expected that an inefficiency of cDNA synthesis/conversion into amplifiable 
sequences would be reflected in the loss of rare cDNAs. In fact, some of the 
expression discrepencies occur in relatively highly expressed cDNA species: a 
stochastic failure could cause relative abundance differences between the two pools 
but would be unlikely to result in the absolute differences that were seen in some of 
these cases. If we can then assume that those clones displaying the cDNA 
Southern/Northern inconsistances represent only a small fraction of the initial cDNAs 
then it is necessary to find a transcript-specific or sequence-specific explanations. 
Nevertheless, an experiment was carried out to determine if the expression differences 
were due to the cDNA pools used in the subtraction being of poor quality. Because of 
the excess ribosomal RNA material present in early mRNA preparations (see previous 
chapter), Sham and ECS hippocampus cDNA pools had been created at an earlier 
time-point but had not been successfully used in subtraction experiments. However, 
these two pools were synthesized entirely independently of those used in the actual 
subtraction and could, therefore, be used to verify the expression differences of the 
isolated clones. Two points must be noted; first, these two sets of cDNA pools were 
created from material obtained from the same batch of rats, and second, this 
experiment should expose stochastic/operator flaws in the synthesis of the pools. A 
selection of PCR products corresponding to ECS and ECD clones were 
electrophoresed on an agarose gel and capillary blotted onto a nitrocellulose filter. 
This filter was subjected to four separate hybridisations using probes derived from 
both sets of ECU and Sham cDNA starting pools (old E and S- and used E and S-). 
In effect, the representation of the clones within the cDNA pools was verified with 
respect to changes brought about by ECS treatment together with changes brought 
about by cDNA pool batch variability. 
The results are shown in fig. 5.7a and 5.7b. Overall, ECU expression differences are 
maintained too a good degree (fig. 5.7a); only a few clones lost their specificity upon 
reprobing with the other set of pools. The results for the ECD clones were not so 
reproducible, as the old ECS probe hybridised to many of the ECD clones. Perhaps 
this represents a slight failure to achieve good representation in the ECS pool used in 
the subtraction (as it should have removed these ECD cDNA species). Some of the 
ECU cDNA clones whose expression appeared to be verified by the second probing 
were used on Northern blots. No differential expression was seen. In the light of these 
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results, it is necessary to find a systemic or sequence-specific (rather than stochastic) 
explanation to the artifactual representation of the pools. 
Polyadenylation 
The differences in the length of the polyA tail would have to be quite extreme to 
permit the failure or otherwise of oligo dT-cellulose purification or oligo dT-primed 
reverse transcription. One factor that argues against this hypothesis is that if false-
positive transcripts exhibited polyadenylation differences after ECS treatment then 
this should be evident on total RNA Northern blots as a shift in the transcript size. No 
cases of such migratory shifts were observed. In addition, an explanation such as this 
would require all parts of the transcript to be affected in the same manner. An 
example of different regions of a transcipt being represented differently in the two 
pools is described in section 5.14. 
Splicing 
The differential splicing hypothesis states that some parts of a cDNA are only 
amplifiable (through size constraints) when the correct arrangement of splicing is 
present and that this is an activity-dependent process. Thus, one splice-form is found 
in Sham transcripts and another after ECS. Because constitutively expressed portions 
of the transcript may also be present in the cDNA clone, analysis by Northern will not 
pick up the subtle rearrangement of transcripts. Clones corresponding to the genes 
phosducin-like protein, NF-YB, and the ECU 8/21 family seemed to be the most 
likely candidates for such a process. In the analysis of these genes and the 
corresponding clones that emerged from the subtraction, it is difficult to know 
precisely which region is up-regulated because multiple forms exist. It was with this 
in mind that a PCR-based approach was applied to phosducin-like protein transcripts 
(detailed in the next section). 
Efficiency of 5' extension by reverse transcriptaseirestriction digestion extent 
One flaw in these hypotheses is that they would produce false-positives in one 
direction only. For example, if the ECS pool was poorly represented, through 
whatever failure in the synthesis process, only Sham false-positives would have been 
apparent. It would not be possible to have false-positives in both pools (as were seen) 
unless there were a combination of different failings occurring simultaneously. 
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Different linker/PCR primer sequences 
The fact that a number of the false-positive clones were derived from genes which 
have published sequences allowed the study of their end-points. We wished to know 
if the individual amplified cDNAs had arisen by the addition of linkers to digested 
cDNA fragments (as expected) or had arisen through priming off a region of 
complementary sequence within an otherwise unamplifiable stretch (as the hypothesis 
suggests). No instance of genes displaying primer-complementary sequences 
corresponding to the ends of the subtracted clones were found. Therefore, with 
respect to these clones, this hypothesis has been disproved. 
In addition, an attempt was made to PCR amplifiy the synthesized pools (pre-
amplification) using a mixture of the primers; in this way it was hoped, the pool-
specificity (caused by primer artefacts) of some of the EC clones would disappear. 
However, the presence of a mixture of primers proved inhibitory to the amplification 
process and, thus, no firm conclusions could be drawn. 
Contrasting representation in cDNA and cDNA pools 
In order to demonstrate that the false-positive subtracted clones were not 
differentially expressed in unamplified/undigested cDNA (derived from mRNA from 
the third batch of rats), the ECU and ECD clones were blotted onto a nitrocellulose 
filter as described at the beginning of this section. This filter was probed with a Sham 
cDNA probe and, separately, with an ECS cDNA probe. No significant differential 
signals were observed. This experiment confirms the Northern and in situ results. 
5.14: Further analysis of selected clones 
Phosducin-like protein 
Fig. 5.3b shows that the two clones corresponding to this gene identified from the 
subtraction contain different exon combinations. PCR primers were directed against 
sequences found in particular exons in the 5' portion of the gene; the region from 
which the subtraction clones originate (fig. 5.5a). The aim of the experiments 
described below was to amplify the various exon combinations from Sham and ECS 
cDNA material in an attempt to see if any were found preferentially after ECS. It 
must be pointed Out that these experiments were designed only to give qualitative 
rather than quantitative expression data. 
A PCR reaction using the primer combination corresponding to exons 3 and 5 was 
carried out on the cDNA pools (fig. 5.5b). The amplification products (verified by 
cloning and sequencing) indicated that the Sham cDNA pool only possessed 
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Figure 5.5 a Cartoon representation of the arrangement of the exons in a PhLP 
transcript. Underneath are indicated the regions to which PCR primers were directed. b 
PCR carried out on sham and ECS cDNA pools using primers B and C (exons 3 and 
5). Products of this reaction were electrophoresed and photographed. It can be seen 
that both pools possess the exon combination 3-4-5, but only the ECS pool possesses 
the exon combination 3-5. Lane 'L' is a size marker. c A similar experiment was 
carried out using primer combinations A and C (exons 2 and 5) or B and C (exons 3 
and 5). The substrate for the PCR reaction was newly synthesized cDNA derived from 
hippocampus rnRNA from the third set of rat dissections. Lanes 'C' are no-DNA 
controls. The PCR products were electrophoresed, blotted onto nitrocellulose paper 
and probed with exons 3-4. It can be seen that there are no exon combinations specific 
to, or up-regulated in, sham or ECS cDNA. PCR primers: exon 2 (ccactgcagcttttctc), 
exon 3 (gggaatttcggctttcggttacttctct), and exon 5 (cggcgccagtcattgatc). Cycling 
parameters: 94°C; 1 mm, 530C; 1 mm, and 72°C; 1 mm (30 cycles). 
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amplifiable cDNA fragments with the exon combination 3-4-5 whereas the ECS 
cDNA pool possessed fragments with the 3-4-5 and the 3-5 arrangement. Hence, the 
3-5 arrangement of exons appeared specific to the ECS-treated tissue. This form 
would result in a protein that lacked the 1/2 pleckstrin homology domain. 
This experiment was repeated on untreated cDNA material obtained from the third set 
of rats (fig. 5.5c). In addition, amplification was performed with a set of primers 
directed at exons 2 and 5. With both sets of primers no difference was seen between 
the Sham and ECS cDNA samples. Exon combination (2-)3-4-5 was amplified to a 
greater extent than the (2-)3-5 arrangement, but this may not necessarily reflect the 
true relative abundance of these two forms. 
8/21 Family 
Two groups consisting of three identical upregulated clones (ECUs 8/14/24 and ECUs 
21/26/35) were identified from the subtraction. When representatives of these were 
used as probes on cDNA Southerns, similar intensities of hybridisation and banding 
patterns were observed. Upon Northerns, they hybridised with the same intensity to 
transcripts of the same molecular weight. 
A novel technique named 'cDNA capture' was applied to both these groups with the 
aim of obtaining longer regions of the parent transcript from which both seemed to be 
derived. This technique is described in greater detail in the Materials and Methods 
chapter but, in essence, the protocol uses the identified clones as immobilised 'DNA 
hooks' in non-radioactive hybridisation experiments to capture longer complementary 
cDNA fragments from the initially created cDNA pools. Representatives from both of 
the clone groups isolated a cDNA fragment corresponding to the size of the cDNA 
species to which they had hybridised on the cDNA Southern experiments. This 1.1 kb 
cDNA was cloned, EcoRI digested and subcloned to permit sequencing in full. The 
results of this sequencing show no homology to any sequence in the database and due 
to lack of a convincing open reading frame, no estimation can be made as to the 
nature of the protein product. There is a region of sequence match between 8/14/24 
and the 1.1 kb clone. This does not extend the full length of 8/14/24 (see fig. 5.6). It 
was thought that the point at which these two sequences diverge might represent a 
splice junction but no consensus splice sites could be found in this region. Of interest, 
was the fact that this clone did not possess any sequence homology to the 21/26/35 
group of clones which had also isolated it. 
A 700 bp EcoRl fragment of the 1.1 kb cDNA clone was used as a probe on a cDNA 
Southern. The originally isolated cDNA clones of the ECU 8/21 family exhibited 
ECS pool-specific expression, whereas the longer probe detected not only the same 
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ECS band as before, but also a band in the Sham cDNA pool (fig. 5.1). This second 
band was of a different size, suggesting that the extent of restriction digestion might 
play a role in the failure to achieve complete representation in the cDNA pools with 
respect to this clone. Hence, different regions of the same transcript were represented 
differently in the two cDNA pools; a result contrary the polyadenylation extent 
hypothesis discussed earlier. 
Another cDNA capture experiment (using regions of the 1.1 kb clone and ECU 21 as 
the 'hooks'), isolated a fragment of approximately 700bp which contained a region of 
identity to the entire length of the ECU 21/26/35 group. This clone was present in the 
database as a number of human expressed sequence tags. A possible reading frame is 
present which shows no significant database homologies. 
Fig. 5.6 
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Figure 5.6 Two larger fragments of the putative 8/21 family were obtained by 
cDNA capture. A 1.1 kb fragment contained a region which was identical to one end 
of ECU 8. A 700 bp fragment (not completely sequenced; as denoted by dashed 
central portion) contained a region of identity with the entire length of ECU 21. It 
also contained an ORF at the 3' end. Two human ESTs have been isolated which 
show homology with this end of the cDNA. Arrows under the two captured cDNAs 
indicate the probable 5'-3' direction of their parent transcript(s) as deduced by in situ 
sense/antisense hybridisation (1.1 kb fragment) or ORE direction (700 bp fragment). 
See Appendix for all 8/21 family sequences. 
In conclusion, the exact relationship of the two groups (8/14/24 and 21/26/35) has not 
yet been conclusively determined: there is circumstantial evidence for their common 
origin in a parent transcript, but no conclusive sequence evidence. 
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In situ experiments 
In situ experiments were carried out with the assistance from Dr. Muriel Steel (Centre 
for Genome Research) who was responsible for mounting the brain sections on 
microscope slides and for initial instruction on the technique. Sham and ECS rat brain 
(first batch) coronal sections were hybridised (as described in the Materials and 
Methods chapter) with sense and antisense ribonucleotide probes derived from in 
vitro transcription of templates corresponding to the subtraction clones. In the four 
probings listed below (table 5c), the sense probings showed no more than background 
hybridisation signals. As mentioned in section 5.13, no expression differences were 
seen between Sham and ECS sections (fig. 5.8). 
Probe Identity Clone Region Expression Pattern. 
Phosducin-like protein Exons 3 and 4 Ubiquitous but strong 
expression in 
hippocampus, habenula, 
lateral ventricle walls and 
anterior third ventricle 
walls. 
8/21 family 340bp EcoRl fragment of Widespread but strongest 
1.1kb clone expression in cortex, 
caudate putamen, 
hippocampus (CA2 esp.) 
and habenula. 
NF-YB Whole ECU9 Ubiquitous/low level. 
Aconitase -400hp (cDNA captured) Ubiquitous. 
1 aiie 'Ic In situ flybriulsatlon patterns 01 tour ECU clones. No clitterences were seen 
between Sham and ECS brain sections. 
The expression pattern of 8/21 was of special interest because it showed clear 
expression in the CA2 region of the hippocampus. This is one of the few instances 
described in the literature (neurotrophin-3 being another; ref. 50) where a gene has 
higher level expression in CA2 than other regions of the hippocampus. 
5.15: Summary of the subtraction described in this chapter 
The experiments in this chapter concerned the application of a subtraction technique 
to isolate hippocampus transcipts which are subject to long-lasting up- or down-
regulation in response to ECS. The subtraction technique suffered not from a failure 
to enrich specific genes, but from a failure to create starting cDNA pools which were 
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Figure 5.7 a PCR-amplified ECU clone inserts were electrophoresed and blotted 
onto a nitrocellulose filter. This was then hybridised by four different cDNA pool-
derived probes as indicated by the labels under each panel. An asterisk indicates that 
the cDNA used in the probe synthesis was from an early independent batch not used in 
the subtraction procedure (see section 5.13). b The same approach applied to the ECD 
clone inserts. 
Figure 5.8 In situ hybridisation experiments were performed on sham/ECS coronal 
rat brain sections using the ECU/ECD clones as templates for the synthesis of 
riboprobes. ECU 8/21 on a sham section (a) and an ECS section (b). ECU 10 on an 
ECS brain section (c). Hybridisation patterns are described in section 5.14. Sense 
probes gave no detectable hybridisation signals. X-ray film images were scanned using 
Canon CLC 10, magnified, and printed (hence low resolution). 
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representative of the true mRNA expression profile of the hippocampus. Several 
explanations for this failure were put forward and tested. 
As this and other subtractions (Chapter IV) have shown, the enrichment process has 
selected those cDNAs which were artifactually specific to one pool and increased 
their proportion. Assuming that genuinely ECS-induced/-downregulated genes were 
present in the eDNA pools, it could be inferred that their expression levels and fold 
enrichment were not equal to those false positives that were obtained in this screen. It 
is possible that the 72 hr time-point represents a phase of hippocampal synaptic 
modification that is independent of transcriptional change. It is with this possibility in 
mind that experiments may be undertaken in the future to examine expression 
changes at an earlier time-point (24hrs). 
The following chapter assesses the usefulness of this subtraction technique and 
examines ways in which its performance could be improved. 
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Chapter VI 
Summary and Discussion 
'People nowadays tend to over-interpret their findings. Neurobiology is a fascinating 
field, but it has become a bit like Disneyland. There is a lot of self-advertising, which 
is no good for science ....Let's just say the field is a bit overheated right now.' 
Bert Sakmann, as quoted in Thomas A. Bass's Reinventing the Future: 
Conversations with the World's Leading Scientists (Addison Wesley) 
6.1: The aims of the work described in this thesis 
An important direction of biological research concerns underlying mechanisms of 
cognition. Within this, the study of memory has advanced quickly due to the relative 
ease with which it may be assayed and because a discrete brain region, the 
hippocampus, seems to have a key role in its formation. To make further insights 
into the cellular mechanisms of the hippocampus responsible for memory, it will 
become necessary to use specific transgenic manipulation. Hipp ocamp u s- specific 
perturbation of cellular function by transgenesis requires the use of appropriate 
regulatory elements. 
To obtain such genetic elements, a search was undertaken to identify genes whose 
expression is restricted to this region. In addition, it was hypothesised that some 
transcripts might be restricted to the hippocampus, but only expressed in response to 
neuronal activity. Hence, later experimentation attempted to identify such gene 
expression changes. 
Hippocampus- specificity within the brain was defined, for our purposes, as restricted 
expression at the levels of sensitivity of Northern and in situ hybridisation. Because 
of the intention to create hippocampus-specific transgenes, there are certain 
characteristics which an obtained hippocampus-specific gene would ideally possess. 
These include moderate to high levels of expression in the adult and little or none 
during development. 
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6.2. Summary of techniques applied to the search for hippocampus-speczflc genes 
The techniques applied to the search for hippocampus-specific gene expression 
included degenerate PCR of multi-gene families (Chapter II), differential screening 
of a hippocampus cDNA library using a subtracted probe (Chapter III), and a PCR-
based subtraction strategy (Chapter IV and V). 
Degenerate PCR 
The use of degenerate PCR directed against large multi-gene families (outlined in 
Chapter II) yielded sequences from a total of 28 genes present at varying abundances 
in the hippocampus. All but two of these genes had been cloned and described in the 
literature previously. With respect to hippocampus specificity, a protein tyrosine 
phosphatase (PTP 'y) showed the greatest restriction of expression to this brain 
region. However, because the distribution of this gene is widespread before brain 
maturation, its use in transgenic experiments would be subject to the interpretational 
problems described previously. If one of the inducible transgenic techniques recently 
described (such as the tetracycline system) were combined with the restricted 
distribution, specific manipulation of hippocampus function at the molecular level 
might be possible. 
Two novel protein tyrosine phosphatases cloned been characterised to a limited 
extent. While their expression distributions limit their usefulness for transgenic 
experiments, they, nevertheless, possess features which make them interesting in 
their own right. Both appear to be transmembrane receptors with anticipated roles in 
cell-cell interactions and adhesion. With such processes generating interest in studies 
of development and actvity-dependent changes in the CNS, the precise functions of 
these molecules deserve to be investigated further. 
Differential screening/subtraction 
The techniques subsequently employed had the advantage of objectivity, in that the 
selection process was made on the basis of actual hippocampal expression rather 
than the assumption that some members of a gene family might be expressed 
specifically. This objectivity is not without problems itself. Without the selectivity of 
the PCR approach, the success of these techniques depends on the transcriptional 
complexity of the tissue. Hence, ubiquitous, higher abundance transcript expression 
has to be discarded before relevant genes can be obtained. In this respect, the brain is 
the most testing tissue for these techniques. 
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A number of difficulties were encountered with the combined subtractive probe 
enrichment and differential screen outlined in Chapter III. These can be summarised 
as a lack of efficiency of the subtraction process and technical inconsistencies 
occurring in the cDNA library differential screening. Among the clones obtained 
were those corresponding to genes which were clearly ubiquitous but had escaped 
subtraction because of their high expression levels. Others exhibited a small degree 
of enrichment in the hippocampus, such as SNAP-25. Most genes obtained by this 
method were restricted to the high abundance class of transcripts. Thus the 
sensitivity of this technique was seriously limited. 
Chapter IV described the application of a second subtraction protocol based on 
repeated subtractions of PCR-amplifiable cDNA pools created from hippocampus 
and 'rest of brain' mRNA. Two variations on the approach were applied to the search 
for hippocampus-specific gene expression; the major difference of the second was 
the use of separate linker sequences for the creation of the hippocampus and rest of 
brain cDNA pools. This was to ensure that sequences in one pool did not 
contaminate those in the other as was the case in the first subtraction described in 
Chapter IV. 
The second subtraction described in Chapter IV resulted in the cloning of a number 
of genes which are enriched in the hippocampus. In addition, their expression levels 
were generally lower than the clones described in Chapter III, indicating that the 
subtraction process was progressively removing non-specific, high abundance 
transcripts. A feature of subtractions using this technique was that the enrichment 
process seemed to be very efficient: cDNA fragments that were specific to one 
cDNA pool (present at a wide range of initial abundances) were present at high 
abundance in the final subtracted material. Hence, as a general method to enrich for 
such sequences, this particular technique is extremely efficient and represents a 
significant improvement over the single-step subtraction experiments detailed in the 
introduction to Chapter III. 
However, because the starting cDNA pools were not a true representation of the 
genuine tissue mRNA populations, the full potential of this technique could not be 
realised. If the representational failures had been equivalent in both pools, this would 
have been acceptable because the comparative abundance of a sequence in the two 
pools would have remained equivalent to that in the original mRNA populations. 
The results of 'cDNA Southern' and Northern analyses were indicative of pool- and 
sequence-specific representation failures in the two pools. In Chapter V, several 
121 
hypotheses were discussed as to how these inconcistencies could have arisen. In 
summary, plausible explanations were the use of separate linkers for the two pools 
(leading to non-comparable amplification) or inefficiencies in the stages of the 
cDNA pool synthesis process (for example, the failure to achieve complete 
restriction digestion of the cDNAs). 
One other factor hindered the isolation of hippocampus-specific genes. Because the 
rest of brain cDNA pool represents the average expression levels of genes in the 
non-hippocampal brain, contributions of high-level gene expression restricted to one 
particular region, such as the striatum, would be diluted out. Thus, driver derived 
from RoB would not remove these sequences from tracer, even though they were not 
hippocampus-specific. This most likely led to the selection of false-positives such as 
hippocalcin and the 5-HT1a receptor. 
6.3: Activity-dependent gene expression in the hippocampus 
The subtraction described in Chapter V had two main goals; the identification of 
genes whose expression levels were subject to long-term alterations resulting from 
electroconvulsive stimulation (ECS), and the characterisation of those genes to 
determine if any were hippocampus-specific. The latter goal was based on the 
assumption that some genes might only be expressed as a consequence of 
hippocampal activity. If the function of the hippocampus is the formation of 
memory, and this is dependent on the synthesis of new mRNA and protein, then it is 
possible that region-specific transcript expression might be induced by hippocampus 
neuronal activity. Certainly, in the large number of reports concerning activity-
dependent immediate early gene induction, expression is often restricted to the 
hippocampus; particularly the dentate gyrus. 
The precise nature of the stimulus can affect the location of expression. Ideally, the 
expression of transcripts would be examined after behavioural induction rather than 
by artificial means. However, the quantity of neurons expressing these transcripts 
has to be over a threshold before they are detectable by current techniques. This has 
necessitated the utilisation of more powerful stimulation techniques, as described in 
section 5.4. ECS was chosen as the stimulatory method in experiments described 
here as this is known to have widespread and long-lasting effects on synaptic 
plasticity. 
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Subtractive hybridisations were performed such that ECS up- and down-regulated 
genes would be obtained. In comparison to previous subtractions using this 
approach, a large number of clones were isolated which were found in one cDNA 
pool but not the other. This showed that the subtractive steps were operating 
efficiently. However, as before, these results were not corroborated by Northern 
studies of gene expression. Selected clones were studied in greater detail, but none 
revealed a more subtle activity-dependent enrichment. 
Several other problems may have contributed to the subtraction failure. First, in 
order to avoid the cloning of immediate early genes, analysis of gene expression was 
carried out at a late post-stimulus time-point (72 hours). While the activity-
dependent expression changes in some neuronal genes have been seen to persist for 
weeks, the degree of expression change is only moderate. This contrasts with 
immediate early gene expression changes which are very large, if only transient. The 
difference in these two profiles of induction may mirror their different roles; 
immediate early genes are required to bring about rapid changes in the synapse, 
whereas those genes that show small expression changes which persist for days or 
weeks may be responsible for the long-term alteration of synaptic efficacy or the 
maintenance of those changes. It may be the case that a subtractive technique is not 
suitable for the isolation of genes exhibiting small expression changes. Second, the 
use of halothane anaesthesia has been shown to affect LTP induction and, in some 
cases, prevent the expression of immediate early gene family members. It might be 
the case that long-term gene expression changes are not so pronounced after such 
anaesthesia. However, the negative effects of halothane are probably superseded by 
the potency of ECS stimulation. 
In addition, activity-related changes in synaptic transmission efficacy are seen in 
regions outside of the hippocampus, such as the cortex and cerebellum. It is not 
unreasonable to assume that the molecular mechanisms underlying these processes 
would be similar to those occurring in the hippocampus; even to the extent of the 
expression of a similar set of genes. This may add to the difficulty in isolating 
activity-dependent hippocampus-specific gene expression. 
6.4: Can the subtraction technique be improved? 
The weakness in the subtraction technique applied in Chapters IV and V lies not in 
the enrichment process itself, but in the creation of PCR-amplifiable cDNA pools 
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which suitably reflect the expression of transcripts in the mRNA populations from 
which they were derived. Several modifications to the protocol which may result in 
the lessening of the observed problems are listed below. 
First, each cDNA pool taken through the subtraction process should be derived from 
the summation of several independent cDNA pool syntheses so that a more 
representational collection of cDNA fragments would result. 
Second, in preparation for for the initial PCR amplification, the two pools should be 
created using identical linker oilgonucleotides. This would ensure that the primary 
pools are amplified in a more comparable fashion; size being the major remaining 
factor affecting cDNA fragment amplification. Following this amplification 
competence step, different linker sequences could be ligated onto the cDNA pools to 
prevent cross-contamination during the subsequent subtraction process. Parallel 
subtractions, reversing the linker assignments to each pool, would eliminate 
sequence-dependent cDNA amplification effects. 
Third, in order to solve the problem associated with the dilution of an individual 
brain region's contribution to the rest of brain cDNA pool, separate subtractions of 
hippocampus cDNA pools against other brain sub-regions (such as cortex, 
cerebellum, thalamus, and brainstem) could be carried out. cDNA fragments 
enriched in all of the separate subtractions would most likely represent genuine 
hippocampus- specific transcripts. 
6.5: The existence of hippocampus-speczjic transcripts 
A question that arises at this point is whether the functions of a particular sub-region 
of the brain are defined by the wiring pattern/connectivity of the constituent neurons 
or by the intrinsic nature of those neurons. To put this question in another form, is it 
the developmental patterning or the adult capabilities of the neurons that dictate the 
operation of a brain region? The answer has important implications for the molecular 
biological techniques described in this thesis because, if the former is true, then adult 
brain regions would not be distinguishable at the transcriptional level. However, to 
have created these sub-regions during development, the primordial cells would have 
been subject to instructions specifying cell-fate, migration and association rules; 
instructions likely to be transcriptional in nature. It is less certain that these 
transcriptional identities are maintained in the mature brain. Anatomical 
characterisation of neurons, descriptions of pharmacological properties of neuron 
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types, and the analysis of patterns of gene expression in the brain all show that 
regional distinctions do exist, but the limitation of one particular feature to just one 
particular brain region is a much rarer occurrence. Rather, a gene that is highly 
expressed in the hippocampus, for example, is usually also expressed in another 
region of the brain such as the cortex or the cerebellum. Many experiments have 
defined the specialised role of the hippocampus in the brain, but the question still 
remains whether its function is sufficiently distinct from other brain regions to merit 
specific gene expression. 
The penultimate section of Chapter I made reference to a study which attempted to 
categorise transcripts into expression distribution and abundance groups. The results 
implied an inverse correlation between the expression level of a gene and its degree 
of brain specificity. Putative hippocampus-specific genes may thus be expressed at a 
level below that of the sensitivity of the differential screening/subtraction techniques 
applied in this thesis. In addition, these results have implications for the use of the 
promoter/enhancer elements of such a gene for the control of transgene expression. 
6.6: Have hippocampus-specific genes been described elsewhere? 
Few groups have published any data concerning the existence of genes restricted in 
expression to the hippocampus. The only case of such a transcript being cloned in a 
screen for hippoc ampal- specificity is that from Dietmar KuhFs laboratory (personal 
communication, D. KUhl and ref. 1). In the screen which isolated the activity-
regulated gene, arg3.1 (see 5.3), another clone was found on the basis of its failure to 
hybridise to a cortex-derived probe. This has since been identified as neuropsin, a 
serine protease gene which may be regulated in an activity-dependent fashion. This 
gene has been cloned independently by degenerate PCR amplification in a Japanese 
laboratory (see section 5.3 also) and in this laboratory (B. Davies, personal 
communication). It appears to be expressed at a low abundance (perhaps explaining 
the failure to isolate the gene in the experiments described in this thesis) principally 
in the limbic regions of the brain including the hippocampus and amygdala. The 
applicability of this gene to transgenic intervention has not yet been investigated. 
Other cloned genes show expression patterns which are highly enriched, but not 
specific, to the hippocampus. Brain-derived neurotrophic factor (BDNF) was 
originally isolated from the hippocampus. Expression is very high in this brain 
region. All splice variants of this gene show significant induction by kainate 
administration (ref. 2). Interestingly, one particular exon of this transcript is 
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expressed virtually exclusively to the dentate gyrus of the hippocampus upon kainate 
treatment. 
A degenerate PCR approach directed at the G protein-coupled receptor class of 
serotonin receptors has identified two novel members (ref. 3). One of these, MR22, 
has an expression pattern limited to the hippocampus (CA 1 pyramidal cells), medial 
and lateral habenular nuclei, and raphe nuclei. Its expression level in these regions is 
extremely low, requiring 1Otg of polyA+  mRNA on a Northern blot to generate a 
detectable hybridisation signal. 
A member of the eph/elk receptor tyrosine kinase family (embryo brain kinase, Ebk; 
ref. 4) has also been cloned using degenerate PCR. Its expression in mouse is 
widespread throughout the developing brain but becomes progressively more 
restricted during maturation (reminiscent of PTP y; see section 6.2). Adult 
expression is described as being entirely restricted to the hippocampus (CAl 
especially, with lower levels in the other CA regions and the dentate gyrus) except 
for trace levels of expression in the subicular region. Perhaps this represents the gene 
most closely matching the requirements for hippocampal specificity. The abundance 
of this transcript is not fully described but it is detectable by Northern hybridisation. 
A probe corresponding to this gene has been used on a rat hippocampus/rest of brain 
cDNA Southern which suggested a lack of specificity (data not shown) but this has 
yet to be confirmed by Northern hybridisation. Admittedly, the expression in the 
mouse (relevant for the transgenic approach) appears convincing even though the 
developmental expression pattern leaves it subject to the interpretational problems of 
transgenic use discussed previously. 
In this laboratory, other techniques have been employed in the attempt to isolate 
hippocampus-specific genes. A differential screen mentioned in Chapter III (ref. 5) 
identified a gene, hct- 1, which encodes a cytochrome P-450. This gene's expression 
seems to be largely restricted to the hippocampus in rat but is widespread in mouse 
brain. Therefore, this limits its usefulness in transgenic experiments. It may, 
however, be possible to reproduce the rat expression pattern in mouse transgenics by 
using rat regulatory elements as a promoter. Another line of research concerns the 
investigation of several gene-trap lines (ref. 6) which show expression in the mouse 
hippocampus (M. Steel, personal communication). One of these, Kin, appears to be 
largely restricted to the hippocampus and may prove useful for transgenic 
experimentation. By engineering a transgene into the gene-trap locus a similar 
pattern of expression may be adopted. 
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In conclusion, despite intensive screening, both in this laboratory and elswhere, no 
absolutely hippocampus-specific gene has yet been purposefully isolated. 
6.5: Alternatives to hippocampus-speczficity 
It may be possible to achieve specific transgenic intervention in the hippocampus 
even without possession of a hippocampus-specific gene. Several experimental 
approaches describing alternatives to hippocampus specificity are set out below. 
Promoter manipulation 
It might be possible to alter the promoter of a gene which is expressed 
predominantly in the hippocampus so that it becomes exclusively expressed there. 
This approach presupposes there to be discrete promoter/enhancer domains within 
gene promoters that define site of expression. The reality may not be so clear-cut, 
with disparate genetic elements each contributing to the final expression distribution. 
However, evidence for the subtlety of promoter/enhancer-directed expression comes 
from a study of the expression patterns of several promoter deletion constructs of a 
cerebellum specific gene, L7 (ref. 7). LacZ was used as a marker for the cerebellum 
expression pattern of each of the constructs. Surprisingly, the promoter of this gene 
revealed itself to be governed by a number of positive and negative control elements 
such that several deletion constructs directed expression to restricted domains within 
the cerebellum. 
If a minimal hippocampus-specific promoter could be isolated, this would provide a 
simple means for the transgenic manipulation of hippocampus-dependent processes. 
Combinatorial expression 
Expression levels of putative hippocampus-specific genes may be unsuitable for 
transgenic experimentation. It may be possible to apply the genetic elements which 
direct higher abundance expression in a combinatorial fashion. The method requires 
two genes; one (A) expressed in the hippocampus and another brain region(s), and a 
second (B) expressed in the hippocampus and a different set of other brain regions. 
The key point is that A and B share a site of expression only in the hippocampus. if 
the transgene could be made to function only in the common region of expression 
then its activity would be hippocampus-specific. Moreover, it might be possible to 
select promoters which overlap only within defined domains of the hippocampus, 
allowing even more selective experimentation. 
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One experiment might involve the expression of the tTA gene product (see section 
1.19) from promoter A and the expression of cre recombinase from B. Mice 
containing both of these transgenes would act as the 'background' strain to which 
mice containing the experimental transgene would be mated. The experimental 
transgene would consist of a construct expressing a transcript under the control of 
the tTA gene product but this would produce no functional protein upon translation. 
If, however, the construct was located in cells expressing cre recombinase then it 
would be altered to produce translationally competent transcripts (possibly by the 
deletion of a 5' exon containing stop signals in all frames). The features of such a 
system would include hippocampus specificity and inducible action; tetracycline 
could either be administered to the mother to prevent developmental expression of 
the transgene or administered to the adult mouse to observe a return to the wild-type 
phenotype. 
Naturally, these experiments are critically dependent on the availability of suitable 
'A' and 'B' promoters. Candidates might include the promoters of BDNF, the 
neurotransmitter receptors, Ebk, PTP y,  neuropsin etc. 
6.6: Future research into hippocampal function 
Transgenic techniques, if applied in a specific manner, represent a very important 
tool for the analysis of hippocampus function. Two questions deserve to be early 
subjects of such experimentation. 
First, with functional disruption limited to the hippocampus, it will become possible 
to categorise the exact cognitive processes with which the hippocampus is 
associated. It is to be expected that the spatial learning role of this brain region will 
be joined by many others requiring the use of its particular attributes. As such, it is 
becoming increasingly necessary to devise more precise behavioural assays with a 
view to examining the role of the hippocampus in these cognitive systems. 
Second, at the molecular level, activity-dependent changes in gene expression need 
to be investigated more thoroughly. Constitutive expression of genes described in 
section 5.3 might be possible using hippocampus-specific promoters. In some cases 
it would be expected that permanently potentiated synapses would result; causing 
similar saturation effects to those described in the context of ECS (section 5.5). 
Studies of the elec trophy siology, synaptic morphology, and gene expression 
perturbation in such animals would go some way to revealing the functions of these 
genes in long-term synaptic plasticity. 
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It is to be hoped that the knowledge and experience gained from the study of the 
hippocampus will be soon be applied to the study of the neocortex. It is widely held 
that the hippocampus acts only as a temporary repository for memories before they 
are transferred to the neocortex. Does synaptic plasticity in the neocortex operate 
according to the same rules as that in the hippocampus? Some evidence exists for 
gene induction in defined cortical regions after specific behavioural activities. A 
truly informative approach to the study of memory would arise if it were possible to 
detect activity-dependent gene expression changes (by marker genes under the 
control of activity-dependent regulatory elements) in defined sub-regions of the 
hippocampus and the cortex in response to specific behavioural tasks. In this way a 
'molecular phrenological' map could be envisaged, matching specific behaviours to 
specific gene expression in sub-regions of the hippocampus and neocortex. 
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Materials and Methods 
Materials:- 
For most materials and methods, the following manual was used:- 
'Molecular Cloning - a Laboratory Manual' (1989) Sambrook, J., Fritsch, E.F., and 
Maniatis, T., Second Edition, Cold Spring Harbor Laboratory Press. 
Ma.]: Suppliers of reagents and enzymes 
Enzymes 
Superscript II Reverse Transcriptase GIBCO BRL 
Tag Polymerase Boehringer Mannheim 
Tag Polymerase Promega 
Restriction Endonucleases Boehringer Mannheim 
DNA Ligase Boehringer Mannheim 
DNA Ligase New England Biolabs 
Alkaline Phosphatase Boehringer Mannheim 
Polynucleotide Kinase Boehringer Mannheim 
T4 DNA Polymerase Boehringer Mannheim 
Klenow Polymerase Boehringer Mannheim 
E.coli DNA Polymerase Boehringer Mannheim 
E.coli DNA Ligase Boehringer Mannheim 
E.coli RNase H Boehringer Mannheim 
T7/T3 RNA Polymerase Boehringer Mannheim 
'Seguenase II' United States Biochemicals 
Reagents 
Most salts/Solvents/Acids BDH (AnalaR) 
SDS/Guanidine tc./Mineral oil Sigma 
Tris base Boehringer Mannheim 
NaCl/EDTA/S olvents/Phosphates Fisons 
Bacterial media constituents DIFCO 
Phenol GIBCO BRL 
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32P dCTP*/35S dATP*/HybondN filt ers Amersham 
32P CTP/UTP* NEN 
Equipment 
Flowgen; sequencing apparatus 
Pharmacia; electrophoresis tanks 
GIBCO BRL; electrophoresis tanks 
Techne; heating blocks, hybridisation ovens. 
Sorval; centrifuges 
Cecil; spectrophotometer 
Gilson, Bibby; pipettes 
Hybaid; PCR cycling machines 
Ma.2: Standard solutions used for molecular biology 
Ampicillin 
50 mg/ml in water 
Used at 60 pg/m1 
Denhardt's Reagent (50X) 
5 g Ficoll (Type 400, Pharmacia) 
5 g Polyvinylpyrrolidone 
5 g Bovine Serum Albumin (Fraction V, Sigma) 
Water to 500 ml. 
EDTA (Ethylene Diamine Tetra Acetate) 
0.5 M mixture made to dissolve by adjusting pH to 8.0 with NaOH. 
Gel Loading Buffer 
0.25% Orange G dye 
30% Glycerol in water 
IPTG (IsoPropy1Thio--D-Galactoside) 
20% solution made in water. 
Phenol/Chloroform 
20 ml phenol 
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20 ml chloroform 
10 ml TE buffer, pH 7.5. 
Vigourously mixed and allowed to separate into organic and aqueous phases 
overnight at 40C. 
PBS (Phosphate Buffered Saline) 
0.8% NaCl 
0.02% KC1 
0.144% Na2HPO4 
0.024% KH2PO4 
pH adjusted to 7.4 with HC1 
SDS (Sodium Dodecyl Sulphate) 
10% solution 
2OXSSC 
175.3 gNaCl 
88.2 g NaCitrate 
Adjust pH to 7.0 with NaOH 
Made up to one litre with water. 
STE (TEN) 
0.1 M NaCl 
10 mM Tris-HC1, pH 8.0 
1 mM EDTA 
TAE (tris acetate) 
50X 
242.2 g Tris base 
57.1 ml glacial Acetic acid 
100 ml 0.5 M EDTA 
Water to a litre 
TBE (tris borate) 
lox 
108 g Tris base 
55 g Boric acid 
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40 ml 0.5 M EDTA 
Water to a litre 
TE Buffer 
10 mM Tris-HC1, pH as appropriate with HC1 
1 mM EDTA 
Tetracycline 
5 mg/ml in ethanol 
Used at 50 pg/m1 
Tris Buffer (one molar) 
121.1 gper litre 
Adjust to required pH with HC1 
X-gal (5-Bromo-4-Chloro-3-Indolyl- 13-D-Galactoside) 
20 mg/ml solution made up by dissolving powder in dimethylformamide. 
Stored at -20°C in light-tight container. 
Ma.3: Solutions for bacterial culture etc. 
Maltose 
20% in water (filtered) 
SM Buffer 
5.8gNaCl 
2 g MgSO4.7H20 
50 ml lm Tris-HC1, pH 7.5 
5 ml 2% Gelatin 
Water to one litre 
LB Medium (Luria-Bertani) 
10 g Bacto-Tryptone 
5 g Bacto-Yeast Extract 
lOgNaCi 
Water to one litre 
pH adjusted to 7.0 with NaOH 
133 
Autoclaved 
SOB/SOC medium 
20 g Bacto-Tryptone 
5 g Bacto-Yeast Extract 
0.5 gNaCl 
10 ml of 250 m KC1 
Adjust pH to 70 with NaOH 
Water to one litre 
Autoclave 
Before use, add 0.5% of sterile 2M MgC12 
In the case of SOC. 2% of 1 M Glucose is also added. 
2X TY Medium 
16 g Bacto-Tryptone 
10 g Bacto-Yeast Extract 
5 g NaCl 
Water to one litre 
pH adjusted to 7.0 with NaOH 
Autoclaved 
Agar Plates 
Bacto-Agar added to LB medium in the following quantities:- 
Bottom 15 g/l 
Top 7g/l 
For top agarose (colony transfer experiments) use 7 g/l agarose. 
Methods: - 
Me.]. Brain/hippocampus dissection 
Rats were sacrificed by carbon dioxide asphyxiation and subsequent cervical 
dislocation. 
After decapitation, the top of the skull was exposed and the constituent plates of 
bone overlyimg the brain were removed in a posterior to anterior direction such that 
the whole brain (including olfactory bulbs) could be removed in an intact state. 
Access to the hippocampi was achieved by peeling back the two neocortical 
hemispheres from the midline to the sides. 
Corpus striatum tissue was scraped off the hippocampi and then incisions were made 
rostrally and caudally to sever the attachments of the hippocampi to the rest of the 
brain. 
The two hippocampi could then be removed as a distinct 'sausage-shaped' structures 
1 cm in length and 0.5 cm in diameter (size varying according to age and sex). 
Other tissue regions obtainable as discrete dissectable units included olfactory bulbs, 
cerebellum, cortex, brain-stem, and 'rest of brain' which was the entire brain after 
removal of the hippocampi. 
All tissue samples were immediately frozen in liquid nitrogen or on dry ice and then 
stored prior to use in a -700C freezer. 
Me.2: Total RNA extraction 
After Chomczynski et al., Analytical Biochem. 162:156-59 (1987) 
Solution D 
4 M Guanidinium Thiocyanate 	 100 g 
25 mM Na Citrate pH 7.0 	 7 ml of 0.75 M 
0.5% Sarcosyl 	 10.5 ml of 10% 
then 117 ml H20 
The mixture was heated to 65°C to dissolve and then filtered through 0.45 tm filter. 
0.36 ml 3-mercaptoethano1 was added per 50 ml D prior to use. 
One gram (or 1 cubic cm) of was tissue was homogenized in 9 ml of solution D for 
30 sec in a 50 ml Corning tube. 
The following solutions were added sequentially with inversion of the tube after 
each addition. 
1 ml 2 M Na Acetate pH 4.0 
10 ml water-saturated phenol 
2 ml Chloroform:Isoamyl alcohol (25:1 ratio mixture) 
This mixture was shaken for 10 sec and then transferred to a 35 ml Corex centrifuge 
where it was left for 15 min on ice. 
The tubes were spun at 10,000 x g for 20 min at 4°C. 
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The aqueous layer (containing the RNA) was removed from the organic layer and 
interface (containing DNA and proteins) and mixed with an equal volume of 
isopropanol and left for 1 hr at -200C. 
The tubes were spun at 10,000 x g for 20 min at 4°C. 
The resulting pellet was resuspended in 3 ml of solution D. 
An equal volume of Isopropanol was added and then stored at 200C  for 1 hr. 
The tubes were spun at 10,000 x g for 10 n-dn at 4°C. 
The pellet was washed once in cold 75% Ethanol. 
The tubes were spun at 10,000 x g for 5 min at 4°C. 
0.5 ml of 0.5% S.D.S. was added and the pellet resuspended at 65°C for 10 mm. 
The absorbance of a one hundred-fold diluted aliquot of this RNA was measured at 
260 nm and 280 nm in a Cecil 4400 spectrophotometer. 
An absorbance of 1 at 260 nm indicated a concentration of 40 g/m1 RNA. 
A ratio of absorbances at 260 nm/280 nm above 1.8 indicated that the RNA was 
largely free of protein contamination. 
Me.3. Poly A + purification 
A 'Fast Track' mRNA isolation kit Version 3.5 (Invitrogen Corporation) was used for 
the preparation of mRNA for use in the degenerate PCR work. 
Alternatively, for the subtractions described in Chapters IV and V, total RNA from 
section me.2 was resuspended in 'Binding Buffer'; 
0.5MNaCl 
10 mlvi Tris-HC1, pH 7.4 
1 mM EDTA 
This was then heat denatured (65°C for 5 mm) and applied to a column packed with 
oligo dT-cellulose which had previously been equilibriated with the binding buffer 
solution. The flow-through was re-applied to the column and allowed to run out. 
Several washes were then performed using the same solution. 
Bound mRNA was eluted from the oligo dT-cellulose column using 0.5 ml aliquots 
of 'Elution Buffer':- 
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10 mM Tris-HCl, pH 7.4 
0.1 mM EDTA 
Those aliquots which contained the eluted RNA were pooled and subjected to a 
second round of polyA+  selection as before. 
Absorbance readings were performed as described in previous sections. 
Generally, approximately 1 tg of PolyA+  mRNA was obtained from one 
hippocampus (two per brain). 
Me.4: Reverse transcription / cDNA synthesis procedures 
(Adapted from Gibco BRL Life Technologies Inc. protocol for use in conjunction 
with their RNase H- Reverse Transcriptase enzyme). 
mRNA (max. 5 jig) and 0.5 jig/jig oligo dT primer were mixed in a total volume of 9 
jil. 
This was incubated at 70°C for 10 mm (to remove secondary structure from the 
mRNA) and then rapidly cooled on ice for 3 mm. 
The following reagents were added (on ice) to create a total volume of 20 jil; 
1 jil RNA Guard 
4 jil 5x Reaction Buffer; 
250 mM Tris-HC1 pH 8.3 
375 mM KC1 
15 mM M902 
2 p10.1 M D.T.T. 
1 p1 mixed dNTP stock (10mM each) 
1 p1 (200 U)! 1 jig mRNA Reverse Transcriptase enzyme (Superscript 
II) 
3 p1 were taken and added to 0.5 j.tl (5 jiCi) a— 32P dCTP for the purpose of 
determining the size distribution and efficiency of first strand cDNA synthesis. 
Reverse transcription reactions were typically carried out at 42°C to reduce 
secondary structure interference in the full readthrough of a transcript. Incubation 
times of 1-2 hr were used. 
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Assaying the quality of the first strand synthesis reaction 
The cDNA synthesis tracer reaction was made upto 100 p1 with water and 90 p1 used 
for size analysis, with the remainder used for analysis of the synthesis efficiency. 
Size analysis was achieved by Phenol/Chloroform extraction of the tracer aliquot 
followed by precipitation using 0.4 volumes of 5 M Ammonium Acetate and 2.5 
volumes of ethanol. The resultant pellet was devoid of protein and unincorporated 
isotope. After resuspension in water and addition of 0.1 volume of 1 M NaOH it was 
incubated at 37°C for 5 min to denature the cDNA from its complementary mRNA. 
This mixture was run on a normal agarose gel in Tris-B orate running buffer together 
with a radio-labelled DNA marker ladder (Gibco BRL). 
The gel was then dried on Whatman 3MM paper and exposed to autoradiography 
film. 
A normal disribution of cDNA lengths exhibited an average size of between 1 and 2 
kilobases. 
cDNA synthesis efficiency analysis 
The 10 j.tl aliquot was divided into two 5 p1 aliquots and one added to; 
0.6 t1 0.2 M NaPyrophosphate 
50 !.tl 5 mg/mi B.S.A. (carrier) 
0.15 ml 50% Trichloroacetic Acid (TCA) 
After 10-20 min on ice, the solution was pipetted onto a Whatman GF/C filter, 
washed with 5% TCA, and left to dry. 
The second aliquot of tracer was added directly to another Whatman filter. This 
represents the total amount of isotopically-labelled dCTP in the reaction whereas the 
precipitated and washed aliquot represents the label incorporated into the cDNA. 
The filters were subjected to Cerenkov radiation counting and the following 
equations used to ascertain the efficiency of the synthesis: 
incorporated cpm 
total cpm 	 = 	ratio of incorporation 
dNTP quantity in reaction (nmoles) x ratio incorporation x 330 ng/nmole= ng 
synthesized 
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ng cDNA synthesized 
ng mRNA in reaction 	= 	% conversion 
typical values for conversion were 5-20% 
Second strand synthesis 
For some applications, such as the Biotin/Streptavidin subtraction, it was necessary 
to have the cDNA in double-stranded form. 
The protocol is based on the RNase H-mediated nicking of the mRNA/DNA hybrid 
followed by the RNA-primed DNA Polymerase I extension of the second strand. 
The multiple second strand fragments are joined together by the action of the DNA 
Ligase enzyme. 
To achieve this the following reagents were added sequentially on ice to the first 
strand synthesis reaction: 
94.8 p1 D.E.P.C.-treated water 
32 tl 5x Second strand synthesis buffer: 
94 mM Tris-HC1, pH 6.9 
453 mM KC1 
23 mM MgCl2 
750 j.tM 13-N.A.D. 
50 mM (NH4)2504 
3 il mixed dNTPs (10mM each) 
6 p10.1 M D.T.T. 
2 p1 E. coli DNA Ligase (7.5 Units/pI) 
4 p1 E. coli DNA Polymerase I (10 Units/jil) 
0.7 p1 E. coli RNase H (2 Units/pI) 
This was incubated at 16°C for 2-4 hr and then for a final 5-15 min after the addition 
of 10 Unitsflig first strand cDNA T4 DNA Polymerase. 
To stop the reaction 10 p1 of 0.5 M EDTA were added. 
The product was now double-stranded, blunt-ended cDNA. 
Me-5: Polymerase chain reaction (PCR) 
Taq polymerases from Boehringer Mannheim and Promega were used during the 
course of the work described in this thesis. 
The reaction buffer (lOX) from B. M. was as follows:- 
100 mM Tris-HC1, pH 8.3 
15n1MMgC12 
500 mM KC1 
The reaction buffer (lOX) from Promega was as follows:- 
separate addition of M902  (final concentration usually 1.5 mM) 
100 mM Tris-HCI, pH 9 
500 mM KC1 
1% Triton X-100 
General description of the PCR technique 
There are four key points to the amplification process:- 
The DNA template is denatured. 
The two PCR primers anneal to their complementary sequences on 
the + and - template strands at an appropriate temperature. 
A heat-stable DNA polymerase (usually 'Taq' polymerase) utilises 
the primers and reaction constituents to commence synthesis of DNA strands 
complementary to the template. 
The resulting duplicated DNA strands act as templates in 
subsequent cycles of these steps. 
To allow the reaction to work efficiently, a balance has to be struck between PCR 
product quantity and quality (specificity). Achieving this requires the optimisation of 
the reaction protocol for each individual application. The following list highlights 
some of the factors that were adjusted in the PCR reactions described later. 
Cycling conditions 
Efficient PCR requires the complete denaturation of the template prior to primer 
annealing. For short cDNA molecules, a denaturation step of 30 sec to 1 min at 
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940C is sufficient. For genomic DNA template, sonication followed by ten minutes 
of boiling before addition to the PCR reaction is often performed to ensure single-
stranded template. 
Because the sequences of the oligonucleotides designed for the PCR are known, the 
equation:- 
Tm = 4x(No. of 0/C nucleotides) + 2x(No. of A/T nucleotides) 
can be applied to estimate the melting temperature (in centigrade) of a short (10-22 
bp) duplex in 1 M NaCl (Suggs, S.V., Hirose, T., Miyake, T., Kawashima, E.H., 
Johnson, M.J., Itakura, K., and Wallace, R.B. (1981) Use of Synthetic 
Oligodeoxyribonucleotides for the Isolation of Specific Cloned DNA Sequences. 
ICN-UCLA Symposia on Molecular and Cellular Biology, Vol. XXHI, pp.  985-691, 
Academic Press.). A suitable annealing temperature is taken as five degrees below 
the melting temperature. Choosing the correct annealing temperature is vital if non-
specific/mismatched priming is to be avoided. For this reason, a variant on the 
standard PCR reaction is sometimes employed. 'Hotstart' PCR delays the addition 
of the DNA polymerase to the reaction mixture until after the first denaturation 
stage; this prevents premature/incorrect priming at lower temperatures before the 
reaction has commenced. 
It also should be appreciated that the annealing temperature changes during the 
course of the reaction due to a primer concentration factor which is not taken into 
account in the equation. This results in the Tm actually being lower at the start of the 
reaction because of the large excess of primers present. 
The temperature at which the complementary strand is synthesized is 720C; the 
enzyme has maximal polymerase activity at this temperature as well as being 
relatively thermostable. The extension time required is varied according to the 
predicted size of the PCR product, with an extension rate of 1000 nucleotides per 
minute assumed. 
The number of program cycles required to amplify a template to the required degree 
is normally in the range of 25 to 40 but depends largely on the application and the 
target template concentration. 
Reaction constituents 
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Several factors have to be considered in the creation of suitable reaction conditions 
for PCR amplification. 
The concentration of dNTPs can affect the yield, specificity, and fidelity (copying 
accuracy) of the reaction and so must be optimised to create a balance between all 
three factors. A working concentration of 20-200 .tM is generally recommended 
although much of the PCR work that is described in this thesis used a concentration 
of 250 ItM to no detrimental effect. 
The concentration of magnesium ions has important effects on primer annealing, 
melting temperatures, enzyme activity, and reaction fidelity. The standard 'window' 
for magnesium ion concentration (in the form of magnesium chloride) is between 
0.5 and 2.5 j.tM with 1.5 tM being the most widely used figure. 
Primer concentrations of between 0.1 and 0.5 RM are the norm; again a balance has 
to be struck between the amount and the specificity of the of the product 
synthesized, with higher concentrations of primers leading to a greater number of 
mis-priming events. 
Further points 
An ideal PCR reaction would yield the maximum amount of product for the cycles 
used; that product comprising of material with a high signal-to-noise ratio (correctly 
primed product: spuriously amplified product). 
The flanking sequences, against which the the primers will be designed, are chosen 
to ensure good amplification. Because the rate of complementary strand synthesis is 
finite, the distance between the primers should be small enough to ensure efficient 
amplification; typically between 100 and 1000 base pairs. High fidelity, long-range 
polymerase enzymes are now available with processivities which permit the 
amplification of products in the 1-20 kb range, but these were not used here. The 
extension time is also a critical factor when it is considered that after a certain 
number of program cycles the amplification of the products falls below the 
exponential rate as reaction constituents and enzyme activity decrease. If the 
extension time is too brief or the number of cycles too great, then there will be an 
increased percentage of incomplete products synthesized. For that reason, a final 
extension period of 15 min at 720C is often included to ensure that all products are 
double-stranded. 
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Primer design 
Typically, primers contain 18 or more nucleotides complementary to the template 
DNA, 17 nucleotides being the statistically-derived length at which any given 
stretch of DNA is likely to be found uniquely in a mammalian genome. With two 
primers required for amplification of a product, the probabilities of non-specific 
PCR decrease still further. To aid the subsequent cloning of the PCR products, some 
primers are synthesized with appropriate restriction sequences at their 5' ends. It is 
apparent, however, that some restriction enzymes do not readily cleave at positions 
near the termini of a DNA molecule and so extra nucleotides are included on the 
primer's 5' end to provide a '5-clamped' restriction site which acts as a superior 
enzyme substrate. 
Selection of the sequences for these primers is subject to three main criteria:- 
The G/C content must be suitable to create adequately high annealing 
temperatures to prevent spurious priming events. Also, Os and C's at the 3' end of a 
primer should be avoided as these increase the probability of mis-priming. 
Effort should be made to ensure that the primers do not contain regions of 
secondary structure (self-complementarity) which might interfere with the template 
annealing step. 
The two primers should not have any regions of complementarity between each 
other, especially at the 3' ends, as this may cause the preferential production of 
'primer-dimers' instead of genuine products. 
Amplification programs 
PCR amplifications were carried out according to programs described in the text. 
The successful amplification of the protein tyrosine phosphatase family required the 
application of the RT-PCR technique described below. 
Reverse transcription step: 
mRNA (1 j.tg) 	 3.5 tl 
RNA Guard 0.5j..tl 
dNTP mix (2.5mlM) 	 lOjfl 
Promega PCR buffer 2 tl 
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Random hexamers (100 pmol) 	1 tl 
MgCl2 (25 mM) 	 2 .tl 
Reverse transcriptase (Gibco BRL) 1 tl 
37°C 30 mm 
95°C 5 mm 
52°C hold while adding PCR constituents 
PCR reaction:- 
The following reagents were incubated at 94°C for 4 min and then added to the RT 
products held at 52°C. 
5' PCR primer 1 	tl 
3' PCR primer 1 p1 
PCR buffer 8 p1 
MgCl2 (25 mM) 8 j.tl 
Water 61.5 p1 
0.5 tl of Taq polymerase (2.5 units activity) was added to the final mix and then the 
PCR amplification program was initiated. 
72°C 45s 
94°C 30s 
52°C 30s 
35 cycles were carried out and then a final extension of 72°C for 5 mm. The 
expected size of product was approximately 250 bp. 
Me.6: Chemical cross-linking subtraction 
Chapter III describes the application of this technique for the search for 
hippocampus-specific genes. It was based on a protocol published by Hampson et al. 
in Nucleic Acids Research, Vol. 20, No. 11, p.  2899, 1992. 
First strand cDNA was synthesized (as described previously) from approximately 5 
p.g of hippocampus mRNA. The cDNA was purified away from the RNA template 
by alkaline hydrolysis (0.5 M NaOH at 55°C for 15 mm) followed by spin-column 
fractionation (see probe synthesis). 500 ng of this cDNA was hybridised to 10-20 pg 
of mRNA prepared from brain tissue with the hippocampus removed. The 
hybridisation took place in a volume of 10 p1 of:- 
0.5 M NaCl 
25 mM HEPES buffer (pH 7.5) 
5 mM EDTA 
1% SDS 
After 20 hr of incubation at 680C, the solution was diluted 5-fold with distilled water 
and precipitated with ethanol. The resulting pellet was dissolved in 50 41 of:- 
25 mM Tris-HC1, pH 7.5 
1 mM EDTA 
5% D.M.S.O. 
2 mM Ascorbic Acid 
This was incubated at 68°C for five minutes (to remove secondary structure) and 
then mixed with D.Z.Q. (to a final concentration of 200 RM. The DZQ was a 
generous gift from Ian Hampson, Paterson Institute for Cancer Research, University 
of Manchester, England) and left to incubate at 45°C for 20 mm. This material was 
then ethanol precipitated oncemore. 
Depending on the experiment, this cross-linked nucleic acid was either used directly 
as a template for probe synthesis or was subjected to another round of subtraction. 
Probe synthesis used one half of the material prepared and was performed as normal 
except that 6 units of Sequenase' enzyme were used instead of Kienow enzyme (for 
the reasons described in Chapter III) and the isotope quantity was increased to 100 
tCi instead of the conventional 30 or 40 tCi. 
Me. 7• Streptavidin/biotin subtraction technique 
Creation of representative cDNA pools for amplification 
Double-stranded cDNA was made from the two poly A+  RNA pools (either 
hippocampus and rest of brain or E.C.S. hippocampus and Sham hippocampus) as 
previously described. 
The resultant cDNA from each tissue was divided up into two aliquots; one of which 
was digested with Alu I restriction enzyme, while the second was doubly digested 
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with Alu I and Rsa I. The two aliquots were then taken through phenol/chloroform 
purification and ethanol precipitation and finally recombined. 
This material was ligated to 10 j.tg of phosphorylated linker. The phosphorylated 
linker was made by the mixing of equimolar amounts of the two oligonucleotide 
constituents in standard high-salt restriction digest reaction solution. After the 
addition of 10 mM ATP and 1 tl polynucleotide kinase, this mixture was incubated 
at 37°C for 20 mm. This was followed by 45°C incubation for 45 min to permit 
oligonucleotide annealing. 
The sequences of the oligonucleotides are shown below; 
5 	ctcttgcttgaattcggacta 3 linker 
3 acacgagaacgaacttaagcctgat 5 
5 	tgtgctcttgcttgaatt 3 	PCR primer 
The 3' overhang on one strand ensured the directional ligation of the linker onto the 
cDNA fragments and prevented the build-up of concatameric linkers on the ends of 
each cDNA fragment. Ligation products were run briefly (5-10 mm) on a low 
melting temperature agarose gel and a region corresponding to DNA lengths 
upwards of 200 bps was cut out. 
Using 1-2 jil of melted agarose per 100 .tl reaction, the cDNA fragments were 
amplified by the P.C.R. technique (using the primer complemetary to the linker and 
0.7 p1 of Taq enzyme) such that a stock of the cDNA fragments could be built up for 
each tissue sample. 
The P.C.R. program was designed to avoid amplification bias that might favour 
smaller cDNA fragments. 
94°C 	1 mm 
50°C 1 mm 
7 2 °C 	2 mm, with a 25 sec increment with each passing 
cycle. 
30 cycles overall (reduced to 25 for amplifications after each subtraction step). 
146 
Reaction constituents:- 
Agarose/cDNA 1-2 jtl 
Primer 2 	l 
Buffer (lOX) 10 .11 
MgCl2 (25 mM) 6 t1 	(1.5 mM) 
dNTPs (5 mM) 5 fl (0.25 mM) 
Water 75.3 j.tl 
Taq Polymerase 0.7 jil 
The P.C.R. products were chloroform extracted to remove the oil overlay and then 
phenol/chloroform extracted followed by ethanol precipitation. All products from 
one tissue origin were pooled in 50 .tl water and assayed for concentration by 
absorption at 600 nm. 
Correct representation within these initial pools was assayed by cDNA Southern 
analysis (that is, amplified material from the two sources was run on a gel, denatured 
and blotted onto 'Hybond-N' filters) Ubiquitously expressed genes were used as 
probes to ensure correct representation in both pools. 
Preparation of the driver cDNA 
100 .tg of the required cDNA was digested to completion using 1500 units of EcoRI 
restriction enzyme to remove the linker regions from the fragment in order to prevent 
subsequent amplification of residual driver. 
Digestion products were phenol/chloroform extracted, put through a Sephadex G-50 
spin column (to remove linker ends) and then ethanol precipitated. 
The precipitated cDNA was resuspended in l.tg/j.tl photobiotinylation buffer. 
5 mM HEPES buffer, pH 7.5 
1 mM EDTA 
The cDNA was then mixed with an equal volume of an equal concentration of 
photobiotin acetate and incubated on ice under two 150 W bulbs for one hour. 
An equal volume of 0.1 M Tris-HC1, pH 9 was then added. 
Excess unincorporated photobiotin was removed by 3 successive extractions with 
water-saturated butanol. The top organic phase was discarded each time. 
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After ethanol precipitation the photobiotinylation procedure was repeated once more. 
Hybridisation of the tracer and driver 
5 pg of the tracer cDNA was added to the 100 tg of the biotinylated driver and 
resuspended in a volume of 20 p.1 of water. 
This was boiled for three minutes and then 20 p.! of 2X Hybridisation buffer (see 
below) were added to bring the final volume to 40 p.1. 
1.5 M NaCl (0.75 M) 
50 mM HEPES buffer, pH 7.6 (25 mM) 
10 mM EDTA (5 mM) 
0.2% S.D.S. (0.1%) 
After covering the liquid with a layer of oil the solution was boiled for another 3 
minutes and then incubated at 68°C for 20 hours (2 hr for the short hybridisation 
step). 
260 p.1 of 
10 mM HEPES, pH 7.6 
1 mM EDTA 
were then added to bring the final NaCl concentration to 0.1 M. The mixture was 
incubated for 5 minutes at 55°C (this is the equivalent to washing a filter after 
hybridisation). 
20 p.1 of streptavidin (2 p.g/p.l dissolved in 0.15 M NaCl, 10 mM HEPES, pH 7.6, 1 
mM EDTA) was added to the mixture. It was left to stand for 20 minutes at room 
temperature to allow the streptavidin/biotin complexes to form. 
A phenol/chloroform extraction was carried out such that the organic phase together 
with the Streptavidin/Biotinylated cDNA interface were discarded. Four repeats of 
the streptavidin addition and phenol/chloroform extraction were carried out to ensure 
maximum removal of excess driver/driver hybrids. 
The resultant material was ethanol precipitated and either subjected to P.C.R. 
amplification or a second, short, hybridisation with 50 p.g of appropriate biotinylated 
driver. 
A full scheme of the subtraction protocol is presented below. 
Subsequent modification  of the technique 
To prevent the cDNA driver of one tissue contaminating the cDNA tracer of the 
other tissue a modification was made to the protocol. This was based on a suggestion 
made in a paper written by Balzer and Baumlein (see Chapter IV) that the two cDNA 
pools derived from the two tissues should be made independently amplifiable. This 
was achieved by the use of different linker sequences for each pool. Thus, the primer 
used to amplify tracer cDNA after a subtraction step would not be complementary to 
any contaminating driver cDNA (and, hence, would not permit its amplification) 
In the subsequent subtraction steps, one cDNA pool had the previously described 
linker sequences added, whereas the other pool had the following linker added:- 
5 	agttacacgtctagaatggct 3 
3' atagtcaatgtgcagatcttaccga 5' 
Because there is no possibility of cross-amplification, there wass no need for any 
digestion step to remove the ends of the linker from each cDNA. Also, for the same 
reason, there is no need for the purchase of a separate PCR primer for the 
amplification of these sequences as the upper oligonucleotide suffices for this 
purpose. This new linker contains an internal Xba I restriction Site which can be used 
for the cloning of the subtracted material. 
Analysis of subtracted material 
At the end of the subtraction procedure, the material obtained was used in a variety 
of ways, as described in the text of Chapters IV and V. To directly don and analyse 
the material, the final subtracted material was made fully double-stranded. 3 .tg of 
the material was subjected to one round of amplification to achieve this. This was 
then digested with the appropriate restriction enzyme (EcoRI or XbaI), purified, and 
then ligated into a vector cut with the same restriction enzyme (and phosphatased). 
The two vectors used were the plasmid pBluescriptll, KS configuration, and the M13 
filamentous bacteriophage vector, tgl30 or 131. 
The ligation products were transformed (generally by electroporation) into the 
appropriate host bacterial strain as described elsewhere. 
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Me.8: Creation of competent cells 
Conventional competent cells 
A single fresh colony of desired strain (XL1 Blue or DH5a were commonly used) 
was grown for 2 hours in 5 ml of TYM-broth, shaking at 370C. 
2% Bacto-Tryptone 
0.5% Bacto Yeast Extract 
0.1 M NaCl 
0.01 M MgC12 or MgSO4 
This was transferred to 100 ml of fresh TYM-broth and incubated for a further 2-3 
hr, or until the ABS nm was 0.5. 
The cells were spun at 2500 r.p.m. for 5 min at 40C in two 50 ml Corning' tubes. 
The cell pellet was resuspended in 20-40 ml of 'TIb I' per 100 ml of starting culture. 
30 mM KOAc 
50 mM MnC12 
100 mM KC1 
10 mM CaC12 
15% by volume of glycerol 
pH 5.8 (using dilute acetic acid), filtered. 
The resuspended cells were left on ice for 5 min-3 hr, depending on the strain used. 
The cells were spun at 2000 r.p.m. for 5 min at 4°C. 
The pellet was resuspended in 4 ml of 'Tfb II' per 100 ml of starting culture. 
10 mM Na-MOPS pH 7.0 
75 mM CaCl2 
10 mM KC1 
15% by volume of glycerol 
The cells were aliquotted into conveniant volumes for storage at -70°C. 
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Electrocompetent cells 
2X 50m1 volumes of LB medium were each inoculated with 1 ml of overnight 
bacterial culture (XL1 Blue bacterial strain). When the ABS600 reached a value of 
0.5-1.0 the cells were taken through the preparative procedure. 
The cells were chilled on ice for 15-30 mm. 
In 50 ml Corning tubes the cells were centrifuged at 4000 xg for 15 mm. at 4°C. 
The cells were resuspended in lOOmi of ice-cold distilled water. 
The cells were centrifuged as in 2. 
The cells were resuspended in 50 ml of ice-cold distilled water. 
The cells were centrifuged as in 2 
The cells were resuspended in 2 ml of ice-cold 10% glycerol solution. 
After a final spin as in 2, the cells were finally resuspended in 250 p1 of 10% 
glycerol. 
This mix was divided into 40 tl aliquots and stored at -70°C. 
Me .9: Transformation of bacterial cells 
Conventional cell preparations 
1-10il of the ligation was added to 200tl of thawed competent cells and left on ice 
for 30 mm. 
The cells were then subjected to a 90 sec. heat-shock at 42°C. 
After 3 min recovery on ice, 400R1  of LB medium was added and the mixture was 
placed in a shaking incubator at 37°C for 30 mm. 
The cell suspension was then plated on appropriately prepared agar-filled petri 
dishes and left to grow overnight at 37°C. 
Electro -transform ation 
For every ligation to be transformed, one 40 p.1 aliquot of electro-competent cells 
was used. 1 p.1 of the ligation mix was mixed well into the thawed cells and allowed 
to sit on ice for one minute. 
This mixture was then added to the bottom of an electroporation cuvette. The cuvette 
was placed in a 'Gene Pulser' apparatus set at 25p.F, 2.4kV, and 200g. 
After one pulse, the cuvette was immediately removed from the apparatus and lml 
of SOC medium added to the cells. The cells were transferred to a Falcon tube and 
placed in a 370C shaking incubator for a period of 1 hour. 
The cell suspension was then plated on appropriately prepared agar-filled petri 
dishes and left to grow overnight at 370C. 
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Me.10. Preparation of plasmid DNA plasmid mini-preps 
The E. coli colony containing the plasmid of interest was grown overnight (15-16 hr) 
in 1.5 ml of LBM medium in a 37°C shaker. 
The culture was decanted into a 1.5 ml Eppendorf tube and spun for 2 min at 13,000 
r.p.m. 
The pellet was resuspended in 100 tl of 'Lysis Buffer': 
25 mM Tris-HC1, pH 8.0 
10 mM EDTA 
50 mM Glucose 
2 mg/ml lysozyme 
200 p1 of 0.2 M NaOH/1% SDS was added, followed by 10 min of tube inversion. 
Then 150 tl of 3 M KOAc/2 M Acetic acid were added and the solution left on ice 
for 15 mm. 
The cloudy precipitate was removed by a 10 min bench-top centrifugation and the 
450 p1 of supernatant transferred to a clean Eppendorf tube. 
The DNA was phenol/chloroform extracted and then precipitated by the addition of 
imi of Ethanol. 
After 30 min at -70°C the DNA was pelleted by a 15 min spin. 
The pellet was resuspended in 50 p1 of :- 
10 mM Tris-HC1, pH 8.0 
1 mM EDTA 
S mg/ml RNAseA 
After a 20 min incubation at 37°C the solution was analysed for the presence of 
inserted DNA by appropriate restriction digestion. 
For some applications, such as high quality sequencing, the DNA was subjected to a 
further round of purification involving PEG precipitation. This involved the addition 
to the 50 il plasmid preparation of 30 p1 of 20% PEG in 2.5 M NaCl. This mixture 
was left on ice for 1 hour (or overnight) and then spun at 13,000 r.p.m. for 15 mm. 
The pellet was washed several times with 70% ethanol to ensure complete removal 
of PEG solution from the DNA. 
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Me. 11: Radiolabelled DNA probe synthesis 
The template DNA required for the synthesis of the probe usually consisted of 2-3 p.1 
of mini-prep plasmid DNA digested with the relevant restriction enzymes and 
electrophoresed on a low melting temperature agarose gel. The appropriately sized 
band was cut out of the gel and the DNA purified by the use of the 'Gene-Clean II' or 
'Quiaex' kits. 
Purified DNA was resuspended in 18.4 p.1 of water and boiled in a screw-topped 
Eppendorf tube for 5 min followed by quenching in ice for three mm. 
The following reagents were added in the order given: 
6 p.1 OLB (Oligo-Labelling Buffer) 
20 p.1 Solution A 
1.21 M Tris-HCL pH 8.0 
0.121 M MgCl2 
1.74% 3-Mercaptoethanol 
0.484 mM each dATP/dTTP/dGTP 
50 p.1 Solution B 
2M HEPES buffer, pH 6.6 with NaOH 
30 p.1 Solution C 
Hexadeoxyribonucleotides dissolved to 
90 O.D. units/ml in 3 mM Tris-HC1, pH 7 
and 0.2 mM EDTA 
1.2 p.1 of 10 mg/ml enzyme-grade Bovine Serum Albumin 
40 p.Curies of radiolabelled dCTP (4p.1) 
0.4 p.1 Klenow fragment polymerase 
The reaction mix was left at room temperature/37°C for 1-3 hr. 
The reaction mixture was then made up to 100 p.! with STE/TEN buffer and spun 
through a Sephadex G-50 spin column (inil volume equilibriated with STE/TEN 
buffer). This removed unincorporated nucleotides. 
After scintillation counting, the probe was denatured by boiling for 5 min and then 
quenching on ice. 
The probe was then added to the hybridisation vessel. 
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Me.12: Probe hybridisation conditions for Northerns, Southerns and library screens 
Ref: Church and Gilbert, (1984) P.N.A.S., Vol. 81, p.1991. 
Standard hybridisation procedures required the filter(s) to be pre-hybridised for over 
one hour at the desired temperature (usually 650 or 680C). 
(pre)Hybridisation Solution:- 
7% S.D.S. 
0.5 M NaHPO4 (pH 7.2) 
per litre of one molar (pH 7.2): 
71 g anhydrous Na2HPO4 
4 ml H3PO4 (85%) 
1 mM EDTA 
1% Bovine Serum Albumin 
After the addition of the denatured probe, the filter was left to hybridise for 16 hours 
or longer. 
Removal of non-specifically hybridising probe was done by three successive washes 
with wash solution pre-equilibriated to the hybridisation temperature. 
Wash Solution (per 2.3 litres):- 
92 ml of 	 1 M (40 mM) NaHPO4 (pH 7.2) 
4.6 ml of 0.5 M (1 mM) EDTA (pH 8.0) 
23gof 	 S.D.S. 
water to 2.3 litres. 
After the final wash the filter(s) were wrapped in Saran Wrap and exposed to X-Ray 
film for the required period of time. 
N.B. Depending on the size and number of filters, the hybridisations were done 
either in glass hybridisation cylinders or in heat-sealed plastic bags. 
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Me.13. Northern blotting and hybridisation 
RNA samples to be blotted (1-5 .tg poly A, 15-25 tg total RNA) were precipitated 
in ethanol and resuspended in 12 .tl of sample buffer:- 
25 jil lox MOPS 
0.4 M MOPS 
100 mM NaAcetate 
10 mM EDTA 
125 p.1 Formamide 
44.5 p.1 Formaldehyde 
55.5 p.1 D.E.P.C. Water 
The RNA in solution was heated to 60°C for 10 minutes and then quenched on ice to 
ensure loss of secondary structures. 
After addition of loading dye (containing Ethidium Bromide) the samples were 
loaded onto a 1% agarose gel:- 
1.2 g Agarose 
12 ml lOX MOPS 
86.4 ml D.E.P.C. Water 
This was melted then cooled prior to the addition of 21.6 ml Formaldehyde. 
The solution was poured into 120 ml gel tray and allowed to set. 
The set gel was covered with running buffer in the electrophoresis tank:- 
100 ml lOX MOPS 
720 ml D.D.Water 
180 ml Fomaldehyde 
per litre 
The gel was electrophoresed at approx. 90V until the Bromophenol Blue dye had 
progressed one third of the way through the gel. 
After a brief rinse in water the gel was photographed under U.V. light and then 
blotted overnight in the same way as a Southern blot (see below). 
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Me.14: Southern blotting 
DNA samples were electrophoresed in appropriate conditions/agarose percentage. 
The DNA in the gel was then subjected to denaturation for 15-30 min in 1.5 M NaCl, 
0.5MNaOH:- 
4 Litre Stock 
350.64 g NaCl 
50 g NaOH 
Water 
This was followed by neutralization of the gel in 1.5 M NaCl, 1 M Tris-HC1, pH 
7.4:- 
4 Litre Stock 
484.4 g Tris 
350.64 gNaCl 
272 ml HC1 
Water 
A final rinsing step was carried out using 20X SSC. 
The capillary-blotting procedure was carried out as follows:- 
Whatman 3MM paper was used as base for the stack and as a wick because its 
ends were in contact with a bath of 20X SSC. 
Upon this was placed the inverted gel. 
Hybond-N paper was cut to size and placed on the top of the gel. 
Four sheets of Whatman 3MM paper were placed on this followed by a stack of 
hand-towels to a depth of 5-8cm. 
A weight (approx. 1kg) was placed on top of the stack and then the apparatus was 
left overnight. 
The stack was then dismantled and the Hybond-N filter paper baked at 80°C for 2 
hours prior to prehybridisation. 
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Me.15: In situ hybridisation 
Riboprobe synthesis 
The cDNA to used as a probe was cloned into pBluescript II (KS form) plasmid 
vector. One ig per probe of the clone was digested with an appropriate restriction 
enzyme in order to create a linear DNA template which will produce a probe of the 
correct complementarity: antisense or sense control. This was resuspended in 2 j.tl of 
water. To this was added the following reagents:- 
0.75 jtl 
0.75 tl 
2.25 p1 
0.5 pJ 
6.25 j.fl 
1.5 .tl 
1 p1 
200mM DTI' 
2mg/m1BSA 
3.3 mM each of the ribonucleotides not 
present in radioactive ribonucleotide. 
RNA Guard RNase inhibitor 
Radioactive ribonucleotide 
lox Transcription buffer 
T7/SP6/T3 RNA Polymerase 
This was incubated at 37°C for 1 hr. 
DNase (1 p1) was added and incubated at 37°C for 20 mm. 
The reaction was made up to 85 jtl with water and then Phenol/Chloroform 
extracted. 
The probe was purified from excess ribonucleotides by Sephadex G50 spin column 
centrifugation. 
4 p1 of 1 M DTT was added to prevent oxidative degradation. 
Scintillation counting of 1% of the probe should give approximately 300,000-
1,000,000 counts per minute. 
Pretreatment of sections prior to probe hybridisation 
Coronal brain sections mounted on glass microscope slides were dewaxed in xylene 
and then ethanol dehydrated. 
They were then post-fixed in paraformaldehyde in PBS for 20 mm. 
Two PBS washes were carried out on the sections. 
20 jig/ml Proteinase K in 50 mM Tris-HC1, 5 mM EDTA was used for 20 min at 
room temperature to deproteinate the tissue. 
After one PBS wash the sections were re-fixed in paraformaldehyde as before. 
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After a distilled water rinse the sections were placed in a bath with 0.1 M 
triethanolamine. Acetic anhydride was added to a final concentration of 2.5 ml/l. 
This was stirred slowly until fully dissolved and then the sections were left for 10 
mm. 
After 5 min PBS and saline washes the sections were dehydrated through an ethanol 
concentration series and left to air dry. 
Prehybridisation and hybridisation conditions 
The hybridisation mixture consists of:- 
50% deionised formamide 
0.3MNaCl 
20 mM Tris-HC1, pH 8.0 
5 mM EDTA 
10 mM NaPO4, pH 8.0 
10% Dextran sulphate 
lx Denhardt's solution 
0.5 mg/mI yeast RNA 
prior to use the mixture was de-gassed in a vacuum drier. 
400 .tl of this was placed over the sections and then Parafilm cover-slips were put 
over the sections to prevent evaporation. The pre-hybridisation was carried out in a 
perspex box with a tissue soaked in 50% formamide/5X SSC included to maintain a 
humid environment. 
This was incubated at 55°C for 2 hours. 
The probe was prepared by dilution in hybridisation solution such that the specific 
activity was 104-105  counts per minute/.tl. DTT was added to a final concentration 
of 10mM. Just before use the probe solution was denatured at 80°C for 3 mm. 
The coverslips were removed and 200 .tl of the denatured probe added to the top of 
the sections. New coverslips were added and trapped air bubbles removed. 
Incubation was carried out as before at 550C overnight. 
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Washing of hybridised sections 
Coverslips were removed by placing the slides vertically along their long edge in a 
bath of 5X SSC and 10 mM DTT at 55°C. After 15-30 min the slides were removed 
and taken to the washing steps. 
High stringency wash solution:- 
50% Fomamide 
2X SSC 
0.1 M Dill' 
The first wash was carried out at 65°C for 20-30 mm. 
Three washes with: 
0.5MNaCl 
10 mM Tris-HC1 
5 mM EDTA 
were carried out at 370C for 10 min each. 
RNase (to a concentration of 20 j.tg/ml) was added to this solution and left to 
incubate at 37°C for 30 mm. 
A final wash with this solution was carried out prior to the second high stringency 
wash (as before). 
Two final washes, one 2X SSC and one 0.1X SSC, were performed followed by 
ethanol series dehydration. 
After air drying, the slides were placed against BioMax autoradiography film and 
allowed to expose for 24 hr-i week. 
Me.16: DNA sequencing 
Both double-stranded plasmid preparations and single-stranded M13 preparations 
were sequenced by dideoxy sequencing. The sequencing of plasmid DNA generally 
gave poorer results. 
Sequencing reaction 
Approximately 12 p.1 out a 50 p.1 plasmid prep was sufficient for an individual 
sequencing reaction. This was precipitated with ethanol and resuspended in 18 p.1 of 
TE buffer. To this was added 1 p.1 of 20 ng/p.l of oligonucleotide primer (T3/T7ISP6) 
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together with 1 p.1 of 4 M NaOH. This mixture was left at room temperature for 5 
mm. to permit the complete denaturation of the double-stranded plasmid DNA. After 
ethanol precipitation and 70% ethanol washing, the pellet was resuspended in 7 p.d of 
water. To this was added 1 p.1 Di-methyl Sulphoxide (DMSO) and 2 p.1 of (5X) 
sequencing buffer:- 
0.2 M Tris-HC1 buffer, pH 7.5 
0.1 M MgCl2 
0.25 M NaCl 
A stock reaction solution was made up such that for every plasmid sample to be 
sequenced an additional :- 
1.1 p.10.1 MDTT 
1.76 p.1 water 
1.95 p.1 TE buffer 
0.44 p.l labelling mix (1.5 p.M each of dGTP, dTT'P, and dCTP) 
0.5 p.1 35S-dATP (=5 p.Ci) 
0.28 p.1 Sequenase Enzyme 
was added. 
From this reaction solution stock 5.25 p.1 was transferred to each of the plasmid 
samples and then left for 5 min at room temperature. This step causes the newly 
forming strand to be labelled with isotope to a high specific activity. 
Four 3.5 p.1 aliquots from each sequencing reaction were placed in individual wells 
of a 96-well plate. To each of the four aliquots for any one plasmid sequencing 
reaction 2.5 j.tl of one particular dideoxy termination solution was added such that 
termination reactions at all four bases were represented for each plasmid. The 
termination mixtures consisted of:- 
8 p.M of the relevant dideoxynucleotide 
80 p.M each of the other three deoxynucleotides 
LiI)K[i] 
50 mM NaCl 
After 5 min of incubation at 37°C this final reaction step was stopped by the addition 
of 4 p.1 of:- 
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95% Formamide 
20 mM EDTA 
0.05% Bromophenol Blue dye 
0.05% Xylene Cyanol FF dye 
Sequencing gel 
The gel was poured between glass plates, one of which had been silicon treated, and 
a square-teeth comb was used to create the wells in situ. 
The gel was made using solutions obtained from the 'Sequagel' kit of National 
Diagnostics. For a 50 ml gel the following quantites were used:- 
14.4 ml Concentrate 
39.6 ml Diluent 
6 ml Buffer 
0.48 ml 10% Ammonium Persuiphate 
50 i1 TEMED (N, N, N', N'-Tetramethyl-Ethylene-Diamine) 
The sequenced DNA samples were denatured at 80°C for 10 min and then 2 gl of 
each was loaded into the wells in a defined order (T-C-G-A was used here). The gel 
was subjected to electrophoresis (30-40 W, 1200 V) for 3 hours or more. 
The gel, while still attached to one of the glass plates, was fixed for 15 min in the 
following solution:- 
10% Acetic Acid 
10% Methanol 
Water 
The gel was then transferred to two sheets of Whatman 3MM paper and covered 
with Saran wrap. This was then vacuum-dried at 800C using an ice-trap to condense 
the evaporating fix solution. 
The dried gel was then placed against Kodak BioMax autoradiography film in a 
cassette and left to expose overnight. By assigning base composition and order of the 
electrophoresed bands it was possible to deduce the sequence of the DNA. 
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Me.17: Methods associated with bacteriophage A use 
Library plating: plating bacteria 
1 ml of an overnight (tetracycline selected) culture was added to 25 ml of LB 
medium supplemented with 0.2% maltose. 
This was shaken in a 370C incubator until the ABS600 was approximately 1. 
The cells were pelleted by 10 minutes centrifugation at 4000 xg and then 
resuspended in 25 ml of 10 mlvi MgSO4 
Library plating: plating 
The bacteriophage was diluted to the correct concentration in SM solution such that 
the correct number of plaque forming units per plate was contained in a few 
microlitres. This quantity was placed inside a Falcon tube into which 1.32 ml of 
plating cells had been pipetted. The cells were briefly mixed with the 'phage and 
then left motionless at 37°C for 20 mm. 
Meanwhile, 15 cm diameter petri dishes were filled to a depth of 1 cm with bottom 
agar, dried so that the surface was just furrowed, and then left at 37°C to equilibriate 
to that temperature. Top agarose was melted and then placed in 13 ml aliquots in 
Falcon tubes and left at 480C. 
The top agarose contents of one tube were gently poured into the tube containing the 
cells so that the two mixed without the creation of bubbles. This was then quickly 
poured over the bottom agar to form a level covering of top agarose before it setted. 
Each poured plate was left to stand at room temperature and then inverted and placed 
in a 37°C incubator. 
After 4-5 hr the bacterial lawn was apparent and several hours after that the 'phage 
plaques began to appear. Plaque sizes of 1-2 mm were chosen as an indication that 
the plates were ready for storage at 4°C. 
Library plating: plaque lifts 
After an hour-overnight at 40C the plaques were transferred to nitrocellulose filters. 
Plates were placed on a light box and a correctly-sized filter slowly placed onto the 
agarose surface. This was left in place for 1 minute, during which time three holes 
were punched through the filter and into the agarose using a syringe needle. 
Successive filter-lifts were taken using the needle holes to orient the positions for 
subsequent filter marks. For each successive lift, the time in contact with the plate 
was doubled. 
All filters were treated as follows:- 
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2 minutes on top of 3MM paper soaked with denaturation solution 
(see Southern section). 
5 minutes on top of 3MM paper soaked with neutralisation solution 
(see Southern section). 
2-3 minutes on top of 3MM paper soaked with 2XSSC solution. 
After air-drying, the filters were baked in a 80°C oven for 2 hours. 
The filters were subjected to the relevant hybridisation 
experiments. 
Library plating. picking colonies 
Hybridisation signals on the X-ray film were aligned to corresponding plaques on 
the plates using the needle holes as a guide. These plaques were isolated by the use 
of 'pastettes' with the tips cut off so that the diameter of the exposed end was 
approximately 0.5 cm. These were used to suck up the plaque and the surrounding 
region. The plaque plug was expelled into 1 ml of SM solution and left overnight for 
the bacteriophage particles to diffuse out into the solution. Secondary and tertiary 
screens were then performed at lower plating densities using aliquots of the plug 
suspensions to obtain pure isolates of the plaques. 
Library plating. in vivo excision 
Because the lambda strain used to create the principle hippocampus cDNA library 
was AZAPII (Stratgene), in vivo excision could be carried out to obtain a bacterial 
plasmid containing the correct cDNA insert which enables its easier preparation and 
manipulation. 
Approximately 105  plaques in 100 t1 of SM buffer were added to 200 .tl of XL1 
Blue plating cells and 1 jil of 'ExAssist' helper phage. This was mixed briefly and 
left to incubate for 15 min at 37°C. 
To this mixture was added 3 ml of 2X TY medium and then the cells were left for 3 
hours in a shaking 37°C incubator. 
The cells were lysed in their tubes by 20 min incubation in a 70°C water bath. 
Cellular debris was removed from the lysate by centrifugation for 5 min at 4000Xg. 
The supernatant was transferred to a sterile tube. 5 fl of this was added to 200 t1 of 
SOLR cells and the mixture was incubated for 15 min at 370C. 
Various amounts of the product were plated out on 8 cm ampicillin-containing agar 
plates and left to incubate overnight at 37°C. Colonies should contain the excised 
cDNA insert within 'pBluescriptll KS' plasmid vector. 
163 
Me.18: Bacteriophage M13 methods 
M13 bacteriophage plating 
The procedures required for plating M13 bacteriophage are very similar to those for 
X. The following list describes the major differences:- 
eDNA inserts ligated into M13 bacteriophage vector (tgl3l; 
Kieny, M.P., Lathe, R., and Lecocq, J.P. (1983) Gene, Vol. 26, pp.  91-99) have to be 
transfected into bacterial cells (XL1 Blue was used as a suitable host strain). This 
was achieved either by conventional transfection or electro-transfection as described 
elsewhere. 
Transfected cells were added to the top agarose as before except 
that IPTG (10 .t1) and X-GAL (100 .il) were also included (if the conventional 
transfection technique was used then extra plating cells (200 .t1) derived from an 
ABS600=1 incubation were added). 
Plates were left overnight and the white plaques obtained 
represented insert-containing vectors. 
Filter lifts were performed as before except that no denaturation or 
neutralisation steps had to be carried out on the filters because the M13 plaques 
contain single-stranded DNA. 
Plaque plugs were taken as before (and stored in LB medium) or 
plaques were stabbed with a sterile toothpick which was then used to streak another 
plate to obtain isolated plaques. 
M13 Bacteriophage single-stranded DNA preparations 
Single-stranded bacteriophage vector DNA can be used for direct sequencing or as a 
template for PCR amplification of the cDNA insert. 
10 p.1 of the plaque suspension was added to 25 p.1 of an XL1 Blue overnight 
bacterial culture and 2 ml of LB medium. This was left to shake at 37°C for 4-5 
hours. 
This was centrifuged in a microfuge at 8000rpm for 15 mm. 1 ml of the supernatant 
was removed. 
To this was added 200 p.1 of 20% PEG (polyethylene glycol) in 2.5 M NaCl. This 
was left at room temperature for 30 mm. 
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This was centrifuged as before and all the supernatant was discarded. The pellet was 
resuspended in 100 .tl of 1.1 M NaOAc, pH 7 and incubated at 650C for 10 mm. 
After phenol/chloroform and chloroform extractions the aqueous phase was 
precipitated with ethanol. 
After a half hour chill at -200 or -70°C the precipitate was pelleted by a 20 minute 
microfugation. The pellet was washed in 70% ethanol, dried, and resuspended in 20 
.tl TE buffer. 
For sequencing purposes, 5 j.tl was incubated with 20 ng of '-40' primer at 550C prior 
to the sequencing reaction. 
PCR amplification of the eDNA insert was carried out using the -40 primer and a 
primer designed to be complementary to a sequence on the bacteriophage vector 
distal to the insert. The amplification program was 30 cycles of:- 
94°C 	1 mm 
54°C 1 mm 
72°C 	1 mm 
PCR products were used as probe templates or cloned into pBluescriptll plasmid 
vector for more extensive sequencing/in situ template creation etc. 
Me .19: Electroconvulsive stimulation (ECS) protocol. 
Male hooded Lister rats were used. 
Light halothane anaesthesia was used prior to the shock or by itself in the case of the 
sham rats. 
The ECS shock consisted of a 200 V (sine wave) pulse, 40-60 mA for 2 seconds. 
Tonic-clonic seizures were observed. 
ECS treatments were separated by 48 hr. 
A total of 10 stimulations were applied and then the rats were sacrificed at 72 hr 
post-stimulation. 
Me.20: cDNA Capture 
In order to obtain longer fragments of cDNAs cloned in the subtraction process a 
novel technique was devised. 
The clone of interest (1/4 of a single-strand M13 bacteriophage prep. was sufficient) 
was denatured in a volume of 20 p1 of water and applied to a 1 cm by 2 cm piece of 
Hybond nitrocellulose. This was baked for 2 hr at 80°C. 
The filter was then placed in a 15 ml Coming tube and 6 ml of Church and Gilbert 
hybridisation solution added (see me. 1 1). Prehybridisation of the filter was carried 
out by inserting the tube into a hybridisation cylinder filled with paper towels and 
placing this into a normal hybridisation oven for 2-4 hr at 65°C. 
5 .tl of a typical PCR amplification of the initial cDNA pool was denatured in a final 
volume of 25 p.1 and then added to the 15 ml Corning tube. Hybridisation was carried 
out overnight as before. 
Washes were carried out as described in me. 1 1. The washed filter was added to 100 
p.1 water in an eppendorl and boiled for 5 mm. 
The water was removed and ethanol precipitated with a glycogen carrier. The 
resulting pellet was resuspended in 10 p.1 of water from which 1 p.1 was used in a 
PCR reaction using the appropriate cDNA pool primer and standard amplification 
program. 
PCR products were electrophoresed on a 1.2% agarose gel. Often discrete bands 
were visible which could be cloned directly. Alternatively, the captured material 
could be compared to the original cDNA pool by Southern blotting and probiong 
with the original cDNA fragment. Much greater hybridisation to the captured 
material should be seen. 
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Appendix 
Chapter II 
PTP 4 PCR product nucleic acid sequence 
gaggactcagacatgtatggggacatcaagatcacg ctg gtaaagacagagacactggc 
tgagtacgtggtgcgcacctttgccctggagcggagaggttactcagcccgg catgaggt 
ccgccagttccacttcacagcgtggccagag catg gtgttccctaccatgccacngggct 
g ctg g ccttcatccgg cncgtgaagg cttccactccacctgatgctg gg cctgttgtcat 
t 
PTP 24 PCR product nucleic acid sequence 
ttcacg gaag aacccattgcttatg gag acatcaccgtg gag atggtctctgag gaagaa 
cag gag gactgggccag cag acacttccg gatcaattatgctgacgag g cccagg atgt 
gatg cactttaacnacacggcctgg ccagaccatg g cgtg cctccag caaatg ctg ctga 
gag catcctg cagttcgtgtacactgtccgg cag caagccaccaag ag caaaggaccca 
tgatcatc 
PTP 4 5' nucleic acid sequence from cDNA clones 
acaggg cag cttcaccctgcagtacgagtgg ctg acctgctg cag cacatcaaccag at 
gaagacagccgagg nctacggcttcaagcaagagtacgagagtttctttgaaggctggga 
tg ccaccaagaagaaag acaag ctgaag ag cg gccg g cag gagccagtgtctgcctatg 
accg acaccg agtgaag ctg cacccg atn ctgg gag accctgatg ccg actacatctct 
gccaactacatag acggctaccacaggtcaaaccacttcatag ccactcaag g n ccaaa 
gcctgagatgatctacgacttctgg cncatggtgtggcagg ag cag tgtgtag agatcgt 
catgatcagcaag ctg gtagaggtgggcagggtaaagtgctctcgatactg gcccgagga 
ctcagacatgtatggggacatcaagatcacg ctg gtaaagacagag acactgg ctg agta 
cgtggtgcgcacctttgccctg gag cg gag aggttactcagcccggcatgaggtccgcca 
gttccacttcacagcgtg gccagagcatggtgttccctaccatg ccac ng gg ctg ctgg C 
cttcatccggcncgtg a a g gcttccactccacctgatg ctg gg cctgttgtcattcactg 
cagtgcaggcact 
PTP 24 5' nucleic acid sequence from cDNA clone 18.1 
cctccaaaatcactcttcg cagtgaacaaaacg cag acatcggtcaccctg ctttgg gtt 
gaggagggcgtan ntg atttctttgaagtcctctgtcag aagctcgg gtctg gccacgat 
gg caaactccag g aaccggtag ctgtttcctcccacgtg gtgaccatctccag cctcctc 
ccagccactg cctacaactgcagtgtcaccag cttcag ccacg acagtccagtgtcctac 
gttca tag ctg tctccacaatggttacagag gtgaacctaatgtggtg g 
A 
PT? 24 5' nucleic acid sequence from cDNA clone 10.1116a.1 
gag gtgaaccctaatgtg g tggtgatctcggtgctggccatcctcagcatacttttaattg 
gactgctgttagtgacccttgtcattcggag aaagaagcacctgcagatg gccagggagt 
gtg g g gctgg cacgtttgtcaattttccatccttgg ag ag gg aagg gaaactcccctaca 
gttg gagtaaaaatg g cttaaagaagaggaaactgacgaaccctgttcagctg gacgatt 
ttg attcttacatcaag gacatggccaag gactctg actataaattctctcttcagtttg a 
ggagttgaagttg attg g actggatattccacactttgctgcagatcttccgct 
'gg' highlighted by bold print indicates the point at which the insertion was found in 
cDNA clone 16a. 1 (see below). 
PT? 24 83 base pair insertion present in cDNA clone 16a.1 
taggagtgtctttactttcttaaccctgctgccctcattctgtggactgactatctgttcgcattttatattaacccttg 
ctcccctacagttg.... gagtaaaaatggctt. 
Chapter III 
Sub 18 nucleic acid sequence 
aaacccctacaaatttg ag gaatgtggaaaggactttcagtattttg cat gccttaataat 
tcccatgggaatgtgcacactg gag aaaaattctgtgactgcaagg aatgttg g aaagcc 
ttcacg gtttcctcacacctaactcag catgtatcg attcacactg aagaaaaatcaaag 
gtgtaagatatgt 
IsJ 
Chapter IV 
Nucleic acid sequences of putatively unsubtractable clones 
mb6IlS 
a cat cttaattcttccag g gtttg gaattatttcacatgtagttacctattactctg g aaa 
aaaag aacccttcg gatatatag gtatg gtatgagccataatatctattg g cttcctag g  
tttattgtatg agcacatcacatatcacagtag g cctag atgtag acaccg a  cctactt 
acatctg ccactatatatcg caatcctacag gcgtaaag atttcag 
mbl2 
acg aatacag accgtg aaag cg  g  cctcacgatccttctg accttttgg gttttaagca 
g  aggtgtcagaaaagttaccacagg g ataactggcttgtggcggccaagcgttcatag c 
g ac  tcg ctttttg atccctttcgatg tcg g ctcttcctatcattgtg aag cag aattcac 
caagc 
C 
Chapter V 
NF-YB (ECU 9) rat nucleic acid sequence aligned with 3' end of published mouse 
cDNA 
C T T C C T G A T G C T T G A C T A A T T G A G G T G T T Majority 
10 	 20 
1 	C T T C C T G A T G C C T G A C T A A T T GAGGTGTT rat NF-YB (ECU 9) 
1 C T T C C T G A T G C T T G A C T A A T T G A G G T G T T mouse NF-YB 
A A T T C T G A C T T G A G A A T C T T T T T C A T G A A Majority 
30 	 40 	 50 
I I I 
30 	A A T T C T G A C T T G A G A A T C T T T T T C A T G A A rat NP-YB (ECU 9) 
30 A A T T C T G A C T T G A G A A T C T T T T T C A T G A A mouseNF-YB 
T G A T T T T A A A A G A A A A A A A A A T T G G A T T T Majority 
	
60 	 70 	 80 
I I 
59 T G A T T T T A A A A G A A A A A A A - - T T G G A T T T rat NP-YB (ECU 9) 
59 T G A T T T T A A A A G A A A A A A A A A T T G G A T T T mouseNF-YB 
T A A A G G G T A T T A A A A A T A T T T T T G T T T T G 
I 	 I 
Majority 
90 100 	 110 
86 T A A A G G G T A T T A A A A A T A T T T T T G T T T 7 G rat NP-YB (ECU 9) 
88 TAAAGG - TATTAAAA - TATTTTTGTTTTGrtCuseNP-YB 
TACGAGAGTTTGTTGCTCTGTATGACGCC 
I 	 I 
Majority 
120 130 	 140 I I 
115 T A C G ? G AG T G T G T T G C T C T G T - - GAO G C C rat NP-YB (ECU 9) 
115 T A C G A G A G T T T G T T G C T C T G T A T G A C G C C mouseNP -YB 
T G T A T G C A T T G T A T A T T G C G A T T T A T T A C 
I 	 I 
Majority 
150 150 	 170 
142 T G T A T G C A T T G T A T A T T G C G A T T T A T T A C rat NF-Y3 (ECU 9) 
144 T G T A T G C A T T G T A T A T 7 7 C A A T T T A 7 T A 0 mouse NP-YB 
TGTC AG AGATTT G 	AGAC AG T T T C TTATT Majority 
153 	 190 	 230 
I I 
171 T G T C A C A GA T T T G T A G A C A G T T T C T T A T •T rat NP-YB (ECU 9) 
173 TGTCAGAGATTTGTAGACAGTTTCTTATT mouseNF-YB 
7 T C A T A T T G A A T C A T G T C A T T T G T A A T T C Majority 
210 	 220 	 230 
200 T T C AT AT C GA A TO AT G C TAT C T G T A AT T C rat NP-YB (ECU 9) 
202 T T C A T A T C G A A T C A 7 G C T A T C T G - A A T C C mouse NP-YB 
AA G A A CACAO T G T G C TO CTGC TT GATT GA Majority 
240 	 250 	 253 
I I 
229 AAGAAGAGACTGTGCTCTTGCTTGATTGA rat NF-YS (ECU 9) 
230 A A G - - - - - - - - - - - - - - - - - - - - - - - T A A mouse NP-YB 
CAGACACTTACAAGTTCATTTTTGCTGGG Majority 
270 	 280 	 290 
258 C AG A C A C T T AC A AG T T C A T T T T T G C T G G G rat NP-YB (ECU 9) 
236 C A G - - - - - - - - - - - - - - - - - - - - - C T C G G mouse NP-YB 
T T A A C T A A A T A C G T A T C C C T A A C A T A A C T Majority 
300 	 310 
287 T T A A C C A A A T A C G C A T C C C T A AT A T A AT T rat NP-YB (ECU 9) 
244 T T A A T T - - - - - - - - - - - - - - - - C A T A A T - mouse NP-YB 
IC 
GTTGGT TTAGAGGTT G A A A T G CGTTCTTT Majority 
I 	 I 	 I 
320 330 340 
I 	 I 
316 G T T G G T T T AGAGGTTGAAATGCCGTTCTT rat NF-YB (ECU 9) 
256 - - - - G T T T A - - - - - - - - - - - - - - - - - - - - iuse NF-YB 
TATTCT CAC TGGCCTCAAATTCACTGATA Majority 
I 	 I 
350 360 	 370 
345 TATT C TCAC TGGCC T C A A A T T C A C T G A T A rat NP-YB (ECU 9) 
261 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - rtuseNP-Th 
ATTTTCTCTAAACTAATAAGTGGGTGAGA Majority 
I 	 I 
380 390 	 400 
374 ATT TT C T C T A A A C T A A T A A C T G G G T G A G A rat NP-YB (ECU 9) 
261 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - mouse NP-YB 
T A A C C T C T G T C G T T A C C C A C T G C C C G C T C Majority 
I 	 I 
410 	 420 430 
I I 
403 T A A C C T G T G T C G T T A C C C A C T G G C C G C T C rat NP-YB (ECU 9) 
261 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - mouse NF-YB 
C T A A A C T G G T T T C C A G T C A T C T C C T T T A T Majority 
I 	 I 
440 450 	 460 
I 	 I 
432 C T A A A C T C G T T T C C A G T C A T G T C C 7 C C A T rat NP-YB (ECU 9) 
261 - - - - - - - - - - - - - - - - - - - - - - - CCTTATrrouseNF-YB 
AATGTGATTTTTTTATAAATTGAGGGTAA Majority 
470 	 430 	 490 
461 A A T G T G A T T T T T T T A T A A A T T G A G A G T A A rat NP-YB (ECU 9) 
267 	AATAT - - - - - - - - - - - - -  - -- -  ..AGGGTA - mc use NF-YB 
T A T G T A T A T T G A A G A T C A A A T A A A G A T G T Majority 
500 	 510 	 520 
490 TATGTATATTGAAGATCAAATAAAGATGT ra:NF-YB (ECU 9) 
278 - - - - - - - - - - G A - - - - - - - - - - - - - - - G T mouse NP-YB 
T C T T T A A G T G A A A A A A A A A A 	 Majority 
50 540 
519 T C T T TA AG T GA A A A A A A A A A 	 rat NP-YB (ECU 9) 
232 	T  - - - - - - - - AAAAAAAAAA mcuseNF -YB 
Motifs which may act as polyadenylation signals are underlined. 
E 
A selection of EC clones which were used as probes on Northern blots. Not all 
represent full sequences of the clones. 
ECU 2 nucleic acid sequence 
cacagtggtgaaggacctggcacagaactcataagcgtctcctcgcaaagggctttccac 
acctcgcctggtcacactcgatgcctatttctactgaccaagttgaagaacaccctctac 
tgaccttagaaacacacgcactctcatacagacacatgaacctttgga 
ECU 11 nucleic acid sequence 
ggactacaattcgcg g ccgcttttttttttgaagcagctg gttctttgtattccgtcacta 
aaaacacaagagctctacaggcacagcag cttactcacacacactcgaactgcaccaga 
ctgtagcaaatggagaaagatggatgccttcaagttcactgggtggaactatgaaaagta 
gaccttgggaatctcttg 
ECU 12 nucleic acid sequence 
cggttacttctatttctctaagcaagcgttctttgttg gtgaccg gagttgctagtccaga 
aggaacagactgagtgagcgaggtccaaaaggggtgatcaatgactggccccgcttcaa 
gcagttggagacagagcagagggaggagcagtgccgggagatggagcgctgatcaaaag 
ctgtctatgagctgccag gtcccatctg 
ECU 15 nucleic acid sequence 
cttatggacataaggacacaggggcatcatcaaaggagggaaaagagaaaaaagagaag 
cataagacgaagacgccccaacagattgccaaggacatg gag cggtgggcccgagtctc 
aacaagcaaaagaaacttcaaaacgcttccagcctattagt 
ECU 35 nucleic acid sequence 
tctatatattcttggctgcctttg aattcactttgtagacgaggctgacctcgaactcaga 
acctctgg aag agcttaacacat 
ECD 26 nucleic acid sequence 
tttgtttgtttaaagatcctaacagaacatagcctaacagtactggtcttccagttttatt 
catttcaattatgtgtagtgcgctgagcagaaccactgtgtgttacttctttaaagagctg 
ctacactttaaatgttcatagctagatg gccagcccttcagtgtgtacttgaataatatat 
ECU 8 nucleic acid sequence 
ctccaatagagacaccagaagcccaaaatagaggctttctcgagggactatttg 
agtaaacaaatcgcctaa cat gtcctgaatattatcacacatttcttgg ctatatgttaac 
cgttgaattc 
Region highlighted by bold print is homologous to that in the captured cDNA fragment 
below (1.1 kb). 
F 
ECU 21 nucleic acid sequence 
tgatgtgtctcttgataaagccctcgatgagctgatg gat ggtgatat cat cgtgtttcag 
aaggatgacccggaaaactataacagtgagtagtccgaattc 
1.1 kb 'captured' nucleic acid sequence containing region of homology to ECU 8 
atg aag gacagg cattataccttgtctccccaactg aaattcaacggttaacatatagcc 
aagaaatgtgtgataatattcaggacatgttaggcgatttgtttactcc aacaatag a  
acaccagaagcccaaaata gag gctttctcaagggactatttggtggaagtggac 
agacatttgacagagaagaactctttggggaagcctcagcaggaaaagcatctcgcagc 
ctcgcacagcacattcctggaccgggcagcatagaagggatgaagggcgctgctggcgg 
ggtgatgg gag agctaacccgagcccggattgcacttatgagagagggcagcgtctgggt 
gag ctg gag gag aagactgcaggcatgatgaccagtgcagaagcatttgccaagcacgC 
acacgagctaatgctgaaatataaggacaagaaatggtaccagttctaacttttaccttc 
taaagaagctgtggtgctctgagaaccagtattcagggaaaccaaattgattcccagcat 
cacgattcaactgctagaaccagtttcttctacaa gat gtcc cat atagtccatctgaagt 
tctcgtaaag gag acttctccaaggcagaagcactgcacaacaaaaggctggaccctgg 
ttaaaatcccaag agatg gccgaacctgtcttttccccacgag gaatg aatattatcatc 
ttg g cat gtaacttgttaagaattcatgtttgg aa act atgggg agtccttttg atttg aat 
ttcctgtacaaacaaaagcattaatgcgcttaatgaaaattctttgcatgataaattaaCa 
tcttaagaggaaagaaacaaagcatgttataacagaaggaaaggatttatggtaaactac 
tttcacgaattgggccacacccaacaattttaaaatctgcgttagaa gat atgagtgcatt 
tcaagtgtatttgccctacccaaccgaaggaatcaaaacatacccagattttcttctcat 
ctgaa act ctccttatatactagaa cat act g aattctta cat caagaatccgattaatgt 
ttctctctctctcgtatttca cat cacttacag 
Region highlighted by bold print is that which is found in the first half of ECU 8. 
700 bp 'captured' nucleic acid sequence containing region of homology to ECU 21. 
From 5' end 
act gtggacacatctacacacccatatctgtaaaatacgtgacttgctcccggttatgtgt 
gacagagcaggatttatccaggatactagccttatctctatgaggaagttgagccgaatt 
taacaga gag aattcaggactat gat gtgtctctt gat aaagccctc gat gagct 
gat g gat ggtgacatcatcgtgtttcagaag gat gacccggaaaacgataac 
agtgag 
Region highlighted by bold print is that which is identical to ECU 21. 
G 
From 3'end 
cgg act act ccacgg cttttttacattcttctaacaggtcccg gacacagccatgcttctc 
tgg gtatagtgttatttcctcttccctaaattg gctgtttaaccatatacacttaaaacttc 
tcctgttctcaaagtccgtgattttcatcttaagctgctgatagtaaagtttcttaggttgt 
cttg gcttgaag aattgtag aag atctcttaaagtaccttcgtaattatg cctaagg gg at 
taccggggccgtccctataaccttg agacttgaaaaactgaagcaacatggggtcgtgtt 
gagcctc 
41 
